data_1wki_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wki _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 100' ' ' GLY . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 42' ' ' ILE . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 HG12 HG11 ' A' ' 106' ' ' VAL . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.4 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.44 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.88 0.371 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.461 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.406 HG11 HG12 ' A' ' 64' ' ' ILE . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 58' ' ' PHE . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.413 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 ' CD1' ' CD2' ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.432 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 68' ' ' ILE . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.445 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.416 ' CG1' HD13 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.426 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' HG13 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo . . . . . 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.945 0.402 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' CB ' HG13 ' A' ' 97' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 58' ' ' PHE . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' MET . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG23 ' HA2' ' A' ' 100' ' ' GLY . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.553 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CG ' HG13 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG12 ' CB ' ' A' ' 101' ' ' ARG . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.437 ' CB ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.42 HG13 ' CG ' ' A' ' 58' ' ' PHE . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.418 ' HE3' ' CZ ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' MET . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.45 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' THR . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 25.0 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.409 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' HG12 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 54' ' ' MET . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 68' ' ' ILE . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.904 0.383 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.404 ' CD1' ' HA2' ' A' ' 122' ' ' GLY . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.427 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 58' ' ' PHE . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.413 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.4 ' CA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.555 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.421 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.452 HD11 HG21 ' A' ' 68' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 HG11 ' CA ' ' A' ' 43' ' ' THR . 1.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.397 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.4 ' HE2' ' CE1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.407 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.441 ' HE2' ' CD2' ' A' ' 104' ' ' PHE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.406 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 58' ' ' PHE . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.419 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 42' ' ' ILE . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.438 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 68' ' ' ILE . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 43' ' ' THR . 4.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.922 0.391 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.427 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.407 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.417 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.427 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.553 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.436 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD1' HG12 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 26.9 Cg_exo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' TRP . 2.2 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.418 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG1' HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.436 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.55 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.422 ' HE2' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.425 HD13 ' CE2' ' A' ' 104' ' ' PHE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 43' ' ' THR . 1.6 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.802 0.334 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 106' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.444 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 ' HA2' ' A' ' 100' ' ' GLY . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.55 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 104' ' ' PHE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.422 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 58' ' ' PHE . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.419 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 119' ' ' ARG . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 33' ' ' GLY . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 3.2 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.463 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.42 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.929 0.395 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 101' ' ' ARG . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 58' ' ' PHE . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.438 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.43 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ARG . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' HG13 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 43' ' ' THR . 2.3 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 ' CD1' ' A' ' 58' ' ' PHE . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.4 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.431 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.433 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 117' ' ' ALA . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.453 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.858 0.361 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.549 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CG ' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 66' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.832 0.349 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 104' ' ' PHE . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.434 HG11 ' CG ' ' A' ' 58' ' ' PHE . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 104' ' ' PHE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.891 0.376 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CG2' ' A' ' 129' ' ' THR . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.422 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.441 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 117' ' ' ALA . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.99 0.424 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 58' ' ' PHE . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.402 HD11 HG22 ' A' ' 129' ' ' THR . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' A' ' 129' ' ' THR . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.41 ' CA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CB ' ' HB3' ' A' ' 41' ' ' TRP . 1.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.959 0.409 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.422 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 1.3 ttt180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.4 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 104' ' ' PHE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 101' ' ' ARG . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.47 ' CB ' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.433 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.229 -0.009 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.439 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.428 ' CG ' HG13 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 21.6 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.912 0.387 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG11 ' CB ' ' A' ' 101' ' ' ARG . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.42 ' CB ' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.439 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG1' HD13 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 58' ' ' PHE . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.409 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 54' ' ' MET . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.433 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.428 HG11 ' CG ' ' A' ' 58' ' ' PHE . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.551 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.406 ' HG2' HD22 ' A' ' 125' ' ' LEU . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 104' ' ' PHE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.45 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 58' ' ' PHE . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 46' ' ' GLN . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 33' ' ' GLY . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.411 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 46' ' ' GLN . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' HA ' HG13 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.549 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.453 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 43' ' ' THR . 2.5 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.436 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.424 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.526 0.021 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.416 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CD1' HG12 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.355 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.457 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' A' ' 58' ' ' PHE . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.418 ' CD1' HG21 ' A' ' 96' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.466 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.437 ' CD1' HG12 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 25.3 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.418 HG21 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.429 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.466 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 114' ' ' ALA . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.406 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.409 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.413 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.4 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CG ' HG13 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.455 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG13 ' CB ' ' A' ' 101' ' ' ARG . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.416 ' CB ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.447 HG13 ' CG ' ' A' ' 58' ' ' PHE . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.408 ' HE1' ' CZ ' ' A' ' 32' ' ' TYR . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HA2' ' A' ' 100' ' ' GLY . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' HG13 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.4 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.965 0.412 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.416 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.426 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.429 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.418 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 104' ' ' PHE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo . . . . . 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 ' CG1' HD12 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.405 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.06 -38.56 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mmm -140.02 88.05 12.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.78 171.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.589 2.192 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -112.4 44.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -157.43 -44.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.45 147.7 50.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.828 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.22 100.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -93.37 145.97 24.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -146.63 172.56 13.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.79 164.45 24.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -102.62 120.5 40.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 60.62 160.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.79 -41.95 2.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -68.11 163.97 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.43 121.63 8.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -82.08 -27.57 32.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.92 -83.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.61 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 67.96 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.06 98.41 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.12 27.94 3.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.54 85.49 1.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.46 131.09 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -112.5 -48.96 2.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -161.6 -68.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.643 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 61.72 118.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.273 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 62.3 142.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.03 -173.14 55.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.03 -31.84 9.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 100' ' ' GLY . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 42' ' ' ILE . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 HG12 HG11 ' A' ' 106' ' ' VAL . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.4 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.44 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 122.32 8.75 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.26 -46.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 124.74 89.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.01 151.45 27.31 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.09 . . . . 0.0 112.19 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -122.87 99.08 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.6 p -119.17 143.94 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.049 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.73 31.35 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 121.89 39.63 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.76 -56.33 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.457 2.105 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mt -114.52 132.51 56.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.71 33.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -87.58 110.52 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 60.74 32.33 20.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mmm -138.21 134.85 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.16 163.84 9.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -95.14 18.09 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.34 -74.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.14 128.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.9 159.94 53.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -74.93 111.72 10.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.51 141.26 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.72 46.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.8 -177.81 46.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.89 157.35 24.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.33 170.15 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.461 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.406 HG11 HG12 ' A' ' 64' ' ' ILE . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 58' ' ' PHE . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 137' ' ' TYR . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -77.42 165.31 24.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.04 89.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 133' ' ' ARG . 11.1 t0 66.69 44.7 2.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.014 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.657 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.74 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.657 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.9 m-85 -126.81 113.42 16.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.38 160.37 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -73.23 147.82 44.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.57 101.03 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.847 0.356 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.44 103.27 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.754 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -141.53 105.34 5.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.76 56.96 4.87 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.486 2.124 . . . . 0.0 112.621 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.27 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -132.78 168.46 18.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 mtt -63.51 144.19 57.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -59.88 -64.91 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.12 44.46 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.7 124.28 27.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -86.26 142.16 28.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 117.52 34.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -114.44 160.62 18.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.42 46.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.42 51.32 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.429 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.15 147.46 39.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.87 85.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -27.53 28.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.1 -156.7 40.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.16 104.51 12.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -102.26 -28.92 11.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 151.12 51.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.975 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.2 -48.41 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.582 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.87 129.55 2.07 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.539 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.91 144.63 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -114.39 -48.13 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.867 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -164.79 -41.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.616 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 74.84 -73.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.213 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.73 164.93 27.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.21 162.91 31.66 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -76.31 -30.59 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 ' CD1' ' CD2' ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.432 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 68' ' ' ILE . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.95 105.49 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.97 -44.85 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -66.91 143.98 98.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.045 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.74 149.85 43.8 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.546 2.164 . . . . 0.0 112.373 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -106.24 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.2 p -119.44 105.01 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -87.43 81.17 7.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 117.77 65.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.05 157.33 62.16 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.063 . . . . 0.0 112.275 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.36 118.44 22.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.08 121.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 102.34 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.35 -170.24 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.0 tpt -73.26 145.86 45.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.91 142.76 25.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.11 18.06 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.47 -101.11 2.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -45.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.37 -143.67 17.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -122.18 143.71 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -90.32 147.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -94.65 43.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.14 -164.36 42.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.63 147.47 45.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.17 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.445 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' CG1' HD13 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG22 ' CE1' ' A' ' 137' ' ' TYR . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -79.09 165.47 23.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -47.4 90.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.251 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.6 t70 66.77 44.09 2.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.136 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.646 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.68 94.49 4.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.401 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.646 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.8 m-85 -126.83 106.76 9.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.947 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -98.77 148.91 23.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.02 120.68 17.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.29 98.86 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.9 mp 59.47 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.74 109.76 43.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 173.82 8.9 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.236 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.73 89.52 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -140.35 32.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 103.79 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.64 31.77 2.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -149.07 162.29 40.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.29 149.72 26.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.99 33.71 2.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -93.51 113.31 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.88 121.8 41.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -84.69 118.87 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.87 -34.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -91.05 160.0 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.53 136.24 36.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -27.65 18.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.042 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.11 3.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 164.5 3.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.42 105.17 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 43.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.557 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.68 102.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.41 130.87 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' A' ' 27' ' ' VAL . 20.5 t80 -83.53 -75.6 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.993 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 26' ' ' TYR . 53.1 t -157.36 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.788 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 50.29 -173.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.349 . . . . 0.0 111.4 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.71 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.56 13.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.642 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -58.48 -41.46 85.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' HG13 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.78 111.08 2.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.5 -44.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 135.04 86.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.697 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 160.66 46.21 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.392 2.062 . . . . 0.0 112.251 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 2.8 t80 -126.08 92.49 3.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.6 p -119.23 107.75 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.134 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 5.3 mmtp -139.75 101.37 4.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.56 94.41 44.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.0 -45.01 44.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.489 2.126 . . . . 0.0 112.204 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.64 155.38 40.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.14 84.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.5 t -87.26 129.0 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 59.01 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 62.6 mtp -144.78 130.83 19.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.39 85.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -105.95 17.98 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.15 44.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -162.77 118.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.34 144.47 16.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -124.09 127.52 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 p -106.04 124.94 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.086 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -93.8 46.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.85 175.75 42.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.367 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.62 161.89 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.17 172.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.225 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' CB ' HG13 ' A' ' 97' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 58' ' ' PHE . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' MET . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.536 ' C ' ' H ' ' A' ' 135' ' ' ASP . 4.8 ttt180 -68.19 165.62 17.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -56.88 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.3 m-20 -164.12 26.44 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.601 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -115.6 93.98 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 3.8 m-85 -128.29 104.06 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -85.9 96.67 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -72.18 170.61 13.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.72 96.49 6.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.913 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.816 0.341 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.33 82.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 mmm -135.24 109.72 10.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 168.13 19.78 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.335 2.023 . . . . 0.0 112.313 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 61.17 96.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -164.47 89.17 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.9 mtt -81.96 169.3 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.26 117.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -108.51 152.29 24.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 108.56 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.56 156.56 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 128.22 35.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.55 130.28 43.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -76.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.56 -95.72 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.621 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 163.23 22.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.08 142.14 30.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -88.1 -27.56 21.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.53 -119.95 1.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.644 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.18 164.51 3.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.12 -174.5 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.42 178.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.22 116.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.569 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.77 144.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.24 102.88 1.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.402 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.9 p90 -107.42 -38.8 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 25.2 t -159.96 145.97 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.79 -72.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.439 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -138.59 -56.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.37 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.59 155.16 0.73 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.049 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -54.89 -32.94 61.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG23 ' HA2' ' A' ' 100' ' ' GLY . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.553 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CG ' HG13 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.93 104.42 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.59 -42.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 129.58 94.03 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.83 157.28 29.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.498 2.132 . . . . 0.0 112.168 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -127.0 101.96 6.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.9 p -119.09 127.07 53.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -86.75 111.74 21.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.2 94.38 30.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.53 176.96 8.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.422 2.081 . . . . 0.0 112.252 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.39 128.62 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 60.64 75.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.924 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.67 127.32 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -35.89 14.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -102.83 31.15 4.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.72 96.46 0.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.67 18.12 22.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.7 0.286 . . . . 0.0 111.287 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.58 -117.0 0.79 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -125.29 110.27 13.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 0.0 110.803 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.69 -137.79 7.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -71.41 133.61 46.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.332 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.36 137.48 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.67 52.0 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -173.94 49.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -115.73 151.31 35.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.84 155.73 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.186 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG12 ' CB ' ' A' ' 101' ' ' ARG . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.437 ' CB ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.42 HG13 ' CG ' ' A' ' 58' ' ' PHE . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.418 ' HE3' ' CZ ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' MET . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.45 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 137' ' ' TYR . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -80.3 165.5 22.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -46.84 89.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.3 t70 65.48 45.83 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.014 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.635 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.8 94.29 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.635 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.9 m-85 -127.03 101.0 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.985 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.02 93.53 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.05 141.85 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.8 106.87 19.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.906 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.782 0.325 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.93 137.75 20.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.06 93.51 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.527 2.151 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.03 96.05 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -92.67 127.37 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tpt -93.72 169.78 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 148.28 38.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -165.42 35.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.991 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 162.5 14.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 65.83 126.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -73.99 166.89 22.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -85.2 118.22 24.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 60.49 179.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.62 -47.06 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -137.73 139.38 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.78 31.22 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -27.53 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.27 24.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.58 158.53 22.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 111.059 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -150.35 77.75 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.35 152.54 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.59 91.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.61 136.54 16.11 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 141.57 53.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.3 p90 -107.66 -46.15 3.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 18.0 t -161.09 -49.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.677 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.55 -69.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.486 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -122.38 169.2 11.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.8 148.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.685 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.79 -38.46 85.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' THR . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 25.0 Cg_exo -62.82 106.79 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.33 -46.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 120.08 78.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.7 141.78 52.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.266 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.89 100.23 8.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.7 p -119.31 130.65 55.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -91.41 115.18 27.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.935 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -107.22 94.35 11.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.61 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.479 2.119 . . . . 0.0 112.248 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 tp -74.63 121.13 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 62.39 85.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.23 137.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.178 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -87.2 -79.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.6 mtp 55.02 179.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.75 29.25 64.13 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.33 -18.13 14.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 111.169 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.67 -53.92 0.15 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -162.38 145.31 11.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.79 106.42 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -70.11 138.78 52.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.0 157.82 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.96 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.78 -173.11 53.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -123.29 164.01 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.0 167.74 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.409 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 137' ' ' TYR . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.02 165.55 21.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.93 88.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.425 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 133' ' ' ARG . 2.6 t70 66.73 44.06 2.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.984 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.69 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.78 94.43 4.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.392 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.69 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.8 m-85 -126.83 116.19 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -103.88 157.54 17.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.51 107.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.56 98.26 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.904 0.383 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.18 168.14 19.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.73 148.1 34.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.32 113.37 3.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.76 104.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -83.03 -32.29 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -94.32 130.42 40.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt 61.67 153.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.3 167.58 10.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -80.75 124.41 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.16 107.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.26 135.03 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.57 125.58 42.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.43 159.97 8.92 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.502 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 60.76 157.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.1 122.64 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -27.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.53 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 134.18 56.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.314 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.13 33.41 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -104.92 144.35 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.36 -176.62 21.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.442 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.1 -102.85 2.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.0 128.09 27.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.34 -47.61 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.981 0.42 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.0 t -160.25 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.812 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.21 -69.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -124.62 168.42 13.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.174 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.36 154.64 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.634 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -66.29 -33.31 75.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' HG12 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 54' ' ' MET . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 68' ' ' ILE . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo -72.83 104.41 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.21 -40.21 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -78.41 130.31 71.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.798 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 147.67 63.65 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.42 113.7 24.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.2 p -118.78 131.21 56.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -96.6 72.14 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -113.66 94.35 32.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.56 -171.37 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.41 2.073 . . . . 0.0 112.298 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 133.37 42.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 60.13 101.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.16 119.71 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -97.34 168.3 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 ttt 60.88 36.23 19.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.64 -165.94 16.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.503 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -100.14 -18.04 17.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.266 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.1 -98.64 1.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.75 109.24 2.03 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.583 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -135.58 154.22 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.796 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.96 129.93 56.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -93.22 55.73 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.43 -175.92 5.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.426 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -107.13 163.98 12.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.29 171.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.354 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.404 ' CD1' ' HA2' ' A' ' 122' ' ' GLY . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG23 ' OH ' ' A' ' 137' ' ' TYR . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -76.32 165.47 24.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.185 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.8 t0 67.05 44.92 1.85 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.971 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.652 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.77 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.487 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.652 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.9 m-85 -126.93 108.53 11.05 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.78 114.89 26.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.85 103.72 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.55 95.25 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.182 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.958 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.5 157.05 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.31 145.16 30.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.21 -23.9 17.46 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 112.39 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 64.21 164.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.55 116.61 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 mtm -86.25 167.15 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -94.06 177.64 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 62.97 77.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -111.98 118.19 34.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.27 81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.006 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -106.05 116.89 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.95 115.56 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -72.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.31 -78.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -174.91 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.1 -167.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -78.85 -7.89 58.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.384 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.77 76.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.565 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 133.75 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 111.112 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -83.7 -178.45 7.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -65.15 175.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -37.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.91 -129.36 1.85 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.66 -177.74 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.467 . . . . 0.0 110.996 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -136.7 116.16 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.536 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 26' ' ' TYR . 3.0 t -25.75 -47.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.102 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 73.09 -77.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -115.91 163.12 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.05 136.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.693 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -26.92 63.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.89 106.71 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -129.1 21.36 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.1 119.68 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.36 142.45 47.29 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.373 2.049 . . . . 0.0 112.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.53 95.99 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 p -119.26 147.09 44.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -137.45 50.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.429 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -108.72 138.62 20.34 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.897 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.4 177.91 7.73 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.476 2.117 . . . . 0.0 112.285 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.05 116.55 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -163.2 -52.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.31 147.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 38.77 3.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.98 149.98 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.08 158.8 22.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 -18.14 22.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.146 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 139.95 -58.25 0.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.489 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 -30.74 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.61 132.02 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.57 69.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 p -74.75 150.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.25 50.03 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.826 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.2 178.11 2.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.7 164.05 12.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m -128.99 174.4 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.327 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 58' ' ' PHE . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.413 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.23 165.69 21.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -45.07 88.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 70.31 40.32 1.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.481 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.586 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.7 94.83 4.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.899 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.4 m-85 -126.43 92.82 3.64 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -115.92 130.88 57.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.14 104.41 3.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.15 94.95 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.9 0.381 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.98 -67.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.92 112.61 26.22 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.64 125.63 7.66 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.45 2.1 . . . . 0.0 112.374 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.64 134.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 58.32 106.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.36 129.8 36.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -67.52 -30.98 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.71 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.27 154.61 18.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -127.0 -45.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -66.46 120.34 13.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 155.67 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -109.59 168.48 9.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.75 -72.92 0.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -115.37 176.82 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.58 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.824 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -82.32 -27.48 32.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.83 -94.56 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.11 115.07 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -108.27 32.94 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -84.27 148.69 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 25.92 8.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.36 171.4 13.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.548 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -94.9 17.47 13.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.688 0.28 . . . . 0.0 111.399 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' A' ' 27' ' ' VAL . 91.9 t80 51.39 -92.48 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.167 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 4.6 t -165.26 -79.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.4 . . . . 0.0 110.047 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 51.79 176.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.827 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 62.91 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.509 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.28 168.9 21.25 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.891 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.03 -41.27 86.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.4 ' CA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.555 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.421 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.452 HD11 HG21 ' A' ' 68' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo -71.09 108.88 2.43 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -120.89 -41.55 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 126.84 87.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.95 155.11 57.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.424 2.083 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -127.5 88.76 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.209 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.4 p -119.43 135.76 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.62 121.02 18.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 147.56 45.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.47 125.67 11.46 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.71 126.62 29.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 65.9 -68.8 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.9 148.77 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.23 147.62 47.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.8 ttm -164.21 177.22 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.33 172.65 21.58 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -96.02 18.07 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.619 0.247 . . . . 0.0 111.152 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.31 -148.38 5.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 -31.79 11.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.51 134.03 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.412 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.74 152.0 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.12 138.27 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.049 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.34 47.56 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.91 178.81 31.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.483 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.34 163.46 12.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 HG11 ' CA ' ' A' ' 43' ' ' THR . 1.4 m -137.81 174.62 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.4 ' HE2' ' CE1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.407 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -92.55 118.48 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 42.14 -104.42 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.494 0.664 . . . . 0.0 111.801 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.78 46.12 0.94 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.108 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.72 93.88 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.354 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 3.0 m-85 -127.84 117.5 21.94 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.91 94.47 6.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.75 103.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.75 98.74 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.844 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.15 176.75 7.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.11 102.2 37.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -51.59 -176.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 62.57 112.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 170.58 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.42 172.6 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 59.99 157.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.66 127.82 32.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.94 152.5 27.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -24.23 67.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -63.97 129.87 41.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.48 142.81 44.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.73 -44.73 6.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.826 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.16 155.24 21.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 60.17 160.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.73 -178.24 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 23.53 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.09 67.91 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.39 153.63 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 p -80.61 -31.57 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -130.52 103.79 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.76 148.26 19.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.61 179.65 33.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -21.34 25.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.698 0.285 . . . . 0.0 111.103 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 41.8 t80 69.43 -99.06 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 4.9 t -168.88 126.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 29' ' ' PHE . . . -50.52 -70.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.754 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 71.2 m-85 -158.61 -47.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.05 157.02 2.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.828 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.89 -36.93 65.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.441 ' HE2' ' CD2' ' A' ' 104' ' ' PHE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo -71.38 104.39 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.18 -47.13 2.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.19 142.13 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.59 153.57 44.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.422 2.082 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.41 87.42 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 p -118.98 139.08 52.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -108.3 63.63 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 94.21 45.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.05 -58.53 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.697 2.265 . . . . 0.0 112.218 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.49 143.32 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.4 -177.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.61 148.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -57.95 -31.12 66.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -88.35 148.09 24.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.92 -156.59 23.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -85.11 -18.14 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.36 42.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -177.4 151.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.46 135.73 1.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.571 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -84.88 94.6 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -80.2 136.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.12 60.08 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.3 -154.65 52.69 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -123.99 149.67 45.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.49 172.57 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.294 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.406 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 58' ' ' PHE . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.419 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 137' ' ' TYR . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -75.78 165.39 25.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -48.89 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.112 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 133' ' ' ARG . 24.3 t0 73.63 38.92 0.59 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.621 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.88 94.16 4.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.1 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.621 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 2.1 m-85 -127.19 119.05 25.52 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.031 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.2 94.74 9.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.68 112.62 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.46 104.38 11.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.859 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.4 120.79 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.59 127.49 60.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.74 132.26 48.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.413 2.075 . . . . 0.0 112.258 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -84.25 99.26 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 60.98 -175.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mtt -63.41 122.68 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -68.2 110.95 4.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 166.67 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.17 119.37 36.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -120.64 -54.45 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -64.0 152.33 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -107.22 149.7 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.08 5.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.01 153.81 34.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.8 166.21 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.9 133.73 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -96.43 23.53 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -96.28 178.26 34.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -59.11 172.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.18 151.95 33.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.23 -179.29 16.51 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.96 108.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.29 154.13 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CB ' ' A' ' 27' ' ' VAL . 3.8 t80 -179.4 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' TYR . 39.7 t 123.07 -80.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.294 0.996 . . . . 0.0 109.93 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 56.55 167.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.476 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 3.9 m-85 62.63 -79.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.91 165.01 30.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.69 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -71.96 -26.08 62.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 42' ' ' ILE . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.438 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 29' ' ' PHE . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 68' ' ' ILE . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.8 112.16 3.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -132.02 -45.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 126.18 89.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.38 171.48 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 2.3 t80 -124.5 86.1 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.9 p -119.32 128.56 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -104.93 30.79 5.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 96.73 40.46 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 149.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.577 2.185 . . . . 0.0 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.47 134.49 34.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.35 -46.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.94 134.69 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.96 92.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.7 88.14 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.13 136.15 7.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.424 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -87.1 -18.14 31.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.92 -88.69 2.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 157.11 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.28 -160.46 31.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.487 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -59.54 119.02 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.38 137.07 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 mm-40 -87.0 55.64 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 -170.28 28.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.92 157.42 18.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 43' ' ' THR . 4.0 m -146.07 174.49 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.137 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.407 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.417 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.87 165.42 21.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.84 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.4 t70 71.96 37.68 1.0 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.705 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.583 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.75 94.89 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.743 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.583 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.4 m-85 -126.38 89.96 3.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.68 129.13 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.49 107.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.39 94.83 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.049 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.906 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.22 106.04 2.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.88 116.35 58.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.2 -28.02 19.19 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.427 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -165.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 64.1 99.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 ptp -80.0 115.45 19.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.83 -35.63 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -88.56 -179.9 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.65 132.65 53.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -122.4 114.2 20.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -88.05 137.86 31.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.8 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -164.32 102.11 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.61 68.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.35 164.01 14.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 -170.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -88.94 -27.5 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.54 89.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.23 164.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 0.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.94 140.68 49.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 153.74 30.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.88 -172.09 25.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.573 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 58.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -176.08 4.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.976 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -139.43 117.62 11.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.763 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' TYR . 6.3 t -28.56 -74.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.843 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 63.06 126.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.206 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 59.58 96.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.57 167.82 18.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.07 -38.72 15.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.553 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.436 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD1' HG12 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 26.9 Cg_exo -62.33 129.37 26.61 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.46 -46.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -76.86 111.41 16.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.69 124.54 10.32 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.348 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 8.2 p90 -102.41 144.41 30.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.598 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 p -118.79 135.96 54.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.124 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -142.25 113.54 7.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -112.68 94.37 28.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.66 -42.8 63.96 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.555 2.17 . . . . 0.0 112.223 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 161.53 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.32 154.07 42.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.52 154.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.87 -46.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.15 103.34 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.96 95.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -18.04 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.664 0.268 . . . . 0.0 111.227 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -156.65 57.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -145.14 61.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.82 109.37 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -95.11 95.71 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.1 p -65.09 137.03 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.66 28.81 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.31 171.78 13.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.417 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.32 158.23 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' TRP . 2.2 m -136.11 173.83 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.418 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG1' HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.436 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.453 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -87.13 165.86 15.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -43.99 87.99 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.713 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.4 t0 69.25 40.25 1.55 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.494 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.58 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.76 95.01 5.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.4 m-85 -126.24 112.9 16.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.89 116.0 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.02 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 131.95 40.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.03 97.04 8.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.8 0.333 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.72 -45.99 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mmt -113.26 90.07 15.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -51.08 173.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.506 2.138 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -73.64 136.98 43.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -132.26 100.58 5.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.58 154.32 40.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 113.44 7.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 60.65 51.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -110.98 118.12 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -114.36 148.74 37.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.11 164.65 10.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.92 117.14 33.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -47.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.31 140.57 11.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 60.35 164.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.44 141.42 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -27.61 17.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.86 -58.97 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.53 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.69 140.7 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.102 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.06 59.18 5.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -116.86 173.11 6.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.34 -43.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.521 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.51 -109.33 1.84 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.356 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.12 118.35 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.311 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.477 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.4 p90 -107.88 -50.33 3.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 2.5 t -170.99 132.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -108.84 99.83 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 62.12 170.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.01 -173.35 35.36 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.46 -42.88 7.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.55 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.422 ' HE2' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.425 HD13 ' CE2' ' A' ' 104' ' ' PHE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo -63.0 104.55 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 -43.69 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 142.84 87.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.86 146.06 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.95 85.97 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.2 p -119.37 107.67 13.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.225 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -69.12 100.68 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.671 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.49 94.31 8.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -167.69 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.477 2.118 . . . . 0.0 112.118 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 104.3 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.79 120.88 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.04 130.13 67.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? 60.63 68.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 ptm -178.78 101.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.9 41.88 0.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.444 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -98.24 18.1 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.44 -136.85 4.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -177.61 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.9 -114.87 4.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -115.4 133.03 56.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.332 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -83.78 149.88 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.6 48.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -169.7 30.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.59 154.77 25.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 43' ' ' THR . 1.6 m -134.74 174.49 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 106' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.422 HG22 ' CE1' ' A' ' 137' ' ' TYR . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.74 165.79 21.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -44.66 88.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.479 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.5 t70 68.25 43.17 1.57 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.078 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.661 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.75 94.61 4.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.277 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.661 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 2.0 m-85 -126.62 108.35 11.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.62 127.87 55.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.785 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.55 114.18 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.45 98.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.17 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.789 0.328 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.25 117.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtp -121.55 139.94 30.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.62 143.09 29.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.82 165.11 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 128.89 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 ptp -80.02 153.9 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -142.58 -47.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -61.94 141.0 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.35 111.82 23.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp 60.69 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -74.11 121.51 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -94.03 129.72 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 60.14 -173.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.37 89.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -105.03 160.43 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -83.87 171.18 13.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -78.74 -27.63 44.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.78 63.87 0.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.543 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 99.89 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.334 . . . . 0.0 111.125 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -109.98 -32.13 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 136.09 40.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.61 34.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.564 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.51 -26.82 3.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.602 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -73.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.119 0.485 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.3 OUTLIER 62.29 118.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.692 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 26' ' ' TYR . 28.7 t -34.07 143.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.261 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.27 77.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 111.586 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 0.1 OUTLIER 170.58 -58.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.89 -167.65 11.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.03 -47.17 78.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 ' HA2' ' A' ' 100' ' ' GLY . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.55 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 104' ' ' PHE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.66 123.03 6.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -137.83 -46.07 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 144.07 98.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.27 156.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.554 2.169 . . . . 0.0 112.317 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.55 88.19 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.043 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.6 p -119.27 105.04 10.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.045 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 22.7 mttm -112.64 81.03 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.12 94.24 47.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.728 2.285 . . . . 0.0 112.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 148.53 28.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.996 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.23 130.69 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 t -76.76 133.54 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.89 75.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -31.98 71.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.84 126.41 3.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -18.12 36.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.708 0.289 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.74 -112.01 0.91 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -110.12 -31.83 7.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.78 138.93 10.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.523 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -105.99 126.44 52.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.378 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 p -76.17 140.09 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -89.18 53.23 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.79 172.56 5.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.86 162.71 12.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.928 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.92 172.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.274 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.422 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 58' ' ' PHE . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.419 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 119' ' ' ARG . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.468 HG23 ' CZ ' ' A' ' 137' ' ' TYR . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 135' ' ' ASP . 3.2 ttt180 -94.83 166.05 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -45.61 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.9 t0 75.7 28.41 0.92 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.39 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.34 94.92 4.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.677 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.5 m-85 -126.48 108.14 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.29 121.47 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -76.22 152.03 36.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.82 106.82 16.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.879 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.14 30.65 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.15 89.15 38.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.14 168.29 22.48 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.569 2.179 . . . . 0.0 112.409 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.3 134.67 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -136.58 -46.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 103.46 2.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -34.72 6.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.66 127.69 56.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 123.51 30.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -62.89 -40.17 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.58 150.72 32.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.86 120.67 41.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -134.96 31.2 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.78 156.42 27.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.9 174.31 6.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.11 83.3 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.69 23.59 14.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.36 80.22 0.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.93 126.5 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.077 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.96 110.0 19.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.17 36.92 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.94 126.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.04 136.38 6.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.63 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.41 -172.59 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 110.864 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 116.52 10.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.881 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 134' ' ' ARG . 2.4 t -30.05 -45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.984 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.79 -71.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.298 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.69 154.22 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.59 161.41 10.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.663 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.5 -45.43 30.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.463 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HA ' ' CD2' ' A' ' 58' ' ' PHE . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.42 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo -64.9 109.96 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -124.6 -52.15 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -66.91 139.2 95.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.85 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 158.3 57.92 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.262 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 6.1 t80 -127.4 94.66 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.8 p -119.37 116.66 26.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 19.3 mttt -142.5 42.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.52 110.47 3.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -45.07 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.369 2.046 . . . . 0.0 112.323 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.98 158.2 15.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.59 -31.16 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.58 135.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.76 139.27 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.28 -104.26 0.51 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.525 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -100.87 18.11 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.681 0.277 . . . . 0.0 111.236 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.57 -62.35 0.5 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 30.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.99 116.49 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -130.68 134.91 47.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.05 138.33 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -95.49 41.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.81 -173.11 53.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.73 164.03 18.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.36 173.1 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 101' ' ' ARG . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 58' ' ' PHE . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.438 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.43 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -97.04 120.89 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 40.88 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.537 0.684 . . . . 0.0 111.917 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.01 46.46 0.92 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.129 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.74 94.63 4.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.581 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.9 m-85 -127.03 118.05 23.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.57 159.96 16.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -63.47 102.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.06 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -35.6 7.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 ttp -143.47 86.16 9.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -68.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.488 2.126 . . . . 0.0 112.458 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.8 mtt85 -161.47 111.6 1.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.0 135.52 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.78 127.14 50.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -76.09 95.58 3.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.69 86.83 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.69 112.0 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -40.37 91.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.4 118.73 12.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -77.35 138.3 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -31.15 65.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.0 -94.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.92 168.14 9.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.23 170.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -97.39 23.66 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.73 -149.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.05 95.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -123.05 -177.48 3.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -79.95 159.53 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.88 -173.17 13.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.29 -167.48 31.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.32 -174.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 27' ' ' VAL . 45.0 t80 -99.76 -74.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 134' ' ' ARG . 0.9 OUTLIER 177.7 -35.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 69.81 -162.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.967 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.46 165.43 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.161 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 178.44 49.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.594 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -42.27 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ARG . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' HG13 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.67 104.41 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.77 -44.41 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -78.13 139.55 60.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.09 154.58 52.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.445 2.097 . . . . 0.0 112.282 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -107.94 88.99 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.2 p -119.5 122.74 42.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.042 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 31.49 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 145.71 47.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.789 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.76 158.34 55.91 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.519 2.146 . . . . 0.0 112.282 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 105.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -173.29 36.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 142.49 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 147.58 32.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 mmm -68.81 105.03 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.15 71.12 1.28 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -84.92 -18.14 35.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.273 . . . . 0.0 111.153 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.36 -47.01 2.37 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.97 130.46 27.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.88 126.79 1.89 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.574 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -123.3 127.17 48.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.79 151.9 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.51 53.39 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.89 -176.57 1.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.515 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.25 153.89 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 43' ' ' THR . 2.3 m -136.74 170.46 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 ' CD1' ' A' ' 58' ' ' PHE . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.4 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.431 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 -109.31 121.01 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 27' ' ' VAL . 12.8 mmt180 38.71 -105.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.512 0.672 . . . . 0.0 112.098 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -103.07 43.38 1.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.145 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.59 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.71 93.96 4.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.162 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.59 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 2.5 m-85 -127.66 89.89 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.771 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.87 157.39 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -80.41 100.97 8.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.9 5.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.882 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.79 152.88 18.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.75 85.48 16.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.99 178.59 6.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.667 2.244 . . . . 0.0 112.379 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.03 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -148.7 176.75 10.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ttm -72.03 135.84 46.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.68 153.41 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -72.8 178.64 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 133.48 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -79.2 -59.25 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.81 116.68 29.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 114.71 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -103.44 106.57 17.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 91.37 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -96.62 -178.26 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.07 100.61 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 23.64 6.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.998 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 140.02 27.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.28 159.6 25.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 p 50.54 -178.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 60.64 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.01 84.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.84 121.87 0.7 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.15 172.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.05 0.452 . . . . 0.0 111.493 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.466 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -162.49 109.92 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.688 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 26' ' ' TYR . 3.4 t -21.81 -53.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.186 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 73.34 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.235 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.5 159.34 17.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.13 132.73 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.512 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -55.16 -28.12 50.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 117' ' ' ALA . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.453 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo -74.2 108.2 2.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -127.85 -44.75 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.52 143.91 79.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 172.8 12.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.553 2.169 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -127.5 129.75 47.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.0 p -118.72 127.66 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -83.66 120.65 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -113.34 94.48 31.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.38 -173.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.569 2.179 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.31 150.28 23.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 60.37 26.9 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.11 141.12 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 112.6 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.0 ttm 60.46 159.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.1 140.84 48.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.02 18.16 12.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.169 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.87 28.88 6.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.454 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 138.64 16.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 122.4 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.412 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -125.12 135.01 52.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.96 122.5 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -94.14 45.93 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.97 -178.94 49.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.4 m-85 -105.88 134.02 49.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -124.2 165.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -86.07 166.09 16.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.52 87.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.979 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.8 t0 71.59 35.13 1.5 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.987 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.594 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.04 95.18 5.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.579 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -126.07 96.56 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.83 105.26 15.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.45 154.61 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.33 103.05 12.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.918 179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mt 60.31 94.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptm -110.26 135.04 20.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.11 -168.27 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.501 2.134 . . . . 0.0 112.35 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -88.46 122.35 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.78 145.17 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.29 142.95 35.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -96.97 112.9 24.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.11 76.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -85.13 161.9 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.86 103.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.49 152.07 22.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -82.43 133.34 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -148.13 98.96 3.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.75 178.13 44.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.538 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 60.8 -177.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.811 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.26 163.56 33.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -87.8 -27.56 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.08 72.18 0.72 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.48 154.84 21.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 111.095 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -31.86 9.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.98 135.9 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.38 99.13 2.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.532 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.13 -104.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -91.15 24.82 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' CE1' ' CE1' ' A' ' 137' ' ' TYR . 1.8 t80 -79.35 81.42 5.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG13 ' HG2' ' A' ' 134' ' ' ARG . 2.6 t 53.89 101.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -45.09 -81.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 28' ' ' ALA . 43.5 m-85 -145.15 179.56 7.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.12 -124.61 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.546 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 4.8 m-20 -135.55 -52.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.549 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CG ' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 66' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.04 108.82 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -118.94 -47.16 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.0 124.36 86.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.02 159.42 7.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 0.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -124.7 97.89 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 147.23 44.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.71 149.14 46.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -110.03 94.12 16.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.95 -167.24 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.738 2.292 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 161.64 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.761 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.19 -30.0 24.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.91 110.52 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.067 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -178.34 3.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.42 171.65 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.32 -160.79 15.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.564 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -98.87 -18.14 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.2 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.85 -132.49 8.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.509 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.38 80.55 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.82 -104.54 0.71 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.4 134.21 56.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.1 158.26 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.049 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -84.78 57.8 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -178.78 12.22 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.15 163.94 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.0 170.13 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.271 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.446 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 104' ' ' PHE . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.434 HG11 ' CG ' ' A' ' 58' ' ' PHE . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.482 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.528 ' C ' ' H ' ' A' ' 135' ' ' ASP . 1.7 ttt180 -68.87 165.8 19.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.452 ' HG3' ' HA ' ' A' ' 31' ' ' ASP . 4.5 mtm180 -55.28 1.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.5 m-20 -161.15 25.36 0.13 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.83 93.94 4.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 4.4 m-85 -128.54 109.63 11.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.79 93.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.09 155.02 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.5 93.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.27 -38.89 3.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 ttt -65.94 110.04 4.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.316 2.011 . . . . 0.0 112.384 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 53.52 99.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 111.028 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -161.18 -66.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.049 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.418 ' HE1' ' CZ ' ' A' ' 9' ' ' TYR . 3.7 ptt? -71.52 154.48 41.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -87.08 -12.72 46.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.287 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CZ ' ' HE1' ' A' ' 7' ' ' MET . 0.1 OUTLIER 68.22 97.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.885 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 157.27 20.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.64 81.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.88 121.78 34.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.54 126.17 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 60.82 93.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.805 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.05 -28.68 2.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -104.36 161.65 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.27 166.72 19.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.38 23.65 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.22 58.34 5.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.521 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.41 109.58 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.34 -179.13 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 35.32 4.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.23 -122.22 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.09 140.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.96 -81.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.486 ' O ' HG23 ' A' ' 27' ' ' VAL . 10.9 t80 68.92 -67.19 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.06 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 162.68 -27.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.512 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.76 -174.65 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -57.76 113.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.82 150.13 5.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.58 -44.81 77.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 104' ' ' PHE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo -71.69 104.51 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -134.12 31.65 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.06 127.99 14.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.97 143.09 99.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.448 2.099 . . . . 0.0 112.133 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.95 117.23 22.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.9 p -118.78 147.05 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -118.32 31.1 6.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.53 141.25 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.13 -28.56 18.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.515 2.143 . . . . 0.0 112.251 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.53 148.76 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.811 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.59 135.77 55.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.958 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.75 144.2 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 -176.96 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.96 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.34 170.26 37.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -86.67 -18.09 32.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.93 115.28 0.49 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.75 30.41 5.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.17 -156.32 7.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.529 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -109.04 153.07 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.98 136.7 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.27 54.87 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.07 157.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.399 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -90.23 147.86 23.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -121.42 174.51 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.217 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CG2' ' A' ' 129' ' ' THR . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.422 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 -95.44 118.12 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' CA ' HG22 ' A' ' 27' ' ' VAL . 8.6 mmt180 40.4 -102.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.447 0.641 . . . . 0.0 112.085 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -103.47 44.72 1.0 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.081 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.38 4.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.584 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 2.3 m-85 -127.21 104.4 7.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -111.05 150.71 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.08 128.75 36.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -122.73 101.95 7.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 mtt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.73 168.99 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptm -133.09 144.82 54.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.14 104.95 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -89.05 134.35 34.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.9 31.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.67 172.2 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -114.56 91.32 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.22 144.4 22.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.01 153.29 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -66.23 174.85 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.805 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.68 145.99 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -105.53 132.03 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -71.79 164.36 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.71 -101.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.6 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.88 -179.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.83 109.81 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -27.45 13.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.3 64.11 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.535 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 121.35 38.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -178.24 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.6 162.59 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.8 -108.94 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.43 24.26 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.41 163.19 18.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.568 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.6 t80 -177.04 -49.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.568 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 24.9 t 126.47 97.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 124.305 1.003 . . . . 0.0 110.0 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.97 -60.69 2.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.345 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -138.9 -175.76 4.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.67 170.97 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.672 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.5 42.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.441 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 117' ' ' ALA . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo -79.5 105.29 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -126.61 -45.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -66.96 115.98 30.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -51.7 153.05 11.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.31 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 10.4 t80 -119.15 90.08 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.5 p -119.54 130.12 55.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 10.4 mtpp -125.03 36.34 4.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.61 94.38 43.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.37 -25.9 29.95 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.403 2.069 . . . . 0.0 112.242 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.72 157.46 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 86.3 1.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -85.49 126.52 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 63.85 134.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.88 148.79 25.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.16 166.62 24.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.29 18.24 12.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.65 0.262 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.41 -125.26 2.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -133.25 -66.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.98 -163.93 25.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.09 94.18 8.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.25 141.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -87.29 55.19 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.73 176.49 5.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -108.4 156.68 19.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m -132.39 174.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 58' ' ' PHE . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.402 HD11 HG22 ' A' ' 129' ' ' THR . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' A' ' 129' ' ' THR . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -89.39 165.59 14.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -46.62 89.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.606 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ARG . 8.4 t0 71.79 36.4 1.22 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.597 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.578 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.89 94.72 4.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.893 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.578 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.6 m-85 -126.49 91.74 3.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.63 165.28 15.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.79 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -80.46 105.45 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.43 105.22 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.955 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.885 0.374 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 tp -176.47 47.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 ttm -98.52 121.73 55.65 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 170.44 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.477 2.118 . . . . 0.0 112.282 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.2 72.6 0.63 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.28 155.35 5.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.58 157.97 17.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm 62.44 147.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.69 161.85 19.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -111.44 105.47 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -33.19 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.03 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.02 146.59 41.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.57 116.98 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -130.28 143.19 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.23 107.82 3.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.75 160.68 37.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.72 92.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.34 23.57 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.99 -54.04 5.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 130.73 44.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.141 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -109.17 -30.35 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.98 167.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.48 -108.89 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.46 -140.97 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.93 -178.79 5.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.006 0.432 . . . . 0.0 111.029 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -145.96 118.5 8.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.771 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 26' ' ' TYR . 9.0 t -30.93 -65.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.589 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.99 -68.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -95.17 144.52 25.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 111.085 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 173.08 1.7 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.713 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -40.39 18.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 130' ' ' LYS . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.41 ' CA ' HG11 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo -65.75 104.9 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -113.14 -49.13 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 139.0 80.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.994 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 166.86 27.33 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.434 2.09 . . . . 0.0 112.049 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.61 90.45 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -119.4 108.26 14.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 4.5 mmmt -129.35 138.45 51.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -121.17 94.25 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.5 -34.06 86.43 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 tp -89.63 152.17 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.34 165.51 23.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.62 112.7 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -134.88 -71.94 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.77 100.7 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.32 113.61 2.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.522 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.63 18.12 13.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.275 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.66 114.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -119.4 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.86 -104.81 1.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.43 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 36.16 87.48 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.42 137.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.69 57.63 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.61 161.75 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -83.49 163.56 20.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CB ' ' HB3' ' A' ' 41' ' ' TRP . 1.2 m -142.74 174.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.422 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ASP . 1.3 ttt180 -88.48 165.76 14.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.8 88.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.092 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 71.86 32.3 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.226 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.87 95.02 5.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.429 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-85 -126.28 109.02 11.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.45 126.22 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -71.07 138.08 49.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.72 102.25 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.888 179.925 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mt -119.77 -41.48 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.06 147.86 34.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 145.74 41.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.47 2.113 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 62.64 118.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 106.55 16.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -134.86 31.47 3.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.16 128.43 33.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.08 135.28 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 88.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -104.04 153.95 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -66.51 139.0 57.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.91 170.83 9.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.25 -90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.17 141.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.81 154.38 23.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -103.19 -27.48 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.12 -62.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.06 110.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.839 0.352 . . . . 0.0 111.154 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.16 116.43 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -100.15 87.94 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.58 149.72 5.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.92 61.69 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.48 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.2 t80 63.67 82.58 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.037 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 28' ' ' ALA . 4.4 t 49.04 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.654 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . 84.4 -53.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.92 165.67 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 161.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.688 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.76 -47.43 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.4 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 104' ' ' PHE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo -65.08 130.77 26.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.3 m-20 -134.46 -51.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.84 144.15 38.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.94 173.96 7.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.123 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.54 83.48 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.3 p -119.65 112.78 19.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 31.31 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.796 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.4 100.01 31.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.862 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.32 -42.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.349 2.033 . . . . 0.0 112.33 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 129.93 55.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.844 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.25 59.99 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 t -112.83 106.99 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.48 -73.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mmm -97.38 -56.57 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 57.73 28.45 60.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -102.42 -18.02 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.238 . . . . 0.0 111.2 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.89 -136.73 9.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 -37.7 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.07 -176.48 21.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -122.48 114.73 21.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -106.3 137.57 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -95.57 40.84 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.39 153.2 8.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.551 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.3 m-85 -75.05 159.55 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.3 m -138.38 172.16 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 101' ' ' ARG . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.47 ' CB ' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 27' ' ' VAL . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.433 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.437 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.17 165.37 18.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.51 4.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.594 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.2 m-20 -161.79 23.48 0.12 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.832 0.349 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.558 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.37 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.06 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.558 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 4.5 m-85 -128.16 103.22 7.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.17 93.5 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -73.26 150.53 41.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.74 98.73 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.853 0.359 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mt -152.54 127.07 9.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 mmm -105.83 88.64 3.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.76 132.89 22.59 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.553 2.169 . . . . 0.0 112.283 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 137.47 51.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mtt-85 -150.78 110.88 4.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.19 127.38 32.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -65.93 -23.42 66.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -55.82 110.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.966 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -99.94 149.1 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.29 82.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.11 166.05 23.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -72.26 115.91 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.2 89.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -128.51 1.19 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -87.2 -166.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 46.23 87.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.218 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -27.66 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.59 -147.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.534 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.07 146.96 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 111.099 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 p -74.51 -31.39 62.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.47 131.64 56.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.59 161.91 53.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -179.58 52.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.498 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.85 87.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.153 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -134.93 80.06 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.137 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 28' ' ' ALA . 4.8 t 48.11 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.5 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . 56.82 167.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 66.13 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.527 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.4 174.42 36.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.895 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 134' ' ' ARG . 8.0 m-20 -72.08 -39.61 68.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.439 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.428 ' CG ' HG13 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 21.6 Cg_exo -64.98 114.59 2.86 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.7 -47.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 143.96 98.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.46 163.03 38.7 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 4.5 t80 -127.49 93.12 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -119.16 136.19 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 18.6 mtpt -150.14 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 94.41 48.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -40.73 2.81 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.473 2.115 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.67 157.82 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 46.14 -169.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.352 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.41 142.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -113.38 136.95 52.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -67.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.04 123.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.47 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.41 10.43 29.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.605 0.24 . . . . 0.0 111.369 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.65 32.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 117.93 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.01 -142.67 10.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.84 111.1 21.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.5 149.45 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.95 41.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.59 -179.0 49.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.47 156.81 20.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 162.56 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.42 HG11 ' CB ' ' A' ' 101' ' ' ARG . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.42 ' CB ' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.439 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG1' HD13 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 58' ' ' PHE . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.409 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 135' ' ' ASP . 4.0 ttt180 -67.95 165.36 17.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' CG ' HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -60.59 10.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.467 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 133' ' ' ARG . 3.3 m-20 -165.33 22.43 0.05 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.55 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -116.18 94.05 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 5.6 m-85 -128.44 110.95 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -107.25 93.41 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -77.5 164.4 25.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -118.44 99.2 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.092 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.879 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.893 0.378 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -163.0 154.03 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.89 137.48 29.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.829 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.19 99.91 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.492 2.128 . . . . 0.0 112.198 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -80.78 150.44 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -176.5 140.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.82 170.38 9.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.97 47.77 24.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 59.74 -179.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.96 125.24 53.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -166.13 148.58 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -105.97 122.01 45.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -81.42 150.84 28.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.09 -57.58 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.28 -69.01 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.547 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 61.19 153.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.09 81.66 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -100.48 23.62 10.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.13 162.93 13.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.42 121.74 26.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.0 p -67.99 95.92 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -107.88 125.26 51.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.48 164.13 12.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.46 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.62 -48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.432 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.18 -178.01 4.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.055 0.455 . . . . 0.0 111.022 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -147.66 117.46 7.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.73 179.181 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' TYR . 9.2 t -27.46 105.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.89 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.73 -77.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.174 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -119.68 -176.19 3.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.25 178.64 2.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.603 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -87.58 -39.66 14.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 54' ' ' MET . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.433 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 85.8 Cg_endo -81.82 112.36 2.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -126.91 -40.78 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' CD ' ' CG2' ' A' ' 96' ' ' VAL . 2.4 mtpm? -66.88 109.65 3.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.973 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.54 122.66 8.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.668 2.245 . . . . 0.0 112.46 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 91' ' ' GLU . 5.5 p90 -103.08 147.55 26.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.316 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 p -119.0 137.32 53.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 111.311 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -109.69 -156.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 146.09 88.32 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.814 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.86 148.77 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.512 2.141 . . . . 0.0 112.429 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.37 161.44 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 17.98 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.245 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.05 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -73.9 -37.69 64.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 172.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.33 -143.85 14.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -102.22 18.06 21.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 111.19 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.12 -135.81 4.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -39.62 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.43 120.2 5.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.436 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -116.0 123.35 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 91' ' ' GLU . 14.6 p -64.84 141.92 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CE1' ' A' ' 74' ' ' TYR . 3.5 mm-40 -95.96 29.58 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.282 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.08 166.99 15.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.501 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 7.6 m-30 -111.56 157.52 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.992 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.58 174.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' CG2' ' CD ' ' A' ' 72' ' ' LYS . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' PRO . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.428 HG11 ' CG ' ' A' ' 58' ' ' PHE . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.453 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 -95.13 119.89 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.7 OUTLIER 40.79 -101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.447 0.641 . . . . 0.0 112.003 179.138 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -106.81 45.29 0.99 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.145 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.588 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.68 94.55 4.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.588 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.9 m-85 -126.98 89.94 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.07 121.05 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -96.12 129.74 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.91 104.2 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.077 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.948 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.22 65.76 6.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.0 mtp -107.61 139.02 20.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 79.33 2.71 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.338 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 155.31 45.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -34.69 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.48 106.18 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 129.77 41.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.59 144.8 33.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.94 139.43 36.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -139.62 101.04 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -64.39 141.56 58.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -69.17 115.08 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.28 -66.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.23 162.98 30.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.79 12.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.12 175.48 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -85.55 -27.54 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 89.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.47 15.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 111.098 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.11 -176.81 4.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 134.55 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.98 -177.91 22.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.6 -68.59 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.346 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -99.87 133.54 44.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' VAL . 18.7 p90 -106.35 -47.58 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.417 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 73.7 t -158.01 -78.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.833 -179.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 56.82 31.0 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.529 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 171.66 135.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.48 159.18 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.625 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.76 -34.75 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.551 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.406 ' HG2' HD22 ' A' ' 125' ' ' LEU . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 104' ' ' PHE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.01 132.48 34.62 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -145.73 -48.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -74.37 121.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.787 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.49 157.11 9.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -124.44 89.97 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 p -119.16 132.73 56.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.089 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.6 53.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 136.1 20.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.51 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.535 2.157 . . . . 0.0 112.441 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.79 134.52 38.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 61.18 90.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.89 110.16 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.9 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -139.4 -46.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.86 108.61 0.34 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.598 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -93.87 -18.19 22.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.28 -59.38 0.47 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.499 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -150.72 124.68 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.12 -151.4 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -122.79 130.44 52.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -78.45 124.05 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -91.07 51.48 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.776 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.03 172.94 45.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -105.12 155.84 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.707 0.289 . . . . 0.0 110.854 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 m -136.63 174.51 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.45 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' HD13 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 58' ' ' PHE . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 46' ' ' GLN . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 137' ' ' TYR . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -77.59 165.39 24.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -47.0 89.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.288 178.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.2 t70 67.6 43.36 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.694 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.86 94.65 4.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.694 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.7 m-85 -126.69 92.17 3.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.908 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.02 153.05 38.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.91 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.64 103.83 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.778 0.323 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.2 mt -123.23 -64.15 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mtt -83.24 112.93 42.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.26 97.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.424 2.083 . . . . 0.0 112.233 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.47 33.01 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.16 80.28 8.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mmt -108.51 118.68 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.24 128.25 18.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 170.74 7.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -87.01 153.89 21.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.44 135.18 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -89.56 159.74 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -102.73 156.4 17.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 32.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.42 44.77 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 173.43 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.02 97.12 2.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 23.52 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.7 91.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.49 156.58 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 p -129.26 -178.36 4.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.32 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.73 -116.15 0.63 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.37 64.64 0.8 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -74.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.188 0.518 . . . . 0.0 110.872 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.4 OUTLIER 62.37 119.0 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.869 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 26' ' ' TYR . 8.5 t -30.27 120.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.725 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.86 95.79 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.047 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 63.24 149.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.08 -168.64 34.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.592 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.7 -32.98 6.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' CD1' ' HB ' ' A' ' 129' ' ' THR . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 46' ' ' GLN . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HA ' HG13 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.549 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.453 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 127.36 11.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 11.8 m-20 -148.16 -52.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.13 144.06 98.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 163.57 36.16 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.071 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -127.48 106.09 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.291 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 p -118.93 143.45 47.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -104.97 -152.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -60.68 116.99 20.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -90.43 38.19 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.897 2.398 . . . . 0.0 112.51 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.12 151.23 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 59.19 89.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.941 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -83.38 135.35 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.6 -28.01 12.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 11.8 ttt -172.84 -41.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.64 73.84 0.24 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.542 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -18.06 49.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.68 0.276 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.52 -45.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -126.79 99.62 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.79 -149.62 19.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -117.25 123.08 45.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.1 156.04 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.95 46.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.37 -176.91 40.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.5 m-30 -103.33 163.73 12.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 43' ' ' THR . 2.5 m -147.44 171.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.436 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 58' ' ' PHE . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.424 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.457 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -90.59 165.82 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -46.76 88.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.994 179.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.2 t70 73.16 29.88 1.66 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.481 178.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.99 95.07 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.52 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.2 m-85 -126.42 104.08 7.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.78 93.49 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 118.3 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.85 94.07 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.061 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.889 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.23 111.95 23.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 ttp -104.74 105.29 50.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.34 110.89 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.344 2.03 . . . . 0.0 112.225 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 159.44 36.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.036 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.1 76.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.3 mtt -100.89 164.93 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 78.17 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.54 49.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -76.08 154.73 35.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 177.93 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -67.35 163.01 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -63.6 114.16 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -137.43 39.65 2.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.9 -68.76 0.34 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.529 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.6 153.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.63 104.87 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -97.2 23.59 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.25 -118.17 2.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.94 145.17 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.9 -45.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.63 148.26 19.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.44 -113.61 2.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.56 157.29 32.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.582 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -171.3 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -142.35 118.07 10.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.962 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 134' ' ' ARG . 14.3 t -29.3 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.835 178.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.79 151.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.338 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 64.71 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.83 166.71 50.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.014 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 134' ' ' ARG . 3.1 m-20 -79.46 -27.55 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG21 ' HA2' ' A' ' 100' ' ' GLY . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.416 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' CD1' HG12 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.5 104.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.53 -42.57 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -75.87 124.26 88.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.3 147.43 83.19 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.439 2.093 . . . . 0.0 112.243 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 1.9 t80 -113.01 92.15 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 p -118.95 124.95 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.138 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -153.06 33.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -82.8 110.83 25.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.67 125.58 8.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.474 2.116 . . . . 0.0 112.386 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.98 106.56 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -162.45 -49.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.39 151.84 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -76.84 127.18 32.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.4 ttm -66.3 -179.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.17 -113.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -84.34 -18.11 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 111.217 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.51 -155.53 9.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -145.67 35.75 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 143.74 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.492 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -100.3 146.53 26.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.96 158.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -93.82 40.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.023 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.52 152.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.25 149.07 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.762 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.71 165.52 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.457 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' A' ' 58' ' ' PHE . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.45 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.34 165.49 18.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.432 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 50.0 ttt-85 -58.43 5.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 133' ' ' ARG . 4.7 m-20 -162.37 23.5 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.02 4.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.033 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 6.4 m-85 -128.28 120.26 26.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.67 153.9 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.38 121.06 12.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.13 99.64 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.898 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -47.07 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.68 126.12 23.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.68 137.31 27.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.434 2.089 . . . . 0.0 112.354 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -142.63 47.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 60.74 171.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 118.86 8.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -143.97 146.35 32.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.15 44.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -84.1 145.82 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -99.76 -59.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -104.07 143.81 32.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.68 162.48 16.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -43.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.985 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.64 109.68 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.636 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.75 176.38 5.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.82 119.55 32.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.853 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -109.52 23.61 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -174.25 1.75 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.1 129.73 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.017 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -124.83 -43.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -79.0 91.83 4.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.943 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.84 -124.78 2.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.41 -130.37 6.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.532 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.29 -175.52 2.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 23.8 t80 -173.96 -67.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.016 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 1.1 t 161.04 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.285 179.749 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.1 -75.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.547 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.47 -179.09 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 134.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.447 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -52.33 -31.29 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG22 ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' CB ' ' HG2' ' A' ' 126' ' ' PRO . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.418 ' CD1' HG21 ' A' ' 96' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.466 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' CD1' HG12 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 47' ' ' ILE . 25.3 Cg_exo -62.5 104.54 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.96 -50.63 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -66.95 144.04 98.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 155.88 62.49 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.525 2.15 . . . . 0.0 112.403 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -119.22 119.66 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 168.73 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.661 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -124.58 106.52 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.027 -179.664 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 141.15 30.01 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.451 2.101 . . . . 0.0 112.413 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.26 161.68 15.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.16 -27.55 34.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.26 154.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 64.68 165.45 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.31 137.63 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.55 90.62 0.72 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.568 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -107.56 -18.08 13.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.235 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.73 25.93 4.96 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp 73.07 3.98 4.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.87 137.45 0.01 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -133.62 154.56 50.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.764 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.92 112.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.038 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.71 75.11 7.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.04 -171.97 7.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.426 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -111.14 158.61 18.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.5 m -145.87 164.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.245 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.418 HG21 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 101' ' ' ARG . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.429 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.466 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 114' ' ' ALA . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.406 ' HB3' ' CG2' ' A' ' 106' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.409 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.413 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.34 165.76 17.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 3.1 mtm105 -55.43 -0.29 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ARG . 5.5 m-20 -162.77 27.37 0.1 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.6 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.552 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.54 94.12 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 3.9 m-85 -128.15 115.96 19.2 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.22 105.85 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.64 121.97 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.46 94.42 9.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.12 -172.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.82 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -115.44 86.5 15.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.49 -160.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.574 2.183 . . . . 0.0 112.226 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.46 104.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -177.38 123.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.45 103.32 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.56 78.42 1.26 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.92 156.34 44.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -93.94 141.66 28.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 158.66 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 139.61 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -63.46 123.18 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -119.05 -58.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.9 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.49 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 150.54 8.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.55 163.14 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -81.87 -27.55 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.91 36.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.05 155.68 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -77.47 -32.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -79.62 -179.78 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.41 1.72 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.99 138.65 3.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.23 178.21 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -147.63 118.35 7.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.862 179.269 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 26' ' ' TYR . 14.3 t -31.82 -78.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.549 178.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 54.74 171.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.584 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 m-85 62.42 -81.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.337 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.94 168.66 32.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.749 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -69.81 -34.04 73.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CG ' HG13 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CG ' ' HB3' ' A' ' 29' ' ' PHE . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.455 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo -65.23 134.05 37.66 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.73 -52.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.06 135.24 93.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.9 155.35 23.23 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 106.36 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 p -119.05 147.04 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -115.58 80.83 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -118.47 106.46 44.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.72 163.42 35.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.404 2.069 . . . . 0.0 112.227 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.59 104.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -151.12 157.15 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.59 141.89 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 60.48 94.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.9 ptp -96.33 159.72 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.47 110.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -106.44 -18.08 14.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.629 0.252 . . . . 0.0 111.21 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.06 -49.68 1.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 30.91 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.52 -179.07 52.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -117.54 114.12 22.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 p -83.38 122.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.99 40.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.49 40.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -99.09 164.03 12.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.804 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.0 m -150.89 160.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG13 ' CB ' ' A' ' 101' ' ' ARG . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA2' HG22 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' CB ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.447 HG13 ' CG ' ' A' ' 58' ' ' PHE . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.408 ' HE1' ' CZ ' ' A' ' 32' ' ' TYR . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.423 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -97.58 165.95 11.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -42.49 86.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.86 178.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.7 t70 68.41 40.58 1.97 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.601 179.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.588 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.83 94.87 4.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.815 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.588 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.4 m-85 -126.37 90.59 3.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.46 107.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.59 112.59 8.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.85 97.01 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 tp -104.55 51.65 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.5 mtp -111.51 95.19 25.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.34 -173.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.26 91.86 8.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -143.81 72.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.78 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -90.25 103.39 16.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.79 -34.42 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.56 122.54 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.788 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.51 115.36 24.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.56 110.59 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.55 22.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -106.54 140.66 39.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 62.48 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.96 -179.35 17.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.86 138.13 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.61 142.41 22.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -78.58 -27.5 45.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.65 166.31 7.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.47 126.11 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -131.71 -45.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.7 121.2 14.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.4 133.26 8.87 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.91 175.95 27.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.78 116.35 23.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.0 t80 -100.13 93.3 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 28' ' ' ALA . 17.0 t 43.86 -85.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.685 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . 79.72 -69.34 0.11 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.459 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.05 154.8 17.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.91 153.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.021 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -61.89 -32.68 73.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 179.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 ' HA2' ' A' ' 100' ' ' GLY . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' HG13 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 104' ' ' PHE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.4 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo -75.44 104.71 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.38 29.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.53 136.11 21.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.92 137.06 40.26 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.426 2.084 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CE1' ' HE2' ' A' ' 76' ' ' LYS . 4.1 t80 -107.7 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 p -119.27 127.32 53.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.119 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -103.96 31.17 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.69 156.46 35.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 164.53 31.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.513 2.142 . . . . 0.0 112.295 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.17 109.39 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.37 146.11 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.33 130.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 60.61 178.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.2 mtt 60.27 80.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.63 52.44 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.41 18.22 14.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.678 0.275 . . . . 0.0 111.19 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.93 -103.04 0.64 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.423 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.63 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.937 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.85 -51.87 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.555 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 38.67 86.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.14 154.57 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -95.55 43.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.14 -179.46 49.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.508 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.32 164.12 12.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -151.44 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' HA2' HG23 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 58' ' ' PHE . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.426 HD11 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.429 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.528 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.28 165.72 17.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -56.13 1.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 133' ' ' ARG . 2.3 m-20 -162.02 25.52 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.551 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.71 94.19 4.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 4.3 m-85 -128.19 112.97 15.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.41 116.76 10.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.83 144.77 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.12 97.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.956 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -144.28 117.21 8.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mtt -109.87 81.84 2.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.91 136.88 17.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.547 2.165 . . . . 0.0 112.397 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.24 44.25 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -59.74 154.78 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttp -103.02 167.63 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.5 109.07 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.972 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -121.35 -177.78 3.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.58 156.68 18.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 90.72 2.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -73.76 155.82 38.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 131.36 36.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -127.81 99.94 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.4 35.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.46 152.35 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.65 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -78.49 -27.52 46.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.21 87.77 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.586 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.67 149.59 22.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.46 99.86 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -111.77 -175.84 2.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.94 107.66 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.09 163.79 16.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -177.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.792 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.504 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 47.0 t80 -108.24 -98.94 0.37 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 6.1 t -169.23 -77.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.003 0.43 . . . . 0.0 109.919 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 56.46 167.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.797 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CG ' ' A' ' 65' ' ' PHE . 2.5 m-85 66.01 -82.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.73 166.94 19.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.87 -179.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 -33.81 76.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' HA2' ' A' ' 100' ' ' GLY . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.418 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 117' ' ' ALA . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' CG ' ' CD1' ' A' ' 29' ' ' PHE . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 104' ' ' PHE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HD3' ' CE2' ' A' ' 29' ' ' PHE . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo -65.13 128.45 20.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -160.02 27.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 114.84 8.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.83 117.4 5.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.392 2.062 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' A' ' 91' ' ' GLU . 8.3 p90 -102.38 141.65 34.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.75 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 42.4 p -119.13 120.0 35.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -95.08 104.64 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.39 114.83 27.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.47 -31.77 21.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.41 2.073 . . . . 0.0 112.302 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -110.99 161.42 15.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -71.96 123.2 22.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.1 m -68.64 139.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.27 63.44 8.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.04 107.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 134.56 1.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.517 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -97.54 18.13 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.654 0.264 . . . . 0.0 111.167 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.06 139.84 6.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -140.52 34.01 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.43 -106.82 1.21 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.3 155.29 29.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.41 138.14 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' ' CE1' ' A' ' 74' ' ' TYR . 51.9 mt-10 -82.19 73.71 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.34 -162.42 0.1 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.205 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.61 164.05 20.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.908 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 74' ' ' TYR . 1.9 m -137.69 174.5 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 ' CG1' HD12 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 58' ' ' PHE . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 38' ' ' GLU . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.405 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.438 ' CG2' ' CZ ' ' A' ' 137' ' ' TYR . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -78.05 165.59 23.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -47.73 90.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 133' ' ' ARG . 10.8 t0 73.11 38.35 0.7 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.442 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.585 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.34 4.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.027 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.585 ' HD1' ' C ' ' A' ' 136' ' ' ALA . 1.8 m-85 -126.72 106.35 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.15 122.46 39.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.15 122.3 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.72 94.63 6.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.895 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.546 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 HD22 ' A' ' 125' ' ' LEU . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 42' ' ' ILE . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 66' ' ' ILE . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.785 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ARG . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 120' ' ' ILE . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' C ' HD13 ' A' ' 66' ' ' ILE . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 103' ' ' MET . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 41' ' ' TRP . 3.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.88 0.371 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.641 HG12 ' OE1' ' A' ' 105' ' ' GLU . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.76 ' HB3' HD13 ' A' ' 68' ' ' ILE . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 66' ' ' ILE . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.641 ' OE1' HG12 ' A' ' 102' ' ' VAL . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.584 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 117' ' ' ALA . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.653 HD22 HD12 ' A' ' 42' ' ' ILE . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.701 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.729 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' CG ' HD12 ' A' ' 37' ' ' LEU . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.448 ' CB ' HD11 ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.59 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.831 HD12 HD22 ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 52' ' ' VAL . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.518 ' HE3' HG21 ' A' ' 64' ' ' ILE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.518 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.87 HG12 ' OE2' ' A' ' 105' ' ' GLU . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.609 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.87 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.98 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.98 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.504 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HG3' HD11 ' A' ' 131' ' ' ILE . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.831 HD22 HD12 ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.734 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.513 ' CG ' HD12 ' A' ' 37' ' ' LEU . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 129' ' ' THR . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 96' ' ' VAL . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 125' ' ' LEU . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.613 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 103' ' ' MET . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo . . . . . 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.945 0.402 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 98' ' ' LYS . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' N ' HG12 ' A' ' 97' ' ' VAL . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.481 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.57 ' HE1' HD11 ' A' ' 127' ' ' ILE . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.773 HG13 HD11 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.478 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.846 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.66 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.736 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.812 HD22 HD12 ' A' ' 42' ' ' ILE . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.71 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 36' ' ' ALA . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.846 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 4.8 ttt180 . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 131' ' ' ILE . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.636 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.436 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 94' ' ' VAL . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 68' ' ' ILE . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 66' ' ' ILE . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.825 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 HG21 ' A' ' 42' ' ' ILE . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 43' ' ' THR . 17.0 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.838 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.77 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.724 ' HG3' HD11 ' A' ' 131' ' ' ILE . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.642 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.642 HD12 ' HA2' ' A' ' 122' ' ' GLY . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.691 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.78 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.511 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 128' ' ' LYS . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.757 HD12 HD22 ' A' ' 125' ' ' LEU . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' HD23 ' A' ' 125' ' ' LEU . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 66' ' ' ILE . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.514 HG21 ' HE3' ' A' ' 54' ' ' MET . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 103' ' ' MET . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 25.0 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.814 HG12 ' OE2' ' A' ' 105' ' ' GLU . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.494 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CE2' HD12 ' A' ' 66' ' ' ILE . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.814 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG13 HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.919 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.772 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.772 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.746 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 37' ' ' LEU . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.436 ' CB ' HD11 ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HG2' HD21 ' A' ' 37' ' ' LEU . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.511 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.773 HD21 ' HG2' ' A' ' 130' ' ' LYS . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.869 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.929 HD12 HD22 ' A' ' 125' ' ' LEU . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.512 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.79 ' OE1' HD23 ' A' ' 125' ' ' LEU . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 66' ' ' ILE . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 47' ' ' ILE . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.904 0.383 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 98' ' ' LYS . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.58 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.876 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 117' ' ' ALA . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.591 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD22 HD12 ' A' ' 42' ' ' ILE . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.643 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.483 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 36' ' ' ALA . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.773 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.876 HG23 HD23 ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.635 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.705 HD12 HD22 ' A' ' 125' ' ' LEU . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HB2' HG22 ' A' ' 42' ' ' ILE . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.924 HG23 HG21 ' A' ' 66' ' ' ILE . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.928 ' CD1' HG11 ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HD3' ' A' ' 51' ' ' ARG . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.924 HG21 HG23 ' A' ' 47' ' ' ILE . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 42' ' ' ILE . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 98' ' ' LYS . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 105' ' ' GLU . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.584 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.071 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.071 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.412 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.442 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 117' ' ' ALA . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 42' ' ' ILE . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.599 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.481 ' CB ' HD11 ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.635 ' HG2' HD21 ' A' ' 37' ' ' LEU . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.444 ' HB3' HG21 ' A' ' 94' ' ' VAL . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 HD22 ' A' ' 125' ' ' LEU . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.452 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.46 ' CB ' HD11 ' A' ' 64' ' ' ILE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CD1' HG11 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 51' ' ' ARG . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.999 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 66' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.397 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 35' ' ' VAL . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.767 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 118' ' ' LEU . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.572 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.799 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.823 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HG3' HD11 ' A' ' 131' ' ' ILE . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.687 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.783 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HE2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.823 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 132' ' ' VAL . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HB3' HG21 ' A' ' 94' ' ' VAL . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.695 ' CD1' HD22 ' A' ' 125' ' ' LEU . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' OE1' HD23 ' A' ' 125' ' ' LEU . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 66' ' ' ILE . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.834 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.734 ' CE ' HD13 ' A' ' 64' ' ' ILE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.734 HD13 ' CE ' ' A' ' 54' ' ' MET . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.015 HG21 HG23 ' A' ' 47' ' ' ILE . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 103' ' ' MET . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 43' ' ' THR . 3.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.518 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.446 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE2' HG12 ' A' ' 102' ' ' VAL . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.711 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.793 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 42' ' ' ILE . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.698 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.724 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.451 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.45 ' CB ' HD11 ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.581 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 33' ' ' GLY . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.716 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.755 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.767 HD12 HD22 ' A' ' 125' ' ' LEU . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 42' ' ' ILE . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 66' ' ' ILE . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.873 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.469 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.827 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 41' ' ' TRP . 4.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.922 0.391 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.497 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.611 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.77 HG12 ' OE2' ' A' ' 105' ' ' GLU . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.61 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.687 ' CD2' HD12 ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.77 ' OE2' HG12 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.086 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.086 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.852 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 117' ' ' ALA . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 42' ' ' ILE . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.755 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 36' ' ' ALA . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.852 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 33' ' ' GLY . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.611 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.787 HD12 HD22 ' A' ' 125' ' ' LEU . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.506 HE21 HG23 ' A' ' 42' ' ' ILE . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.847 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.504 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD2' HG12 ' A' ' 52' ' ' VAL . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.847 HG21 HG23 ' A' ' 47' ' ' ILE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 26.9 Cg_exo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 41' ' ' TRP . 2.2 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 41' ' ' TRP . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.523 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.812 HG12 ' OE2' ' A' ' 105' ' ' GLU . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.611 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.696 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.812 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.665 HG13 HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.049 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.411 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 117' ' ' ALA . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 HD12 ' A' ' 42' ' ' ILE . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.494 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 33' ' ' GLY . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 130' ' ' LYS . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.696 HD12 HD22 ' A' ' 125' ' ' LEU . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.456 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.59 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.813 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.834 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 103' ' ' MET . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.6 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.802 0.334 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.858 HG12 ' OE2' ' A' ' 105' ' ' GLU . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.858 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.044 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.044 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 42' ' ' ILE . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.607 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.435 ' CG ' HD12 ' A' ' 37' ' ' LEU . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.431 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 37' ' ' LEU . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 33' ' ' GLY . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HB2' HG22 ' A' ' 106' ' ' VAL . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 96' ' ' VAL . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.598 HD12 HD22 ' A' ' 125' ' ' LEU . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.031 HG23 HG21 ' A' ' 66' ' ' ILE . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' VAL . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.699 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 51' ' ' ARG . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.695 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 47' ' ' ILE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 66' ' ' ILE . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 41' ' ' TRP . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.55 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG13 HD11 ' A' ' 118' ' ' LEU . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.688 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.763 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 117' ' ' ALA . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 42' ' ' ILE . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.793 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.482 HG21 HD12 ' A' ' 125' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.572 ' HG2' HD21 ' A' ' 37' ' ' LEU . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.763 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 33' ' ' GLY . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 3.2 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG11 ' HE3' ' A' ' 130' ' ' LYS . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.809 HD12 HD22 ' A' ' 125' ' ' LEU . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 66' ' ' ILE . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.572 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 51' ' ' ARG . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.566 HD12 ' CG ' ' A' ' 51' ' ' ARG . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 42' ' ' ILE . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.8 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.929 0.395 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.558 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 66' ' ' ILE . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.637 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.54 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.788 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.803 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.809 HD22 HD12 ' A' ' 42' ' ' ILE . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.852 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.653 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 33' ' ' GLY . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.834 HG11 ' HE3' ' A' ' 130' ' ' LYS . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.666 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 HD22 ' A' ' 125' ' ' LEU . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 HG21 ' A' ' 66' ' ' ILE . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 48' ' ' GLU . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.589 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 106' ' ' VAL . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 66' ' ' ILE . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.3 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.666 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 118' ' ' LEU . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.49 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 42' ' ' ILE . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.862 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 125' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.834 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.833 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.753 HG21 HD12 ' A' ' 68' ' ' ILE . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 66' ' ' ILE . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.802 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.516 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CD1' HG11 ' A' ' 109' ' ' VAL . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.488 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.885 HG21 HG23 ' A' ' 47' ' ' ILE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 42' ' ' ILE . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 41' ' ' TRP . 15.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.858 0.361 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 98' ' ' LYS . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 97' ' ' VAL . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.419 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 35' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' CD ' ' A' ' 105' ' ' GLU . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 68' ' ' ILE . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 102' ' ' VAL . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.832 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.577 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD12 ' HA2' ' A' ' 122' ' ' GLY . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.724 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.773 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 36' ' ' ALA . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' HD21 ' A' ' 37' ' ' LEU . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.832 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 HD13 ' A' ' 131' ' ' ILE . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.725 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.563 HD21 ' CD ' ' A' ' 130' ' ' LYS . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.739 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.728 HD12 HD22 ' A' ' 125' ' ' LEU . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.906 HG23 HG21 ' A' ' 66' ' ' ILE . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 51' ' ' ARG . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.551 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.906 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.832 0.349 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 35' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.824 HG12 ' OE2' ' A' ' 105' ' ' GLU . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.725 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.824 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.538 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.736 ' HG3' HD11 ' A' ' 131' ' ' ILE . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HD12 ' A' ' 42' ' ' ILE . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.707 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.739 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.563 ' CD ' HD21 ' A' ' 37' ' ' LEU . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD12 ' HG3' ' A' ' 128' ' ' LYS . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' A' ' 94' ' ' VAL . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' HD22 ' A' ' 125' ' ' LEU . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.563 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.648 HD12 ' HD3' ' A' ' 51' ' ' ARG . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.706 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.5 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.891 0.376 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.549 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 68' ' ' ILE . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.707 HG13 HD11 ' A' ' 118' ' ' LEU . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.46 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.822 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.562 ' HD3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 117' ' ' ALA . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' A' ' 122' ' ' GLY . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.708 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 37' ' ' LEU . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HG2' HD21 ' A' ' 37' ' ' LEU . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 33' ' ' GLY . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.65 HD12 HD22 ' A' ' 125' ' ' LEU . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 42' ' ' ILE . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.88 HG23 HG21 ' A' ' 66' ' ' ILE . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.748 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.88 HG21 HG23 ' A' ' 47' ' ' ILE . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 42' ' ' ILE . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.99 0.424 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 35' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.839 HG12 ' OE2' ' A' ' 105' ' ' GLU . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.584 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.839 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.019 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.797 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.856 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 117' ' ' ALA . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.77 HD12 ' HA2' ' A' ' 122' ' ' GLY . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.727 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.465 ' CB ' HD11 ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.785 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 33' ' ' GLY . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.748 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.754 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 66' ' ' ILE . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.852 ' O ' HG23 ' A' ' 52' ' ' VAL . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.84 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 47' ' ' ILE . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 HG22 ' A' ' 66' ' ' ILE . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.959 0.409 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 41' ' ' TRP . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.593 ' HB3' HD13 ' A' ' 68' ' ' ILE . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.692 HG13 HD11 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.855 ' HG3' HD11 ' A' ' 131' ' ' ILE . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 117' ' ' ALA . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HD12 ' A' ' 42' ' ' ILE . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.748 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.747 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.505 ' CG ' HD12 ' A' ' 37' ' ' LEU . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 36' ' ' ALA . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.632 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.861 HG23 HD23 ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 1.3 ttt180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 125' ' ' LEU . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.888 HG23 HG21 ' A' ' 66' ' ' ILE . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 52' ' ' VAL . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.888 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HB3' ' A' ' 103' ' ' MET . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.53 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.416 HG12 ' CD ' ' A' ' 105' ' ' GLU . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.629 ' HB3' HD13 ' A' ' 68' ' ' ILE . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CD ' HG12 ' A' ' 102' ' ' VAL . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.565 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 117' ' ' ALA . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.69 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' HA2' ' A' ' 122' ' ' GLY . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.73 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' ALA . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.449 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.843 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.229 -0.009 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.868 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.716 HD12 HD22 ' A' ' 125' ' ' LEU . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 66' ' ' ILE . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.779 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' MET . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.6 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.912 0.387 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.544 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.83 HG12 ' OE2' ' A' ' 105' ' ' GLU . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.617 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.83 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.533 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 131' ' ' ILE . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 42' ' ' ILE . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.868 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.84 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.483 HG21 HD12 ' A' ' 125' ' ' LEU . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 132' ' ' VAL . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 96' ' ' VAL . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 125' ' ' LEU . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.87 HG23 HG21 ' A' ' 66' ' ' ILE . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 52' ' ' VAL . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.882 ' HG2' HD12 ' A' ' 64' ' ' ILE . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' ARG . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.882 HD12 ' HG2' ' A' ' 51' ' ' ARG . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.87 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 42' ' ' ILE . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 41' ' ' TRP . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 98' ' ' LYS . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.648 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 66' ' ' ILE . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 118' ' ' LEU . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.92 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.92 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.414 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.812 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.511 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 117' ' ' ALA . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 122' ' ' GLY . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.735 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.459 HG21 HD12 ' A' ' 125' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.812 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 33' ' ' GLY . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 118' ' ' LEU . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.919 HD12 HD22 ' A' ' 125' ' ' LEU . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.592 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.859 HG23 HG21 ' A' ' 66' ' ' ILE . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.464 ' HB2' HD11 ' A' ' 64' ' ' ILE . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.674 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.859 HG21 HG23 ' A' ' 47' ' ' ILE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.487 HD13 ' HB3' ' A' ' 103' ' ' MET . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.846 HG12 ' OE2' ' A' ' 105' ' ' GLU . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.846 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.662 HG13 HD11 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.067 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.067 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.62 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.738 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 42' ' ' ILE . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.652 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.752 ' HG2' HD21 ' A' ' 37' ' ' LEU . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 33' ' ' GLY . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.793 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.457 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.643 HD12 HD22 ' A' ' 125' ' ' LEU . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 66' ' ' ILE . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 48' ' ' GLU . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.486 ' CB ' HD11 ' A' ' 64' ' ' ILE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.988 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 103' ' ' MET . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.5 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 98' ' ' LYS . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.507 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.793 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.528 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.424 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.643 HD22 HD12 ' A' ' 42' ' ' ILE . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.688 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.776 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG2' HD21 ' A' ' 37' ' ' LEU . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.526 0.021 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.838 HD12 HD22 ' A' ' 125' ' ' LEU . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.429 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.936 HG23 HG21 ' A' ' 66' ' ' ILE . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.808 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.546 ' HE3' HG21 ' A' ' 64' ' ' ILE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.67 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.936 HG21 HG23 ' A' ' 47' ' ' ILE . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 103' ' ' MET . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 43' ' ' THR . 3.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.355 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.584 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 68' ' ' ILE . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.646 ' CE2' HD12 ' A' ' 66' ' ' ILE . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 118' ' ' LEU . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.729 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 117' ' ' ALA . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.838 HD22 HD12 ' A' ' 42' ' ' ILE . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.655 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.75 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.423 ' CB ' HD11 ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.464 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.781 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 94' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 125' ' ' LEU . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.46 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 66' ' ' ILE . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 121' ' ' ALA . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HG2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.549 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.859 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 66' ' ' ILE . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 41' ' ' TRP . 10.5 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.45 HG22 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.864 HG12 ' OE2' ' A' ' 105' ' ' GLU . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.622 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.864 ' OE2' HG12 ' A' ' 102' ' ' VAL . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.703 HG13 HD11 ' A' ' 118' ' ' LEU . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.03 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.459 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.703 HD22 HD12 ' A' ' 42' ' ' ILE . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.781 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ALA . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.553 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.4 ' HB3' HG21 ' A' ' 94' ' ' VAL . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 68' ' ' ILE . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 42' ' ' ILE . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.853 HG23 HG21 ' A' ' 66' ' ' ILE . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.78 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 64' ' ' ILE . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.719 ' CD1' HG11 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.853 HG21 HG23 ' A' ' 47' ' ' ILE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.595 HD12 HG21 ' A' ' 42' ' ' ILE . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 43' ' ' THR . 11.0 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.821 HG12 ' OE2' ' A' ' 105' ' ' GLU . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.651 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CD2' HD12 ' A' ' 66' ' ' ILE . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.821 ' OE2' HG12 ' A' ' 102' ' ' VAL . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.072 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.072 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.888 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 125' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 33' ' ' GLY . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.592 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.571 HD21 ' HG2' ' A' ' 130' ' ' LYS . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.627 HD12 HD22 ' A' ' 125' ' ' LEU . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.008 HG23 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.882 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.5 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.549 HG23 ' CG1' ' A' ' 106' ' ' VAL . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.008 HG21 HG23 ' A' ' 47' ' ' ILE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 103' ' ' MET . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.965 0.412 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 98' ' ' LYS . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.592 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.568 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.668 HG13 HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.017 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 131' ' ' ILE . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 117' ' ' ALA . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.627 HD22 HD12 ' A' ' 42' ' ' ILE . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.635 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.721 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 36' ' ' ALA . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.571 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.963 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.972 HG23 HG21 ' A' ' 66' ' ' ILE . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 48' ' ' GLU . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.538 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ARG . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 109' ' ' VAL . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.705 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.972 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 103' ' ' MET . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo . . . . . 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 96' ' ' VAL . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.554 HG13 ' HG2' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.481 HG12 ' OE1' ' A' ' 105' ' ' GLU . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.67 ' CE2' HD12 ' A' ' 66' ' ' ILE . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.094 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.867 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 117' ' ' ALA . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.963 HD22 HD12 ' A' ' 42' ' ' ILE . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.716 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.73 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HG2' HD21 ' A' ' 37' ' ' LEU . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.867 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 33' ' ' GLY . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -115.06 -38.56 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mmm -140.02 88.05 12.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.78 171.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.589 2.192 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -112.4 44.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -157.43 -44.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.45 147.7 50.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.828 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.22 100.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -93.37 145.97 24.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -146.63 172.56 13.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.79 164.45 24.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -102.62 120.5 40.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 60.62 160.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.79 -41.95 2.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -68.11 163.97 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.43 121.63 8.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -82.08 -27.57 32.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.92 -83.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.61 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 67.96 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.06 98.41 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.12 27.94 3.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.54 85.49 1.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.46 131.09 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.655 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 p90 -112.5 -48.96 2.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' TYR . 3.1 t -161.6 -68.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.643 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 61.72 118.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.273 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 62.3 142.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 78.03 -173.14 55.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.03 -31.84 9.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.546 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 HD22 ' A' ' 125' ' ' LEU . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 42' ' ' ILE . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 66' ' ' ILE . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.785 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ARG . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 120' ' ' ILE . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' C ' HD13 ' A' ' 66' ' ' ILE . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 103' ' ' MET . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 122.32 8.75 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.26 -46.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 124.74 89.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.01 151.45 27.31 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.09 . . . . 0.0 112.19 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -122.87 99.08 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.6 p -119.17 143.94 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.049 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.73 31.35 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 121.89 39.63 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.76 -56.33 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.457 2.105 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mt -114.52 132.51 56.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.71 33.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -87.58 110.52 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 60.74 32.33 20.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mmm -138.21 134.85 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.16 163.84 9.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -95.14 18.09 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.34 -74.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.14 128.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.9 159.94 53.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -74.93 111.72 10.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.51 141.26 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.72 46.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.8 -177.81 46.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.89 157.35 24.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 41' ' ' TRP . 3.0 m -137.33 170.15 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' C ' ' A' ' 26' ' ' TYR . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.76 ' HB3' HD13 ' A' ' 68' ' ' ILE . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 66' ' ' ILE . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.641 ' OE1' HG12 ' A' ' 102' ' ' VAL . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.738 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.584 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 117' ' ' ALA . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.653 HD22 HD12 ' A' ' 42' ' ' ILE . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.701 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.729 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' CG ' HD12 ' A' ' 37' ' ' LEU . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.448 ' CB ' HD11 ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.929 HG21 ' OH ' ' A' ' 137' ' ' TYR . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -77.42 165.31 24.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 27' ' ' VAL . 5.4 mtp180 -47.04 89.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 133' ' ' ARG . 11.1 t0 66.69 44.7 2.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.014 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.676 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.74 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.929 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.81 113.42 16.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.38 160.37 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -73.23 147.82 44.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.57 101.03 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.847 0.356 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.44 103.27 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.754 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -141.53 105.34 5.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.76 56.96 4.87 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.486 2.124 . . . . 0.0 112.621 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.27 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -132.78 168.46 18.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 mtt -63.51 144.19 57.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -59.88 -64.91 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.12 44.46 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.7 124.28 27.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -86.26 142.16 28.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 117.52 34.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -114.44 160.62 18.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.42 46.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.42 51.32 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.429 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.15 147.46 39.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.87 85.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -27.53 28.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.1 -156.7 40.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.16 104.51 12.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -102.26 -28.92 11.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 151.12 51.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.975 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.2 -48.41 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.582 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.87 129.55 2.07 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.539 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.91 144.63 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.1 p90 -114.39 -48.13 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.867 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.6 t -164.79 -41.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.616 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 74.84 -73.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.73 164.93 27.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.21 162.91 31.66 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -76.31 -30.59 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.59 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.831 HD12 HD22 ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 52' ' ' VAL . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.518 ' HE3' HG21 ' A' ' 64' ' ' ILE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.518 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 71.8 Cg_endo -76.95 105.49 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.97 -44.85 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -66.91 143.98 98.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.045 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.74 149.85 43.8 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.546 2.164 . . . . 0.0 112.373 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -106.24 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.2 p -119.44 105.01 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -87.43 81.17 7.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 117.77 65.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.05 157.33 62.16 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.063 . . . . 0.0 112.275 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.36 118.44 22.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.08 121.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 102.34 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.35 -170.24 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.0 tpt -73.26 145.86 45.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.91 142.76 25.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.11 18.06 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.47 -101.11 2.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -45.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.37 -143.67 17.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -122.18 143.71 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -90.32 147.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -94.65 43.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.14 -164.36 42.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 21.2 m-85 -120.63 147.47 45.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.939 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.17 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.87 HG12 ' OE2' ' A' ' 105' ' ' GLU . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.609 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.87 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.98 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.98 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.504 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HG3' HD11 ' A' ' 131' ' ' ILE . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.831 HD22 HD12 ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.734 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.513 ' CG ' HD12 ' A' ' 37' ' ' LEU . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.919 HG21 ' OH ' ' A' ' 137' ' ' TYR . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -79.09 165.47 23.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 27' ' ' VAL . 3.0 ttp180 -47.4 90.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.251 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.6 t70 66.77 44.09 2.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.136 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.665 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.68 94.49 4.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.401 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.919 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.83 106.76 9.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.947 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -98.77 148.91 23.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.02 120.68 17.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.29 98.86 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.9 mp 59.47 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.74 109.76 43.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 173.82 8.9 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.236 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.73 89.52 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -140.35 32.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 103.79 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.64 31.77 2.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -149.07 162.29 40.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.29 149.72 26.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.99 33.71 2.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -93.51 113.31 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.88 121.8 41.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -84.69 118.87 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.87 -34.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -91.05 160.0 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -79.53 136.24 36.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -27.65 18.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.042 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.11 3.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 164.5 3.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.42 105.17 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 43.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.557 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.68 102.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.41 130.87 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' VAL . 20.5 t80 -83.53 -75.6 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.993 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 134' ' ' ARG . 53.1 t -157.36 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.788 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.686 ' HB3' HH12 ' A' ' 67' ' ' ARG . . . 50.29 -173.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.349 . . . . 0.0 111.4 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.71 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -112.54 170.56 13.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.642 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -58.48 -41.46 85.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 129' ' ' THR . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 96' ' ' VAL . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 125' ' ' LEU . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.613 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 103' ' ' MET . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.78 111.08 2.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.5 -44.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 135.04 86.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.697 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 160.66 46.21 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.392 2.062 . . . . 0.0 112.251 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 2.8 t80 -126.08 92.49 3.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.6 p -119.23 107.75 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.134 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HZ1' ' HZ3' ' A' ' 41' ' ' TRP . 5.3 mmtp -139.75 101.37 4.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.56 94.41 44.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.0 -45.01 44.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.489 2.126 . . . . 0.0 112.204 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.64 155.38 40.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.14 84.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.5 t -87.26 129.0 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 59.01 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 62.6 mtp -144.78 130.83 19.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.39 85.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -105.95 17.98 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.15 44.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -162.77 118.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.34 144.47 16.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -124.09 127.52 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 90' ' ' VAL . 12.0 p -106.04 124.94 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -93.8 46.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.85 175.75 42.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.367 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.62 161.89 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.17 172.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.225 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 98' ' ' LYS . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' N ' HG12 ' A' ' 97' ' ' VAL . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.481 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.57 ' HE1' HD11 ' A' ' 127' ' ' ILE . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.773 HG13 HD11 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.478 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.846 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.66 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.736 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.812 HD22 HD12 ' A' ' 42' ' ' ILE . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.71 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 36' ' ' ALA . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.846 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.546 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 4.8 ttt180 -68.19 165.62 17.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HG2' HG11 ' A' ' 27' ' ' VAL . 13.6 mtm180 -56.88 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.3 m-20 -164.12 26.44 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.601 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.56 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -115.6 93.98 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.752 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.8 m-85 -128.29 104.06 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -85.9 96.67 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -72.18 170.61 13.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.72 96.49 6.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.913 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.816 0.341 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.33 82.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 mmm -135.24 109.72 10.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 168.13 19.78 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.335 2.023 . . . . 0.0 112.313 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 61.17 96.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -164.47 89.17 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.9 mtt -81.96 169.3 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.26 117.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -108.51 152.29 24.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 108.56 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.56 156.56 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 128.22 35.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.55 130.28 43.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -76.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.56 -95.72 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.621 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 163.23 22.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -98.08 142.14 30.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -88.1 -27.56 21.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.53 -119.95 1.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.644 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.18 164.51 3.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.12 -174.5 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.42 178.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.22 116.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.569 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.77 144.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' ' 102' ' ' VAL . 2.7 m-20 -69.24 102.88 1.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.9 p90 -107.42 -38.8 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 134' ' ' ARG . 25.2 t -159.96 145.97 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.79 -72.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.439 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -138.59 -56.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.37 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -46.59 155.16 0.73 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.049 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -54.89 -32.94 61.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 131' ' ' ILE . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.636 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.436 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 94' ' ' VAL . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 68' ' ' ILE . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 66' ' ' ILE . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.825 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 HG21 ' A' ' 42' ' ' ILE . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.93 104.42 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.59 -42.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 129.58 94.03 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.83 157.28 29.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.498 2.132 . . . . 0.0 112.168 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' HD2' HG11 ' A' ' 94' ' ' VAL . 7.8 t80 -127.0 101.96 6.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.9 p -119.09 127.07 53.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -86.75 111.74 21.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.2 94.38 30.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' HG2' HG22 ' A' ' 81' ' ' VAL . 59.7 Cg_endo -72.53 176.96 8.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.422 2.081 . . . . 0.0 112.252 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.39 128.62 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 60.64 75.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.924 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 78' ' ' PRO . 21.4 t -86.67 127.32 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -35.89 14.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -102.83 31.15 4.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' VAL . . . -115.72 96.46 0.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.67 18.12 22.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.7 0.286 . . . . 0.0 111.287 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.58 -117.0 0.79 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -125.29 110.27 13.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 0.0 110.803 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.69 -137.79 7.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -71.41 133.61 46.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.332 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.36 137.48 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.67 52.0 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -173.94 49.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -115.73 151.31 35.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.463 HG11 ' HD2' ' A' ' 74' ' ' TYR . 17.0 m -141.84 155.73 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.186 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.838 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.77 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.724 ' HG3' HD11 ' A' ' 131' ' ' ILE . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.642 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.642 HD12 ' HA2' ' A' ' 122' ' ' GLY . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.691 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.78 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.958 HG21 ' OH ' ' A' ' 137' ' ' TYR . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -80.3 165.5 22.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.602 ' HA ' HG11 ' A' ' 27' ' ' VAL . 1.2 mtt-85 -46.84 89.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.3 t70 65.48 45.83 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.014 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.652 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.8 94.29 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.958 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -127.03 101.0 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.985 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.02 93.53 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.05 141.85 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.8 106.87 19.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.906 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.782 0.325 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 3' ' ' MET . 0.5 OUTLIER -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.593 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -97.93 137.75 20.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.06 93.51 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.527 2.151 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.03 96.05 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -92.67 127.37 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tpt -93.72 169.78 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 148.28 38.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -165.42 35.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.991 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 162.5 14.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 65.83 126.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -73.99 166.89 22.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -85.2 118.22 24.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 60.49 179.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.62 -47.06 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -137.73 139.38 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.78 31.22 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -27.53 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.27 24.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.58 158.53 22.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 111.059 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -150.35 77.75 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.35 152.54 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.59 91.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.61 136.54 16.11 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 141.57 53.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 27' ' ' VAL . 4.3 p90 -107.66 -46.15 3.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.75 HG11 ' HG2' ' A' ' 134' ' ' ARG . 18.0 t -161.09 -49.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.677 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.55 -69.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.486 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -122.38 169.2 11.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 62.8 148.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.685 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.79 -38.46 85.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.511 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 128' ' ' LYS . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.757 HD12 HD22 ' A' ' 125' ' ' LEU . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' HD23 ' A' ' 125' ' ' LEU . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 66' ' ' ILE . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.514 HG21 ' HE3' ' A' ' 54' ' ' MET . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 103' ' ' MET . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 25.0 Cg_exo -62.82 106.79 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.33 -46.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 120.08 78.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.7 141.78 52.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.266 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 94' ' ' VAL . 11.4 t80 -112.89 100.23 8.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.7 p -119.31 130.65 55.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -91.41 115.18 27.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.935 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -107.22 94.35 11.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' HG22 ' A' ' 81' ' ' VAL . 73.3 Cg_endo -77.61 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.479 2.119 . . . . 0.0 112.248 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 tp -74.63 121.13 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 62.39 85.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 78' ' ' PRO . 20.5 t -99.23 137.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.178 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -87.2 -79.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.6 mtp 55.02 179.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.75 29.25 64.13 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.33 -18.13 14.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 111.169 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.67 -53.92 0.15 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -162.38 145.31 11.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.79 106.42 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -70.11 138.78 52.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG22 ' N ' ' A' ' 91' ' ' GLU . 9.5 p -72.0 157.82 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 mm-40 -94.96 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.78 -173.11 53.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -123.29 164.01 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.8 m -144.0 167.74 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.814 HG12 ' OE2' ' A' ' 105' ' ' GLU . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.494 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CE2' HD12 ' A' ' 66' ' ' ILE . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.814 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG13 HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.919 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.772 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.772 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.746 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 37' ' ' LEU . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.436 ' CB ' HD11 ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HG2' HD21 ' A' ' 37' ' ' LEU . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.913 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.02 165.55 21.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.75 ' HG2' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -44.93 88.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.425 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 133' ' ' ARG . 2.6 t70 66.73 44.06 2.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.984 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.708 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.78 94.43 4.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.392 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.913 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.83 116.19 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -103.88 157.54 17.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.51 107.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.56 98.26 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.904 0.383 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -80.18 168.14 19.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.73 148.1 34.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.32 113.37 3.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.76 104.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -83.03 -32.29 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -94.32 130.42 40.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt 61.67 153.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.3 167.58 10.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -80.75 124.41 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.16 107.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.26 135.03 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.57 125.58 42.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.43 159.97 8.92 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.502 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 60.76 157.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -87.1 122.64 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -27.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.53 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 134.18 56.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.314 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.13 33.41 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -104.92 144.35 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.36 -176.62 21.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.442 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.1 -102.85 2.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 102' ' ' VAL . 10.4 m-20 -137.0 128.09 27.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.0 p90 -119.34 -47.61 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.981 0.42 . . . . 0.0 111.21 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 26' ' ' TYR . 7.0 t -160.25 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.812 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.21 -69.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -124.62 168.42 13.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.174 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 67.36 154.64 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.634 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -66.29 -33.31 75.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.773 HD21 ' HG2' ' A' ' 130' ' ' LYS . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.869 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.929 HD12 HD22 ' A' ' 125' ' ' LEU . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.512 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.79 ' OE1' HD23 ' A' ' 125' ' ' LEU . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 66' ' ' ILE . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 47' ' ' ILE . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo -72.83 104.41 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.21 -40.21 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -78.41 130.31 71.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.798 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 147.67 63.65 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.42 113.7 24.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.2 p -118.78 131.21 56.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -96.6 72.14 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -113.66 94.35 32.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.56 -171.37 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.41 2.073 . . . . 0.0 112.298 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 133.37 42.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 60.13 101.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.16 119.71 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -97.34 168.3 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 ttt 60.88 36.23 19.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.64 -165.94 16.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.503 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -100.14 -18.04 17.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.266 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.1 -98.64 1.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.75 109.24 2.03 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.583 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -135.58 154.22 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.796 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.96 129.93 56.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -93.22 55.73 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.43 -175.92 5.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.426 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -107.13 163.98 12.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.9 m -137.29 171.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.354 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 98' ' ' LYS . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 25' ' ' ASP . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.58 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.876 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 117' ' ' ALA . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.591 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD22 HD12 ' A' ' 42' ' ' ILE . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.643 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.483 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 36' ' ' ALA . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.773 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.876 HG23 HD23 ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -76.32 165.47 24.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HA ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -47.1 89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.185 178.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.8 t0 67.05 44.92 1.85 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.971 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.669 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.77 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.487 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.93 108.53 11.05 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.78 114.89 26.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.85 103.72 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.55 95.25 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.182 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.958 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -60.5 157.05 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.31 145.16 30.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.21 -23.9 17.46 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 112.39 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 64.21 164.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.55 116.61 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 mtm -86.25 167.15 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -94.06 177.64 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 62.97 77.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -111.98 118.19 34.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.27 81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.006 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -106.05 116.89 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.95 115.56 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -72.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.31 -78.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -174.91 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.1 -167.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -78.85 -7.89 58.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.384 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.77 76.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.565 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 133.75 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 111.112 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -83.7 -178.45 7.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -65.15 175.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -37.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.91 -129.36 1.85 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.581 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -91.66 -177.74 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.467 . . . . 0.0 110.996 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -136.7 116.16 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.536 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG11 ' HG2' ' A' ' 134' ' ' ARG . 3.0 t -25.75 -47.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.102 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 73.09 -77.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -115.91 163.12 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 69.05 136.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.693 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -26.92 63.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.635 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.705 HD12 HD22 ' A' ' 125' ' ' LEU . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HB2' HG22 ' A' ' 42' ' ' ILE . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.924 HG23 HG21 ' A' ' 66' ' ' ILE . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.928 ' CD1' HG11 ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HD3' ' A' ' 51' ' ' ARG . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.924 HG21 HG23 ' A' ' 47' ' ' ILE . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 42' ' ' ILE . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.89 106.71 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -129.1 21.36 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.1 119.68 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.36 142.45 47.29 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.373 2.049 . . . . 0.0 112.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.53 95.99 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' VAL . 21.2 p -119.26 147.09 44.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -137.45 50.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.429 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -108.72 138.62 20.34 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.897 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.4 177.91 7.73 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.476 2.117 . . . . 0.0 112.285 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.05 116.55 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -163.2 -52.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.31 147.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 38.77 3.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.98 149.98 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.08 158.8 22.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 -18.14 22.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.146 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 139.95 -58.25 0.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.489 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 -30.74 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.61 132.02 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.57 69.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 75' ' ' THR . 11.5 p -74.75 150.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.25 50.03 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.826 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.2 178.11 2.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.7 164.05 12.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -128.99 174.4 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.327 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 98' ' ' LYS . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 25' ' ' ASP . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.584 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.807 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.071 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.071 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.412 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.442 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 117' ' ' ALA . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 42' ' ' ILE . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.599 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.481 ' CB ' HD11 ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.635 ' HG2' HD21 ' A' ' 37' ' ' LEU . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.854 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.23 165.69 21.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' HG2' HG11 ' A' ' 27' ' ' VAL . 1.7 mtm180 -45.07 88.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.571 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 70.31 40.32 1.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.481 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.586 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.7 94.83 4.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.899 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.854 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.43 92.82 3.64 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -115.92 130.88 57.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.14 104.41 3.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.15 94.95 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.9 0.381 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.98 -67.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.92 112.61 26.22 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.64 125.63 7.66 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.45 2.1 . . . . 0.0 112.374 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.64 134.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 58.32 106.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.36 129.8 36.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -67.52 -30.98 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.71 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.27 154.61 18.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -127.0 -45.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -66.46 120.34 13.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 155.67 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -109.59 168.48 9.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.75 -72.92 0.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -115.37 176.82 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.58 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.824 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -82.32 -27.48 32.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.83 -94.56 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.11 115.07 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -108.27 32.94 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -84.27 148.69 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 25.92 8.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.36 171.4 13.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.548 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -94.9 17.47 13.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.688 0.28 . . . . 0.0 111.399 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 27' ' ' VAL . 91.9 t80 51.39 -92.48 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.167 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 26' ' ' TYR . 4.6 t -165.26 -79.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.4 . . . . 0.0 110.047 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.627 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 51.79 176.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.827 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 62.91 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.509 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -100.28 168.9 21.25 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.891 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.03 -41.27 86.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.444 ' HB3' HG21 ' A' ' 94' ' ' VAL . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 HD22 ' A' ' 125' ' ' LEU . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.452 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.46 ' CB ' HD11 ' A' ' 64' ' ' ILE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CD1' HG11 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 51' ' ' ARG . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.999 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 66' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo -71.09 108.88 2.43 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -120.89 -41.55 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 126.84 87.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.95 155.11 57.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.424 2.083 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -127.5 88.76 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.209 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.4 p -119.43 135.76 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.62 121.02 18.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 147.56 45.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.47 125.67 11.46 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.71 126.62 29.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 65.9 -68.8 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.9 148.77 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.23 147.62 47.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.8 ttm -164.21 177.22 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.33 172.65 21.58 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -96.02 18.07 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.619 0.247 . . . . 0.0 111.152 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.31 -148.38 5.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 -31.79 11.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.51 134.03 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.412 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.74 152.0 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.12 138.27 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.049 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.34 47.56 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.91 178.81 31.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.483 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.34 163.46 12.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.4 m -137.81 174.62 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 35' ' ' VAL . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' O ' ' A' ' 26' ' ' TYR . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.767 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 118' ' ' LEU . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.572 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.799 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.823 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HG3' HD11 ' A' ' 131' ' ' ILE . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.687 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.783 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HE2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.823 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.867 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -92.55 118.48 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.448 ' N ' HG21 ' A' ' 27' ' ' VAL . 2.8 mtm180 42.14 -104.42 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.494 0.664 . . . . 0.0 111.801 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.78 46.12 0.94 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.108 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.72 93.88 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.354 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.867 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.0 m-85 -127.84 117.5 21.94 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.91 94.47 6.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.75 103.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.75 98.74 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.844 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.15 176.75 7.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.11 102.2 37.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -51.59 -176.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 62.57 112.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 170.58 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.42 172.6 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 59.99 157.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.66 127.82 32.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.94 152.5 27.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -24.23 67.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -63.97 129.87 41.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.48 142.81 44.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.73 -44.73 6.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.826 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.16 155.24 21.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 60.17 160.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.73 -178.24 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 23.53 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.09 67.91 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.39 153.63 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 p -80.61 -31.57 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -130.52 103.79 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.76 148.26 19.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.61 179.65 33.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -87.17 -21.34 25.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.698 0.285 . . . . 0.0 111.103 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.804 ' O ' HG23 ' A' ' 27' ' ' VAL . 41.8 t80 69.43 -99.06 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 26' ' ' TYR . 4.9 t -168.88 126.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . . . -50.52 -70.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.754 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 71.2 m-85 -158.61 -47.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -51.05 157.02 2.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.828 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.89 -36.93 65.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HB3' HG21 ' A' ' 94' ' ' VAL . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.695 ' CD1' HD22 ' A' ' 125' ' ' LEU . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' OE1' HD23 ' A' ' 125' ' ' LEU . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 66' ' ' ILE . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.834 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.734 ' CE ' HD13 ' A' ' 64' ' ' ILE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.734 HD13 ' CE ' ' A' ' 54' ' ' MET . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.015 HG21 HG23 ' A' ' 47' ' ' ILE . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 103' ' ' MET . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo -71.38 104.39 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.18 -47.13 2.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.19 142.13 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.59 153.57 44.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.422 2.082 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.41 87.42 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 p -118.98 139.08 52.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -108.3 63.63 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 94.21 45.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.05 -58.53 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.697 2.265 . . . . 0.0 112.218 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.601 HD12 ' H ' ' A' ' 79' ' ' LEU . 4.9 mp -60.49 143.32 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.4 -177.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.61 148.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -57.95 -31.12 66.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -88.35 148.09 24.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.92 -156.59 23.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -85.11 -18.14 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.36 42.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -177.4 151.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.46 135.73 1.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.571 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -84.88 94.6 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -80.2 136.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.12 60.08 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.3 -154.65 52.69 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -123.99 149.67 45.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 43' ' ' THR . 3.3 m -145.49 172.57 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.294 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.518 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 25' ' ' ASP . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 28' ' ' ALA . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.711 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.793 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 42' ' ' ILE . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.698 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.724 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.451 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.45 ' CB ' HD11 ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.581 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.884 HG21 ' OH ' ' A' ' 137' ' ' TYR . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -75.78 165.39 25.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HA ' HG21 ' A' ' 27' ' ' VAL . 11.6 ttp180 -48.89 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.112 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 133' ' ' ARG . 24.3 t0 73.63 38.92 0.59 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.638 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.88 94.16 4.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.1 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.884 ' OH ' HG21 ' A' ' 132' ' ' VAL . 2.1 m-85 -127.19 119.05 25.52 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.031 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.2 94.74 9.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.68 112.62 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.46 104.38 11.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.859 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.4 120.79 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.59 127.49 60.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.74 132.26 48.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.413 2.075 . . . . 0.0 112.258 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -84.25 99.26 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 60.98 -175.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mtt -63.41 122.68 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -68.2 110.95 4.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 166.67 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.17 119.37 36.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -120.64 -54.45 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -64.0 152.33 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -107.22 149.7 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.08 5.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.01 153.81 34.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.8 166.21 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.9 133.73 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -96.43 23.53 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -96.28 178.26 34.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -59.11 172.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.18 151.95 33.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.23 -179.29 16.51 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.96 108.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.29 154.13 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.688 ' O ' HG23 ' A' ' 27' ' ' VAL . 3.8 t80 -179.4 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.7 t 123.07 -80.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.294 0.996 . . . . 0.0 109.93 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.55 167.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.476 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.441 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 3.9 m-85 62.63 -79.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.794 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -90.91 165.01 30.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.69 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -71.96 -26.08 62.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.716 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.755 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.767 HD12 HD22 ' A' ' 125' ' ' LEU . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 42' ' ' ILE . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 66' ' ' ILE . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.873 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.469 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.827 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 29' ' ' PHE . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.8 112.16 3.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -132.02 -45.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 126.18 89.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.38 171.48 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 2.3 t80 -124.5 86.1 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.9 p -119.32 128.56 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -104.93 30.79 5.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 96.73 40.46 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 149.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.577 2.185 . . . . 0.0 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.47 134.49 34.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG23 ' A' ' 81' ' ' VAL . 14.7 pt-20 -159.35 -46.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' A' ' 80' ' ' GLU . 21.6 t -112.94 134.69 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.96 92.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.7 88.14 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.13 136.15 7.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.424 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -87.1 -18.14 31.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.92 -88.69 2.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 157.11 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.28 -160.46 31.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.487 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -59.54 119.02 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.38 137.07 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 mm-40 -87.0 55.64 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 -170.28 28.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.92 157.42 18.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 41' ' ' TRP . 4.0 m -146.07 174.49 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.137 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.497 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.611 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.77 HG12 ' OE2' ' A' ' 105' ' ' GLU . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.61 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.687 ' CD2' HD12 ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.77 ' OE2' HG12 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.794 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.086 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.086 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.852 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 117' ' ' ALA . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 42' ' ' ILE . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.755 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 36' ' ' ALA . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.852 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.87 165.42 21.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.84 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.4 t70 71.96 37.68 1.0 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.705 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.589 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.75 94.89 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.743 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.827 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.38 89.96 3.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.68 129.13 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.49 107.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.39 94.83 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.049 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.906 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.22 106.04 2.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.88 116.35 58.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.2 -28.02 19.19 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.427 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -165.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 64.1 99.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 ptp -80.0 115.45 19.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.83 -35.63 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -88.56 -179.9 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.65 132.65 53.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -122.4 114.2 20.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -88.05 137.86 31.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.8 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -164.32 102.11 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.61 68.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.35 164.01 14.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 -170.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -88.94 -27.5 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.54 89.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . . . -109.23 164.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.748 HG21 HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -131.94 140.68 49.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 153.74 30.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.88 -172.09 25.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.573 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 58.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -141.44 -176.08 4.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.976 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -139.43 117.62 11.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.763 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 28' ' ' ALA . 6.3 t -28.56 -74.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.843 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 63.06 126.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.206 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 59.58 96.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.785 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 111.57 167.82 18.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.07 -38.72 15.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.611 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD13 HG21 ' A' ' 21' ' ' THR . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.787 HD12 HD22 ' A' ' 125' ' ' LEU . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.506 HE21 HG23 ' A' ' 42' ' ' ILE . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.847 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.504 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD2' HG12 ' A' ' 52' ' ' VAL . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.847 HG21 HG23 ' A' ' 47' ' ' ILE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 26.9 Cg_exo -62.33 129.37 26.61 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.46 -46.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -76.86 111.41 16.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.69 124.54 10.32 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.348 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.684 ' CD2' HG13 ' A' ' 94' ' ' VAL . 8.2 p90 -102.41 144.41 30.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.598 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 p -118.79 135.96 54.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.124 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -142.25 113.54 7.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -112.68 94.37 28.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.66 -42.8 63.96 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.555 2.17 . . . . 0.0 112.223 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 161.53 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.32 154.07 42.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 82' ' ' ARG . 21.5 t -93.52 154.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -131.87 -46.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.15 103.34 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.96 95.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -18.04 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.664 0.268 . . . . 0.0 111.227 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -156.65 57.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -145.14 61.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.82 109.37 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -95.11 95.71 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.692 HG22 ' H ' ' A' ' 92' ' ' GLY . 8.1 p -65.09 137.03 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.66 28.81 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 90' ' ' VAL . . . 122.31 171.78 13.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.417 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.32 158.23 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 ' CD2' ' A' ' 74' ' ' TYR . 2.2 m -136.11 173.83 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 41' ' ' TRP . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.523 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.812 HG12 ' OE2' ' A' ' 105' ' ' GLU . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.611 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.696 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.812 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.665 HG13 HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.049 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.411 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 117' ' ' ALA . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 HD12 ' A' ' 42' ' ' ILE . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.494 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -87.13 165.86 15.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' HA ' HG21 ' A' ' 27' ' ' VAL . 26.1 mtp180 -43.99 87.99 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.713 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.4 t0 69.25 40.25 1.55 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.494 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.592 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.76 95.01 5.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.855 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.24 112.9 16.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.89 116.0 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.02 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 131.95 40.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -98.03 97.04 8.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.8 0.333 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.72 -45.99 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mmt -113.26 90.07 15.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -51.08 173.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.506 2.138 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -73.64 136.98 43.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -132.26 100.58 5.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.58 154.32 40.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 113.44 7.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 60.65 51.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -110.98 118.12 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -114.36 148.74 37.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.11 164.65 10.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.92 117.14 33.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -47.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.31 140.57 11.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 60.35 164.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.44 141.42 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -27.61 17.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.86 -58.97 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.53 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.69 140.7 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.102 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.06 59.18 5.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -116.86 173.11 6.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.34 -43.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.521 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.51 -109.33 1.84 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.356 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.12 118.35 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.311 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.827 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.4 p90 -107.88 -50.33 3.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.5 t -170.99 132.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . . . -108.84 99.83 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 62.12 170.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 69.01 -173.35 35.36 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 0.7 OUTLIER -97.46 -42.88 7.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 130' ' ' LYS . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.696 HD12 HD22 ' A' ' 125' ' ' LEU . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.456 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.59 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.813 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.834 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 103' ' ' MET . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo -63.0 104.55 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 -43.69 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 142.84 87.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.86 146.06 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.95 85.97 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.2 p -119.37 107.67 13.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.225 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -69.12 100.68 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.671 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.49 94.31 8.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -167.69 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.477 2.118 . . . . 0.0 112.118 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 104.3 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.79 120.88 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.04 130.13 67.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? 60.63 68.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 ptm -178.78 101.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.9 41.88 0.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.444 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -98.24 18.1 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.44 -136.85 4.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -177.61 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.9 -114.87 4.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -115.4 133.03 56.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.332 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -83.78 149.88 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.6 48.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -169.7 30.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.59 154.77 25.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.6 m -134.74 174.49 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.858 HG12 ' OE2' ' A' ' 105' ' ' GLU . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.858 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.044 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.044 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 42' ' ' ILE . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.607 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.435 ' CG ' HD12 ' A' ' 37' ' ' LEU . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.431 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 37' ' ' LEU . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.9 HG21 ' OH ' ' A' ' 137' ' ' TYR . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.74 165.79 21.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.63 ' HG2' HG11 ' A' ' 27' ' ' VAL . 9.3 mtm-85 -44.66 88.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.479 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.5 t70 68.25 43.17 1.57 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.078 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.677 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.75 94.61 4.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.277 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.9 ' OH ' HG21 ' A' ' 132' ' ' VAL . 2.0 m-85 -126.62 108.35 11.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.62 127.87 55.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.785 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.55 114.18 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.45 98.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.17 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.789 0.328 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.25 117.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtp -121.55 139.94 30.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.62 143.09 29.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.82 165.11 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 128.89 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 ptp -80.02 153.9 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -142.58 -47.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -61.94 141.0 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.35 111.82 23.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp 60.69 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -74.11 121.51 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -94.03 129.72 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 60.14 -173.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.37 89.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -105.03 160.43 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -83.87 171.18 13.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -78.74 -27.63 44.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.78 63.87 0.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.543 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 99.89 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.334 . . . . 0.0 111.125 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -109.98 -32.13 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 136.09 40.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.61 34.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.564 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.51 -26.82 3.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.602 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -73.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.119 0.485 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 62.29 118.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.692 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 137' ' ' TYR . 28.7 t -34.07 143.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.261 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.27 77.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 111.586 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 0.1 OUTLIER 170.58 -58.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.89 -167.65 11.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.03 -47.17 78.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HB2' HG22 ' A' ' 106' ' ' VAL . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 96' ' ' VAL . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.598 HD12 HD22 ' A' ' 125' ' ' LEU . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.031 HG23 HG21 ' A' ' 66' ' ' ILE . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' VAL . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.699 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 51' ' ' ARG . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.695 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 47' ' ' ILE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 66' ' ' ILE . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 72.4 Cg_endo -76.66 123.03 6.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -137.83 -46.07 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 144.07 98.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.27 156.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.554 2.169 . . . . 0.0 112.317 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.55 88.19 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.043 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.6 p -119.27 105.04 10.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.045 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 22.7 mttm -112.64 81.03 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.12 94.24 47.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.728 2.285 . . . . 0.0 112.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 148.53 28.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.996 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.23 130.69 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 83' ' ' MET . 18.0 t -76.76 133.54 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.89 75.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -61.22 -31.98 71.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.84 126.41 3.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -18.12 36.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.708 0.289 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.74 -112.01 0.91 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -110.12 -31.83 7.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.78 138.93 10.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.523 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -105.99 126.44 52.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.378 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 p -76.17 140.09 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -89.18 53.23 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.79 172.56 5.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 18.6 m-85 -99.86 162.71 12.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.928 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.92 172.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.274 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 41' ' ' TRP . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.55 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG13 HD11 ' A' ' 118' ' ' LEU . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.688 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.763 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 117' ' ' ALA . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 42' ' ' ILE . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.793 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.482 HG21 HD12 ' A' ' 125' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.572 ' HG2' HD21 ' A' ' 37' ' ' LEU . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.763 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 33' ' ' GLY . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 135' ' ' ASP . 3.2 ttt180 -94.83 166.05 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -45.61 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.9 t0 75.7 28.41 0.92 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.39 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.34 94.92 4.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.677 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 27' ' ' VAL . 1.5 m-85 -126.48 108.14 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.29 121.47 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -76.22 152.03 36.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.82 106.82 16.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.879 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.14 30.65 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.15 89.15 38.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.14 168.29 22.48 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.569 2.179 . . . . 0.0 112.409 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.3 134.67 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -136.58 -46.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 103.46 2.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -34.72 6.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.66 127.69 56.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 123.51 30.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -62.89 -40.17 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.58 150.72 32.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.86 120.67 41.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -134.96 31.2 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.78 156.42 27.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.9 174.31 6.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -87.11 83.3 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.69 23.59 14.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.36 80.22 0.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.93 126.5 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.077 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.96 110.0 19.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.17 36.92 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.94 126.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.04 136.38 6.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.63 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -71.41 -172.59 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 110.864 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 116.52 10.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.881 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG21 ' N ' ' A' ' 134' ' ' ARG . 2.4 t -30.05 -45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.984 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.79 -71.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.298 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.69 154.22 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 75.59 161.41 10.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.5 -45.43 30.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG11 ' HE3' ' A' ' 130' ' ' LYS . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.809 HD12 HD22 ' A' ' 125' ' ' LEU . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 66' ' ' ILE . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.572 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 51' ' ' ARG . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.566 HD12 ' CG ' ' A' ' 51' ' ' ARG . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 42' ' ' ILE . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo -64.9 109.96 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -124.6 -52.15 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.614 ' HD2' HG21 ' A' ' 96' ' ' VAL . 34.7 tttm -66.91 139.2 95.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 158.3 57.92 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.262 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 6.1 t80 -127.4 94.66 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.8 p -119.37 116.66 26.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 19.3 mttt -142.5 42.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.52 110.47 3.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 79' ' ' LEU . 59.7 Cg_endo -72.27 -45.07 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.369 2.046 . . . . 0.0 112.323 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 78' ' ' PRO . 3.0 mp -96.98 158.2 15.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.59 -31.16 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.58 135.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.76 139.27 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.28 -104.26 0.51 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.525 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -100.87 18.11 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.681 0.277 . . . . 0.0 111.236 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.57 -62.35 0.5 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 30.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.99 116.49 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -130.68 134.91 47.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.05 138.33 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -95.49 41.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.81 -173.11 53.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.73 164.03 18.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.8 m -142.36 173.1 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 72' ' ' LYS . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 25' ' ' ASP . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.558 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 66' ' ' ILE . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.637 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.418 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.54 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.788 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.803 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.809 HD22 HD12 ' A' ' 42' ' ' ILE . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.852 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.653 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -97.04 120.89 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' N ' HG21 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 40.88 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.537 0.684 . . . . 0.0 111.917 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.01 46.46 0.92 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.129 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.74 94.63 4.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.824 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -127.03 118.05 23.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.57 159.96 16.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -63.47 102.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.06 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.56 -35.6 7.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 ttp -143.47 86.16 9.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -68.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.488 2.126 . . . . 0.0 112.458 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.8 mtt85 -161.47 111.6 1.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.0 135.52 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.78 127.14 50.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -76.09 95.58 3.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.69 86.83 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.69 112.0 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -40.37 91.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.4 118.73 12.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -77.35 138.3 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -31.15 65.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.0 -94.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.92 168.14 9.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.23 170.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -97.39 23.66 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.73 -149.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.05 95.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -123.05 -177.48 3.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -79.95 159.53 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.88 -173.17 13.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.29 -167.48 31.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.839 ' HB2' HG23 ' A' ' 102' ' ' VAL . 7.2 m-20 -59.32 -174.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.714 ' O ' HG23 ' A' ' 27' ' ' VAL . 45.0 t80 -99.76 -74.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 177.7 -35.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' A' ' 27' ' ' VAL . . . 69.81 -162.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.967 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.46 165.43 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.161 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 86.27 178.44 49.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.594 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -42.27 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.834 HG11 ' HE3' ' A' ' 130' ' ' LYS . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.666 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 HD22 ' A' ' 125' ' ' LEU . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 HG21 ' A' ' 66' ' ' ILE . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 48' ' ' GLU . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.589 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 106' ' ' VAL . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 66' ' ' ILE . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.67 104.41 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.77 -44.41 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -78.13 139.55 60.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.09 154.58 52.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.445 2.097 . . . . 0.0 112.282 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -107.94 88.99 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.2 p -119.5 122.74 42.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.042 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 31.49 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 145.71 47.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.789 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.76 158.34 55.91 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.519 2.146 . . . . 0.0 112.282 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 105.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -173.29 36.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 142.49 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 147.58 32.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 mmm -68.81 105.03 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.15 71.12 1.28 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -84.92 -18.14 35.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.273 . . . . 0.0 111.153 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.36 -47.01 2.37 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.97 130.46 27.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.88 126.79 1.89 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.574 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -123.3 127.17 48.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.79 151.9 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.51 53.39 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.89 -176.57 1.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.515 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.25 153.89 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.3 m -136.74 170.46 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 25' ' ' ASP . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.666 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 118' ' ' LEU . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.49 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 42' ' ' ILE . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.862 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 125' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.834 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.833 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.849 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 -109.31 121.01 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 27' ' ' VAL . 12.8 mmt180 38.71 -105.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.512 0.672 . . . . 0.0 112.098 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -103.07 43.38 1.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.145 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.607 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.71 93.96 4.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.162 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.849 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 2.5 m-85 -127.66 89.89 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.771 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.87 157.39 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -80.41 100.97 8.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.9 5.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.882 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.79 152.88 18.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.75 85.48 16.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.99 178.59 6.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.667 2.244 . . . . 0.0 112.379 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.03 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -148.7 176.75 10.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ttm -72.03 135.84 46.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.68 153.41 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -72.8 178.64 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 133.48 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -79.2 -59.25 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.81 116.68 29.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 114.71 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -103.44 106.57 17.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 91.37 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -96.62 -178.26 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -140.07 100.61 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 23.64 6.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.998 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 17' ' ' LEU . . . -74.03 140.02 27.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.524 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.28 159.6 25.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 p 50.54 -178.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 60.64 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.01 84.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.84 121.87 0.7 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.15 172.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.05 0.452 . . . . 0.0 111.493 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.466 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -162.49 109.92 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.688 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 3.4 t -21.81 -53.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.186 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 73.34 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.235 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.5 159.34 17.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.834 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 75.13 132.73 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.512 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 21.4 m-20 -55.16 -28.12 50.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.753 HG21 HD12 ' A' ' 68' ' ' ILE . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 66' ' ' ILE . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.802 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.516 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CD1' HG11 ' A' ' 109' ' ' VAL . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.488 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.885 HG21 HG23 ' A' ' 47' ' ' ILE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 42' ' ' ILE . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo -74.2 108.2 2.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -127.85 -44.75 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HD3' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -74.52 143.91 79.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.944 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 172.8 12.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.553 2.169 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -127.5 129.75 47.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.0 p -118.72 127.66 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -83.66 120.65 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -113.34 94.48 31.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.38 -173.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.569 2.179 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.31 150.28 23.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 60.37 26.9 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.11 141.12 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 112.6 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.0 ttm 60.46 159.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.1 140.84 48.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.02 18.16 12.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.169 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.87 28.88 6.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.454 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 138.64 16.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 122.4 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.412 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -125.12 135.01 52.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.2 p -80.96 122.5 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -94.14 45.93 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.97 -178.94 49.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.4 m-85 -105.88 134.02 49.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 41' ' ' TRP . 15.2 m -124.2 165.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG21 ' HD3' ' A' ' 72' ' ' LYS . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 98' ' ' LYS . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 97' ' ' VAL . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 35' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' CD ' ' A' ' 105' ' ' GLU . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 68' ' ' ILE . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 102' ' ' VAL . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.834 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.832 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.577 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD12 ' HA2' ' A' ' 122' ' ' GLY . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.724 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.773 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 36' ' ' ALA . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' HD21 ' A' ' 37' ' ' LEU . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.832 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -86.07 166.09 16.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HG3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -43.52 87.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.979 178.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.8 t0 71.59 35.13 1.5 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.987 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.594 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.04 95.18 5.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.579 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.717 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.0 OUTLIER -126.07 96.56 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.83 105.26 15.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.45 154.61 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.33 103.05 12.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.918 179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mt 60.31 94.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptm -110.26 135.04 20.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.11 -168.27 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.501 2.134 . . . . 0.0 112.35 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -88.46 122.35 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.78 145.17 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.29 142.95 35.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -96.97 112.9 24.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.11 76.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -85.13 161.9 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.86 103.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.49 152.07 22.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -82.43 133.34 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -148.13 98.96 3.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.75 178.13 44.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.538 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.59 ' O ' HD22 ' A' ' 17' ' ' LEU . 7.3 mtt85 60.8 -177.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.811 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -144.26 163.56 33.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -87.8 -27.56 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.08 72.18 0.72 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.48 154.84 21.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 111.095 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -31.86 9.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.98 135.9 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.38 99.13 2.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.532 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.13 -104.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.7 p30 -91.15 24.82 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' CE1' ' CE1' ' A' ' 137' ' ' TYR . 1.8 t80 -79.35 81.42 5.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.937 HG23 ' OH ' ' A' ' 137' ' ' TYR . 2.6 t 53.89 101.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -45.09 -81.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 28' ' ' ALA . 43.5 m-85 -145.15 179.56 7.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.12 -124.61 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.546 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 4.8 m-20 -135.55 -52.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 HD13 ' A' ' 131' ' ' ILE . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.725 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.563 HD21 ' CD ' ' A' ' 130' ' ' LYS . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.739 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.728 HD12 HD22 ' A' ' 125' ' ' LEU . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.906 HG23 HG21 ' A' ' 66' ' ' ILE . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 51' ' ' ARG . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.551 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.906 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.04 108.82 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -118.94 -47.16 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.0 124.36 86.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.02 159.42 7.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 0.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -124.7 97.89 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.521 HG22 HG23 ' A' ' 90' ' ' VAL . 31.1 p -119.28 147.23 44.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.71 149.14 46.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -110.03 94.12 16.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.95 -167.24 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.738 2.292 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 161.64 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.761 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.19 -30.0 24.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.91 110.52 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.067 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -178.34 3.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.42 171.65 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.32 -160.79 15.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.564 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -98.87 -18.14 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.2 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.85 -132.49 8.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.509 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.38 80.55 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.82 -104.54 0.71 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.4 134.21 56.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.521 HG23 HG22 ' A' ' 75' ' ' THR . 11.2 p -65.1 158.26 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.049 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' N ' HG22 ' A' ' 90' ' ' VAL . 1.1 mm-40 -84.78 57.8 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -178.78 12.22 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.15 163.94 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.7 m -139.0 170.13 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.271 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 35' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.824 HG12 ' OE2' ' A' ' 105' ' ' GLU . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.725 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.824 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.538 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.736 ' HG3' HD11 ' A' ' 131' ' ' ILE . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HD12 ' A' ' 42' ' ' ILE . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.707 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.739 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.563 ' CD ' HD21 ' A' ' 37' ' ' LEU . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 1.7 ttt180 -68.87 165.8 19.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HA ' HG11 ' A' ' 27' ' ' VAL . 4.5 mtm180 -55.28 1.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.5 m-20 -161.15 25.36 0.13 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.83 93.94 4.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.937 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.4 m-85 -128.54 109.63 11.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.79 93.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.09 155.02 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.5 93.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.27 -38.89 3.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 ttt -65.94 110.04 4.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.316 2.011 . . . . 0.0 112.384 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 53.52 99.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 111.028 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -161.18 -66.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.049 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -71.52 154.48 41.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.99 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -87.08 -12.72 46.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.287 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.22 97.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 157.27 20.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.64 81.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -92.88 121.78 34.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.54 126.17 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 60.82 93.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.805 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.05 -28.68 2.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -104.36 161.65 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.27 166.72 19.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.38 23.65 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.22 58.34 5.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.521 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.41 109.58 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.34 -179.13 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 35.32 4.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.23 -122.22 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.09 140.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -45.96 -81.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 27' ' ' VAL . 10.9 t80 68.92 -67.19 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.06 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 162.68 -27.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.512 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.76 -174.65 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -57.76 113.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 142.82 150.13 5.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.58 -44.81 77.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD12 ' HG3' ' A' ' 128' ' ' LYS . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' A' ' 94' ' ' VAL . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' HD22 ' A' ' 125' ' ' LEU . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.563 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.648 HD12 ' HD3' ' A' ' 51' ' ' ARG . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.706 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo -71.69 104.51 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -134.12 31.65 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.06 127.99 14.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.97 143.09 99.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.448 2.099 . . . . 0.0 112.133 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.95 117.23 22.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.9 p -118.78 147.05 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -118.32 31.1 6.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.53 141.25 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.13 -28.56 18.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.515 2.143 . . . . 0.0 112.251 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.53 148.76 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.811 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.59 135.77 55.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.958 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.75 144.2 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 -176.96 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.96 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.34 170.26 37.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -86.67 -18.09 32.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.93 115.28 0.49 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.75 30.41 5.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.17 -156.32 7.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.529 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -109.04 153.07 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.98 136.7 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.27 54.87 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.07 157.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.399 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -90.23 147.86 23.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.5 m -121.42 174.51 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.217 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 25' ' ' ASP . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 68' ' ' ILE . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.707 HG13 HD11 ' A' ' 118' ' ' LEU . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.46 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.822 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.562 ' HD3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 117' ' ' ALA . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' A' ' 122' ' ' GLY . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.708 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 37' ' ' LEU . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HG2' HD21 ' A' ' 37' ' ' LEU . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.787 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 -95.44 118.12 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' N ' HG21 ' A' ' 27' ' ' VAL . 8.6 mmt180 40.4 -102.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.447 0.641 . . . . 0.0 112.085 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -103.47 44.72 1.0 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.081 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.602 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.38 4.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 2.3 m-85 -127.21 104.4 7.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -111.05 150.71 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.08 128.75 36.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -122.73 101.95 7.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 mtt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.73 168.99 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptm -133.09 144.82 54.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.14 104.95 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -89.05 134.35 34.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.9 31.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.67 172.2 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -114.56 91.32 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.22 144.4 22.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.01 153.29 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -66.23 174.85 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.805 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.68 145.99 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -105.53 132.03 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -71.79 164.36 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.71 -101.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.6 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.88 -179.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -162.83 109.81 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -27.45 13.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.3 64.11 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.535 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 21' ' ' THR . . . -120.15 121.35 38.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.078 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -169.24 -178.24 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.6 162.59 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.8 -108.94 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.43 24.26 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.41 163.19 18.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 27' ' ' VAL . 4.6 t80 -177.04 -49.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 26' ' ' TYR . 24.9 t 126.47 97.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 124.305 1.003 . . . . 0.0 110.0 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . . . -52.97 -60.69 2.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -138.9 -175.76 4.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.83 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 59.67 170.97 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.672 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.5 42.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.65 HD12 HD22 ' A' ' 125' ' ' LEU . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 42' ' ' ILE . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.88 HG23 HG21 ' A' ' 66' ' ' ILE . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.748 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.88 HG21 HG23 ' A' ' 47' ' ' ILE . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 42' ' ' ILE . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo -79.5 105.29 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -126.61 -45.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -66.96 115.98 30.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -51.7 153.05 11.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.31 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 10.4 t80 -119.15 90.08 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.5 p -119.54 130.12 55.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 10.4 mtpp -125.03 36.34 4.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -116.61 94.38 43.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.795 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.37 -25.9 29.95 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.403 2.069 . . . . 0.0 112.242 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -82.72 157.46 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' H ' HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -145.58 86.3 1.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 79' ' ' LEU . 10.7 m -85.49 126.52 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 63.85 134.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.88 148.79 25.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.16 166.62 24.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.29 18.24 12.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.65 0.262 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.41 -125.26 2.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -133.25 -66.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.98 -163.93 25.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.09 94.18 8.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.25 141.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -87.29 55.19 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.73 176.49 5.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 13.1 m-85 -108.4 156.68 19.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -132.39 174.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 35' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG12 ' OE2' ' A' ' 105' ' ' GLU . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.584 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.839 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.83 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.019 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.797 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.856 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 117' ' ' ALA . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.77 HD12 ' HA2' ' A' ' 122' ' ' GLY . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.727 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.465 ' CB ' HD11 ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.785 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.84 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -89.39 165.59 14.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' HG3' HG11 ' A' ' 27' ' ' VAL . 8.2 mtp180 -46.62 89.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.606 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ARG . 8.4 t0 71.79 36.4 1.22 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.597 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.89 94.72 4.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.893 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.84 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.6 m-85 -126.49 91.74 3.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.63 165.28 15.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.79 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -80.46 105.45 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.43 105.22 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.955 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.885 0.374 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 2' ' ' LEU . 8.8 tp -176.47 47.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 ttm -98.52 121.73 55.65 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 170.44 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.477 2.118 . . . . 0.0 112.282 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.2 72.6 0.63 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.28 155.35 5.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.58 157.97 17.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm 62.44 147.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.69 161.85 19.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -111.44 105.47 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -33.19 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.03 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.02 146.59 41.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.57 116.98 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -130.28 143.19 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.23 107.82 3.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.75 160.68 37.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.72 92.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.34 23.57 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.99 -54.04 5.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 130.73 44.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.141 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -109.17 -30.35 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.98 167.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.48 -108.89 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.46 -140.97 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -76.93 -178.79 5.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.006 0.432 . . . . 0.0 111.029 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -145.96 118.5 8.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.771 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HG3' ' A' ' 134' ' ' ARG . 9.0 t -30.93 -65.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.589 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 71.99 -68.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -95.17 144.52 25.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 111.085 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 173.08 1.7 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.713 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -40.39 18.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.748 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.754 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 66' ' ' ILE . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.852 ' O ' HG23 ' A' ' 52' ' ' VAL . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.84 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 47' ' ' ILE . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 HG22 ' A' ' 66' ' ' ILE . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo -65.75 104.9 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -113.14 -49.13 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' CE ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -72.65 139.0 80.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.994 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 72' ' ' LYS . 56.6 Cg_endo -70.67 166.86 27.33 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.434 2.09 . . . . 0.0 112.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.61 90.45 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -119.4 108.26 14.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 4.5 mmmt -129.35 138.45 51.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -121.17 94.25 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.5 -34.06 86.43 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 tp -89.63 152.17 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.34 165.51 23.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 81' ' ' VAL . 30.7 m -66.62 112.7 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -134.88 -71.94 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.77 100.7 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.32 113.61 2.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.522 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.63 18.12 13.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.275 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.66 114.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -119.4 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.86 -104.81 1.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.43 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 36.16 87.48 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.42 137.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.69 57.63 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.61 161.75 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -83.49 163.56 20.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -142.74 174.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 41' ' ' TRP . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 25' ' ' ASP . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.593 ' HB3' HD13 ' A' ' 68' ' ' ILE . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.692 HG13 HD11 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.855 ' HG3' HD11 ' A' ' 131' ' ' ILE . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 117' ' ' ALA . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HD12 ' A' ' 42' ' ' ILE . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.748 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.747 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.505 ' CG ' HD12 ' A' ' 37' ' ' LEU . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 36' ' ' ALA . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.632 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.861 HG23 HD23 ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ASP . 1.3 ttt180 -88.48 165.76 14.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.636 ' HG3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.8 88.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.092 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 71.86 32.3 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.226 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.87 95.02 5.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.429 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-85 -126.28 109.02 11.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.45 126.22 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -71.07 138.08 49.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.72 102.25 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.888 179.925 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mt -119.77 -41.48 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.06 147.86 34.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 145.74 41.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.47 2.113 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 62.64 118.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 106.55 16.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -134.86 31.47 3.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.16 128.43 33.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.08 135.28 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 88.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -104.04 153.95 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -66.51 139.0 57.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.91 170.83 9.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.25 -90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.572 ' NH2' HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 63.17 141.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.81 154.38 23.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -103.19 -27.48 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.12 -62.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.06 110.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.839 0.352 . . . . 0.0 111.154 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.16 116.43 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -100.15 87.94 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.58 149.72 5.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.92 61.69 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 102' ' ' VAL . 2.3 m-20 -81.48 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.2 t80 63.67 82.58 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.037 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.873 HG23 ' OH ' ' A' ' 137' ' ' TYR . 4.4 t 49.04 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.654 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.71 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 84.4 -53.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.92 165.67 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 161.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.688 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' H ' ' HB2' ' A' ' 107' ' ' ALA . 6.6 m-20 -64.76 -47.43 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' NH2' ' A' ' 16' ' ' ARG . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 125' ' ' LEU . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.888 HG23 HG21 ' A' ' 66' ' ' ILE . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 52' ' ' VAL . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.888 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HB3' ' A' ' 103' ' ' MET . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo -65.08 130.77 26.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.3 m-20 -134.46 -51.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.84 144.15 38.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.94 173.96 7.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.123 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.54 83.48 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.3 p -119.65 112.78 19.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 31.31 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.796 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.4 100.01 31.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.862 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.32 -42.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.349 2.033 . . . . 0.0 112.33 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 129.93 55.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.844 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.25 59.99 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 t -112.83 106.99 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.48 -73.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mmm -97.38 -56.57 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 57.73 28.45 60.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -102.42 -18.02 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.238 . . . . 0.0 111.2 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.89 -136.73 9.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 -37.7 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.07 -176.48 21.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -122.48 114.73 21.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -106.3 137.57 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -95.57 40.84 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.39 153.2 8.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.551 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.3 m-85 -75.05 159.55 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.38 172.16 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.53 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 25' ' ' ASP . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.629 ' HB3' HD13 ' A' ' 68' ' ' ILE . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CD ' HG12 ' A' ' 102' ' ' VAL . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 31' ' ' ASP . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.565 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 117' ' ' ALA . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.69 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' HA2' ' A' ' 122' ' ' GLY . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.73 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' ALA . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.449 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.843 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.491 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.17 165.37 18.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.654 ' HA ' HG21 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.51 4.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.594 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.2 m-20 -161.79 23.48 0.12 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.832 0.349 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.558 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.37 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.06 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.873 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.5 m-85 -128.16 103.22 7.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.17 93.5 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -73.26 150.53 41.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.74 98.73 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.853 0.359 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mt -152.54 127.07 9.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 mmm -105.83 88.64 3.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.76 132.89 22.59 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.553 2.169 . . . . 0.0 112.283 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 137.47 51.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mtt-85 -150.78 110.88 4.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.19 127.38 32.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -65.93 -23.42 66.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -55.82 110.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.966 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -99.94 149.1 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.29 82.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.11 166.05 23.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -72.26 115.91 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.2 89.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -128.51 1.19 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -87.2 -166.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' C ' HD13 ' A' ' 17' ' ' LEU . 1.6 tm? 46.23 87.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.218 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -27.66 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.59 -147.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.534 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.07 146.96 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 111.099 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 p -74.51 -31.39 62.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.47 131.64 56.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.59 161.91 53.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -179.58 52.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.498 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.85 87.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.153 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -134.93 80.06 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.137 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.948 HG23 ' OH ' ' A' ' 137' ' ' TYR . 4.8 t 48.11 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.5 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.82 167.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 66.13 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.527 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -92.4 174.42 36.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.895 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' A' ' 107' ' ' ALA . 8.0 m-20 -72.08 -39.61 68.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HG22 ' A' ' 27' ' ' VAL . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.868 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.716 HD12 HD22 ' A' ' 125' ' ' LEU . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 66' ' ' ILE . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.779 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' MET . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.6 Cg_exo -64.98 114.59 2.86 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.7 -47.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 143.96 98.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.46 163.03 38.7 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 4.5 t80 -127.49 93.12 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -119.16 136.19 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 18.6 mtpt -150.14 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 94.41 48.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -40.73 2.81 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.473 2.115 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.67 157.82 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 46.14 -169.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.352 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.41 142.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -113.38 136.95 52.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -67.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.04 123.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.47 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.41 10.43 29.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.605 0.24 . . . . 0.0 111.369 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.65 32.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 117.93 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.01 -142.67 10.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.84 111.1 21.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.5 149.45 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.95 41.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.59 -179.0 49.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.47 156.81 20.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 162.56 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.544 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG21 ' H ' ' A' ' 27' ' ' VAL . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.617 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.83 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 31' ' ' ASP . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.533 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 131' ' ' ILE . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 42' ' ' ILE . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.868 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.84 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.483 HG21 HD12 ' A' ' 125' ' ' LEU . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.683 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' C ' ' H ' ' A' ' 135' ' ' ASP . 4.0 ttt180 -67.95 165.36 17.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -60.59 10.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.467 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 133' ' ' ARG . 3.3 m-20 -165.33 22.43 0.05 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.55 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -116.18 94.05 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.948 ' OH ' HG23 ' A' ' 27' ' ' VAL . 5.6 m-85 -128.44 110.95 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -107.25 93.41 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -77.5 164.4 25.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -118.44 99.2 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.092 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.879 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.893 0.378 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 3' ' ' MET . 1.3 tt -163.0 154.03 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.471 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -124.89 137.48 29.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.829 -179.931 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.19 99.91 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.492 2.128 . . . . 0.0 112.198 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -80.78 150.44 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -176.5 140.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.82 170.38 9.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.97 47.77 24.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 59.74 -179.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.96 125.24 53.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -166.13 148.58 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -105.97 122.01 45.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -81.42 150.84 28.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.09 -57.58 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.28 -69.01 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.547 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 61.19 153.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.09 81.66 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -100.48 23.62 10.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.13 162.93 13.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.42 121.74 26.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.0 p -67.99 95.92 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -107.88 125.26 51.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.48 164.13 12.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.46 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.62 -48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.432 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -76.18 -178.01 4.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.055 0.455 . . . . 0.0 111.022 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -147.66 117.46 7.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.73 179.181 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 134' ' ' ARG . 9.2 t -27.46 105.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.89 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.784 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -58.73 -77.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.174 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -119.68 -176.19 3.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 61.25 178.64 2.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.603 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -87.58 -39.66 14.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 96' ' ' VAL . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 125' ' ' LEU . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.87 HG23 HG21 ' A' ' 66' ' ' ILE . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 52' ' ' VAL . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.882 ' HG2' HD12 ' A' ' 64' ' ' ILE . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' ARG . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.882 HD12 ' HG2' ' A' ' 51' ' ' ARG . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.87 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 42' ' ' ILE . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 85.8 Cg_endo -81.82 112.36 2.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -126.91 -40.78 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HD2' HG21 ' A' ' 96' ' ' VAL . 2.4 mtpm? -66.88 109.65 3.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.973 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.723 ' HB3' HG21 ' A' ' 90' ' ' VAL . 9.1 Cg_exo -71.54 122.66 8.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.668 2.245 . . . . 0.0 112.46 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.712 ' CD2' HG13 ' A' ' 94' ' ' VAL . 5.5 p90 -103.08 147.55 26.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.316 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 p -119.0 137.32 53.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 111.311 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -109.69 -156.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 146.09 88.32 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.814 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.86 148.77 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.512 2.141 . . . . 0.0 112.429 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.37 161.44 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 17.98 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.245 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.05 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -73.9 -37.69 64.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 172.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.33 -143.85 14.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -102.22 18.06 21.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 111.19 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.12 -135.81 4.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -39.62 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.43 120.2 5.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.436 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -116.0 123.35 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG21 ' HB3' ' A' ' 73' ' ' PRO . 14.6 p -64.84 141.92 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CE1' ' A' ' 74' ' ' TYR . 3.5 mm-40 -95.96 29.58 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.282 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 90' ' ' VAL . . . 114.08 166.99 15.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.501 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.633 ' HE1' HG11 ' A' ' 90' ' ' VAL . 7.6 m-30 -111.56 157.52 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.992 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.712 HG13 ' CD2' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -123.58 174.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.534 HG21 ' HD2' ' A' ' 72' ' ' LYS . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 98' ' ' LYS . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 25' ' ' ASP . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.648 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 66' ' ' ILE . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.784 ' OE2' ' HB3' ' A' ' 28' ' ' ALA . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 118' ' ' LEU . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.688 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.92 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.92 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.414 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.812 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.511 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 117' ' ' ALA . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 122' ' ' GLY . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.735 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.459 HG21 HD12 ' A' ' 125' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.812 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.818 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 -95.13 119.89 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' N ' HG21 ' A' ' 27' ' ' VAL . 0.7 OUTLIER 40.79 -101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.447 0.641 . . . . 0.0 112.003 179.138 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -106.81 45.29 0.99 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.145 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.588 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.68 94.55 4.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.818 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.98 89.94 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.07 121.05 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -96.12 129.74 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.91 104.2 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.077 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.948 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.22 65.76 6.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.0 mtp -107.61 139.02 20.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 79.33 2.71 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.338 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 155.31 45.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -34.69 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.48 106.18 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 129.77 41.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.59 144.8 33.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.94 139.43 36.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -139.62 101.04 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -64.39 141.56 58.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -69.17 115.08 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.28 -66.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.23 162.98 30.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.691 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -142.97 172.79 12.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 0.0 110.942 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -146.12 175.48 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -85.55 -27.54 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 89.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.47 15.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 111.098 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.11 -176.81 4.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 134.55 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.98 -177.91 22.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.6 -68.59 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.346 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -99.87 133.54 44.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' VAL . 18.7 p90 -106.35 -47.58 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.417 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 29' ' ' PHE . 73.7 t -158.01 -78.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.833 -179.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 56.82 31.0 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.529 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 171.66 135.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.791 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.48 159.18 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.625 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.76 -34.75 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 118' ' ' LEU . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.919 HD12 HD22 ' A' ' 125' ' ' LEU . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.592 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.859 HG23 HG21 ' A' ' 66' ' ' ILE . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.464 ' HB2' HD11 ' A' ' 64' ' ' ILE . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.674 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.859 HG21 HG23 ' A' ' 47' ' ' ILE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.487 HD13 ' HB3' ' A' ' 103' ' ' MET . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.01 132.48 34.62 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -145.73 -48.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -74.37 121.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.787 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.49 157.11 9.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -124.44 89.97 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 90' ' ' VAL . 28.7 p -119.16 132.73 56.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.089 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.6 53.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 136.1 20.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.51 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.535 2.157 . . . . 0.0 112.441 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.79 134.52 38.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 61.18 90.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.89 110.16 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.9 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -139.4 -46.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.86 108.61 0.34 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.598 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -93.87 -18.19 22.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.28 -59.38 0.47 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.499 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -150.72 124.68 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.12 -151.4 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -122.79 130.44 52.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 75' ' ' THR . 14.5 p -78.45 124.05 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -91.07 51.48 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.776 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.03 172.94 45.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -105.12 155.84 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.707 0.289 . . . . 0.0 110.854 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.2 m -136.63 174.51 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.846 HG12 ' OE2' ' A' ' 105' ' ' GLU . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.846 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.662 HG13 HD11 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.067 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.067 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.62 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.738 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 42' ' ' ILE . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.652 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.752 ' HG2' HD21 ' A' ' 37' ' ' LEU . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.917 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -77.59 165.39 24.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HA ' HG11 ' A' ' 27' ' ' VAL . 3.4 ttt180 -47.0 89.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.288 178.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.2 t70 67.6 43.36 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.711 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.86 94.65 4.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.917 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.7 m-85 -126.69 92.17 3.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.908 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.02 153.05 38.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.91 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.64 103.83 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' HD23 ' A' ' 2' ' ' LEU . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.778 0.323 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 1' ' ' MET . 29.2 mt -123.23 -64.15 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mtt -83.24 112.93 42.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.26 97.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.424 2.083 . . . . 0.0 112.233 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.47 33.01 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.16 80.28 8.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mmt -108.51 118.68 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.24 128.25 18.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 170.74 7.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -87.01 153.89 21.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.44 135.18 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -89.56 159.74 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -102.73 156.4 17.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 32.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.42 44.77 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 173.43 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -151.02 97.12 2.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.945 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 23.52 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' H ' HD13 ' A' ' 17' ' ' LEU . . . 145.7 91.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.49 156.58 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 p -129.26 -178.36 4.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.32 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.73 -116.15 0.63 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.37 64.64 0.8 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -74.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.188 0.518 . . . . 0.0 110.872 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.4 OUTLIER 62.37 119.0 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.869 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG23 ' OH ' ' A' ' 137' ' ' TYR . 8.5 t -30.27 120.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.725 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -86.86 95.79 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 63.24 149.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 90.08 -168.64 34.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.592 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.7 -32.98 6.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.793 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.457 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.643 HD12 HD22 ' A' ' 125' ' ' LEU . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 66' ' ' ILE . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 48' ' ' GLU . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.486 ' CB ' HD11 ' A' ' 64' ' ' ILE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.988 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 103' ' ' MET . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 127.36 11.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 11.8 m-20 -148.16 -52.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.13 144.06 98.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 163.57 36.16 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.071 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -127.48 106.09 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.291 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 p -118.93 143.45 47.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -104.97 -152.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -60.68 116.99 20.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -90.43 38.19 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.897 2.398 . . . . 0.0 112.51 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.12 151.23 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 59.19 89.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.941 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -83.38 135.35 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.6 -28.01 12.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 11.8 ttt -172.84 -41.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.64 73.84 0.24 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.542 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -18.06 49.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.68 0.276 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.52 -45.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -126.79 99.62 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.79 -149.62 19.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -117.25 123.08 45.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 91' ' ' GLU . 11.3 p -78.1 156.04 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 90' ' ' VAL . 4.9 mm-40 -93.95 46.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.37 -176.91 40.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.5 m-30 -103.33 163.73 12.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.5 m -147.44 171.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 98' ' ' LYS . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.793 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.658 ' OE2' ' HB3' ' A' ' 28' ' ' ALA . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.528 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.424 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.643 HD22 HD12 ' A' ' 42' ' ' ILE . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.688 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.776 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG2' HD21 ' A' ' 37' ' ' LEU . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -90.59 165.82 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -46.76 88.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.994 179.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.2 t70 73.16 29.88 1.66 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.481 178.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.99 95.07 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.52 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.2 m-85 -126.42 104.08 7.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.78 93.49 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 118.3 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.85 94.07 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.061 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.889 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.23 111.95 23.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 6.8 ttp -104.74 105.29 50.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 3' ' ' MET . 37.9 Cg_endo -66.34 110.89 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.344 2.03 . . . . 0.0 112.225 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 159.44 36.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.036 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.1 76.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.3 mtt -100.89 164.93 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 78.17 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.54 49.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -76.08 154.73 35.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 177.93 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -67.35 163.01 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -63.6 114.16 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -137.43 39.65 2.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.9 -68.76 0.34 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.529 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.6 153.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.63 104.87 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -97.2 23.59 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.25 -118.17 2.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.94 145.17 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.9 -45.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.63 148.26 19.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.44 -113.61 2.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.56 157.29 32.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.582 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -80.14 -171.3 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -142.35 118.07 10.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.962 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.836 HG23 ' OH ' ' A' ' 137' ' ' TYR . 14.3 t -29.3 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.835 178.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 65.79 151.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 64.71 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.832 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -79.83 166.71 50.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.014 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 134' ' ' ARG . 3.1 m-20 -79.46 -27.55 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 27' ' ' VAL . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.838 HD12 HD22 ' A' ' 125' ' ' LEU . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.429 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.936 HG23 HG21 ' A' ' 66' ' ' ILE . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.808 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.546 ' HE3' HG21 ' A' ' 64' ' ' ILE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.67 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.936 HG21 HG23 ' A' ' 47' ' ' ILE . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 103' ' ' MET . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.5 104.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.53 -42.57 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -75.87 124.26 88.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.3 147.43 83.19 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.439 2.093 . . . . 0.0 112.243 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 1.9 t80 -113.01 92.15 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 p -118.95 124.95 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.138 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -153.06 33.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -82.8 110.83 25.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.67 125.58 8.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.474 2.116 . . . . 0.0 112.386 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.98 106.56 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -162.45 -49.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.39 151.84 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -76.84 127.18 32.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.4 ttm -66.3 -179.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.17 -113.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -84.34 -18.11 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 111.217 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.51 -155.53 9.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -145.67 35.75 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 143.74 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.492 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -100.3 146.53 26.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 91' ' ' GLU . 11.6 p -71.96 158.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -93.82 40.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.023 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.52 152.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.25 149.07 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.762 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 43' ' ' THR . 3.1 m -125.71 165.52 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.584 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 25' ' ' ASP . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 68' ' ' ILE . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.646 ' CE2' HD12 ' A' ' 66' ' ' ILE . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 118' ' ' LEU . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.729 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 117' ' ' ALA . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.838 HD22 HD12 ' A' ' 42' ' ' ILE . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.655 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.75 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.423 ' CB ' HD11 ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.34 165.49 18.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 50.0 ttt-85 -58.43 5.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 133' ' ' ARG . 4.7 m-20 -162.37 23.5 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.02 4.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.033 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.836 ' OH ' HG23 ' A' ' 27' ' ' VAL . 6.4 m-85 -128.28 120.26 26.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.67 153.9 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.38 121.06 12.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.13 99.64 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.898 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -47.07 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.68 126.12 23.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.68 137.31 27.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.434 2.089 . . . . 0.0 112.354 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -142.63 47.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 60.74 171.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 118.86 8.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -143.97 146.35 32.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.15 44.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -84.1 145.82 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -99.76 -59.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -104.07 143.81 32.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.68 162.48 16.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -43.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.985 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.64 109.68 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.636 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.75 176.38 5.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.82 119.55 32.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.853 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -109.52 23.61 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -174.25 1.75 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.1 129.73 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.017 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -124.83 -43.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -79.0 91.83 4.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.943 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.84 -124.78 2.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.41 -130.37 6.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.532 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.29 -175.52 2.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' VAL . 23.8 t80 -173.96 -67.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.016 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 26' ' ' TYR . 1.1 t 161.04 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.285 179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.1 -75.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.547 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.47 -179.09 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.609 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 64.03 134.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.447 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 134' ' ' ARG . 9.2 m-20 -52.33 -31.29 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.464 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.781 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 94' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 125' ' ' LEU . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 66' ' ' ILE . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 121' ' ' ALA . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HG2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.549 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.859 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 66' ' ' ILE . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.5 104.54 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.96 -50.63 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -66.95 144.04 98.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 155.88 62.49 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.525 2.15 . . . . 0.0 112.403 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HD2' HG11 ' A' ' 94' ' ' VAL . 7.2 t80 -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -119.22 119.66 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 168.73 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.661 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -124.58 106.52 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.027 -179.664 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 141.15 30.01 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.451 2.101 . . . . 0.0 112.413 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.26 161.68 15.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.16 -27.55 34.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.26 154.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 64.68 165.45 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.31 137.63 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.55 90.62 0.72 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.568 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -107.56 -18.08 13.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.235 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.73 25.93 4.96 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp 73.07 3.98 4.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.87 137.45 0.01 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -133.62 154.56 50.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.764 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.5 p -64.92 112.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.038 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.71 75.11 7.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.04 -171.97 7.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.426 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -111.14 158.61 18.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 41' ' ' TRP . 10.5 m -145.87 164.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.245 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.45 HG22 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.864 HG12 ' OE2' ' A' ' 105' ' ' GLU . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.622 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.864 ' OE2' HG12 ' A' ' 102' ' ' VAL . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.703 HG13 HD11 ' A' ' 118' ' ' LEU . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.609 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.03 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.459 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.703 HD22 HD12 ' A' ' 42' ' ' ILE . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.781 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ALA . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.532 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.34 165.76 17.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 27' ' ' VAL . 3.1 mtm105 -55.43 -0.29 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 133' ' ' ARG . 5.5 m-20 -162.77 27.37 0.1 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.6 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.552 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.54 94.12 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.737 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.9 m-85 -128.15 115.96 19.2 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.22 105.85 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.64 121.97 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.46 94.42 9.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -104.12 -172.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.82 179.976 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -115.44 86.5 15.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.49 -160.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.574 2.183 . . . . 0.0 112.226 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.46 104.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -177.38 123.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.45 103.32 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.56 78.42 1.26 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.92 156.34 44.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -93.94 141.66 28.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 158.66 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 139.61 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -63.46 123.18 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -119.05 -58.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.9 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.49 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 150.54 8.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.55 163.14 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -81.87 -27.55 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.91 36.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.05 155.68 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -77.47 -32.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -79.62 -179.78 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.41 1.72 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.99 138.65 3.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -75.23 178.21 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.961 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -147.63 118.35 7.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.862 179.269 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ALA . 14.3 t -31.82 -78.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.549 178.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 54.74 171.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.584 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HB3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 m-85 62.42 -81.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.337 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -90.94 168.66 32.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.749 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 26.1 m-20 -69.81 -34.04 73.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.553 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.4 ' HB3' HG21 ' A' ' 94' ' ' VAL . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 68' ' ' ILE . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 42' ' ' ILE . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.853 HG23 HG21 ' A' ' 66' ' ' ILE . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.78 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 64' ' ' ILE . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.719 ' CD1' HG11 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' CG ' ' HB3' ' A' ' 29' ' ' PHE . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.853 HG21 HG23 ' A' ' 47' ' ' ILE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.595 HD12 HG21 ' A' ' 42' ' ' ILE . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo -65.23 134.05 37.66 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.73 -52.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -67.06 135.24 93.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.9 155.35 23.23 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HD2' HG11 ' A' ' 94' ' ' VAL . 8.6 t80 -127.58 106.36 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.978 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 p -119.05 147.04 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -115.58 80.83 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -118.47 106.46 44.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.72 163.42 35.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.404 2.069 . . . . 0.0 112.227 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.59 104.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -151.12 157.15 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.59 141.89 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 60.48 94.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.9 ptp -96.33 159.72 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.47 110.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -106.44 -18.08 14.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.629 0.252 . . . . 0.0 111.21 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.06 -49.68 1.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 30.91 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.52 -179.07 52.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -117.54 114.12 22.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -83.38 122.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.99 40.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.49 40.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -99.09 164.03 12.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.804 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.468 HG11 ' HD2' ' A' ' 74' ' ' TYR . 11.0 m -150.89 160.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.336 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 72' ' ' LYS . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.821 HG12 ' OE2' ' A' ' 105' ' ' GLU . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.651 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CD2' HD12 ' A' ' 66' ' ' ILE . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.821 ' OE2' HG12 ' A' ' 102' ' ' VAL . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.072 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.072 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.888 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 125' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.9 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -97.58 165.95 11.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 2.8 mtp-105 -42.49 86.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.86 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.7 t70 68.41 40.58 1.97 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.601 179.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.604 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.83 94.87 4.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.815 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.9 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.37 90.59 3.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.155 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.46 107.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.59 112.59 8.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.85 97.01 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 tp -104.55 51.65 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.5 mtp -111.51 95.19 25.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.34 -173.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.26 91.86 8.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -143.81 72.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.78 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -90.25 103.39 16.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.79 -34.42 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.56 122.54 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.788 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.51 115.36 24.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.56 110.59 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.55 22.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -106.54 140.66 39.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 62.48 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.96 -179.35 17.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.86 138.13 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.61 142.41 22.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -78.58 -27.5 45.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.65 166.31 7.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.47 126.11 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -131.71 -45.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.7 121.2 14.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.4 133.26 8.87 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.91 175.95 27.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -84.78 116.35 23.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.0 t80 -100.13 93.3 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.953 HG23 ' OH ' ' A' ' 137' ' ' TYR . 17.0 t 43.86 -85.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.685 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.675 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 79.72 -69.34 0.11 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.459 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.05 154.8 17.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 58.91 153.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.021 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -61.89 -32.68 73.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 179.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.571 HD21 ' HG2' ' A' ' 130' ' ' LYS . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.627 HD12 HD22 ' A' ' 125' ' ' LEU . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.008 HG23 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.882 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.5 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.549 HG23 ' CG1' ' A' ' 106' ' ' VAL . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.008 HG21 HG23 ' A' ' 47' ' ' ILE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 103' ' ' MET . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo -75.44 104.71 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.38 29.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.53 136.11 21.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.92 137.06 40.26 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.426 2.084 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CE1' ' HE2' ' A' ' 76' ' ' LYS . 4.1 t80 -107.7 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 p -119.27 127.32 53.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.119 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -103.96 31.17 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.69 156.46 35.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 164.53 31.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.513 2.142 . . . . 0.0 112.295 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.17 109.39 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.37 146.11 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG12 ' HG3' ' A' ' 82' ' ' ARG . 21.5 t -104.33 130.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG3' HG12 ' A' ' 81' ' ' VAL . 18.3 mtt-85 60.61 178.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.2 mtt 60.27 80.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.63 52.44 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.41 18.22 14.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.678 0.275 . . . . 0.0 111.19 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.93 -103.04 0.64 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.423 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.63 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.937 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.85 -51.87 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.555 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 38.67 86.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 91' ' ' GLU . 9.4 p -92.14 154.57 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 90' ' ' VAL . 33.5 mm-40 -95.55 43.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.14 -179.46 49.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.508 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.32 164.12 12.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.8 m -151.44 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.169 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 98' ' ' LYS . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.592 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.682 HG21 ' H ' ' A' ' 27' ' ' VAL . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.568 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.668 HG13 HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.604 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.017 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 131' ' ' ILE . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 117' ' ' ALA . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.627 HD22 HD12 ' A' ' 42' ' ' ILE . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.635 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.721 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 36' ' ' ALA . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.571 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.543 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.28 165.72 17.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.649 ' HA ' HG11 ' A' ' 27' ' ' VAL . 8.5 mtm105 -56.13 1.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 133' ' ' ARG . 2.3 m-20 -162.02 25.52 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.551 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.71 94.19 4.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.953 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.3 m-85 -128.19 112.97 15.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.41 116.76 10.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.83 144.77 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.12 97.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.956 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -144.28 117.21 8.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mtt -109.87 81.84 2.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.91 136.88 17.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.547 2.165 . . . . 0.0 112.397 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.24 44.25 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -59.74 154.78 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttp -103.02 167.63 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.5 109.07 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.972 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -121.35 -177.78 3.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.58 156.68 18.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 90.72 2.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -73.76 155.82 38.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 131.36 36.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -127.81 99.94 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.4 35.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.46 152.35 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -159.06 132.65 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -78.49 -27.52 46.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.21 87.77 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.586 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.67 149.59 22.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.46 99.86 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -111.77 -175.84 2.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.94 107.66 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.09 163.79 16.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -59.61 -177.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.792 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.807 ' O ' HG23 ' A' ' 27' ' ' VAL . 47.0 t80 -108.24 -98.94 0.37 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 26' ' ' TYR . 6.1 t -169.23 -77.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.003 0.43 . . . . 0.0 109.919 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.46 167.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.797 179.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CG ' ' A' ' 65' ' ' PHE . 2.5 m-85 66.01 -82.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -100.73 166.94 19.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.87 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 -33.81 76.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.963 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.972 HG23 HG21 ' A' ' 66' ' ' ILE . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 48' ' ' GLU . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.538 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ARG . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 109' ' ' VAL . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.705 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' CG ' ' CD1' ' A' ' 29' ' ' PHE . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.972 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 29' ' ' PHE . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 103' ' ' MET . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo -65.13 128.45 20.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -160.02 27.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 114.84 8.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB3' HG21 ' A' ' 90' ' ' VAL . 61.4 Cg_endo -72.83 117.4 5.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.392 2.062 . . . . 0.0 112.203 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD2' HG13 ' A' ' 94' ' ' VAL . 8.3 p90 -102.38 141.65 34.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.75 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 42.4 p -119.13 120.0 35.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -95.08 104.64 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.39 114.83 27.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.47 -31.77 21.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.41 2.073 . . . . 0.0 112.302 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -110.99 161.42 15.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -71.96 123.2 22.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.1 m -68.64 139.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.27 63.44 8.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.04 107.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 134.56 1.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.517 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -97.54 18.13 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.654 0.264 . . . . 0.0 111.167 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.06 139.84 6.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -140.52 34.01 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.43 -106.82 1.21 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.3 155.29 29.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 73' ' ' PRO . 14.9 p -81.41 138.14 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' ' CE1' ' A' ' 74' ' ' TYR . 51.9 mt-10 -82.19 73.71 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.34 -162.42 0.1 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.205 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.61 164.05 20.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.908 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG13 ' CD2' ' A' ' 74' ' ' TYR . 1.9 m -137.69 174.5 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 96' ' ' VAL . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.554 HG13 ' HG2' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 25' ' ' ASP . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.67 ' CE2' HD12 ' A' ' 66' ' ' ILE . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.094 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.867 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 117' ' ' ALA . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.963 HD22 HD12 ' A' ' 42' ' ' ILE . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.716 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.73 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HG2' HD21 ' A' ' 37' ' ' LEU . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.867 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -78.05 165.59 23.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HA ' HG21 ' A' ' 27' ' ' VAL . 43.7 mtt180 -47.73 90.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 133' ' ' ARG . 10.8 t0 73.11 38.35 0.7 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.442 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.603 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.34 4.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.027 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.72 106.35 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.15 122.46 39.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.15 122.3 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.72 94.63 6.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.895 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.546 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 HD22 ' A' ' 125' ' ' LEU . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 42' ' ' ILE . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 66' ' ' ILE . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.785 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ARG . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 120' ' ' ILE . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' C ' HD13 ' A' ' 66' ' ' ILE . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 103' ' ' MET . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 41' ' ' TRP . 3.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.88 0.371 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.641 HG12 ' OE1' ' A' ' 105' ' ' GLU . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.76 ' HB3' HD13 ' A' ' 68' ' ' ILE . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 66' ' ' ILE . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.641 ' OE1' HG12 ' A' ' 102' ' ' VAL . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.584 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 117' ' ' ALA . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.653 HD22 HD12 ' A' ' 42' ' ' ILE . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.701 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.729 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' CG ' HD12 ' A' ' 37' ' ' LEU . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.448 ' CB ' HD11 ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.59 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.831 HD12 HD22 ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 52' ' ' VAL . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.518 ' HE3' HG21 ' A' ' 64' ' ' ILE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.518 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.87 HG12 ' OE2' ' A' ' 105' ' ' GLU . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.609 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.87 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.98 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.98 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.504 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HG3' HD11 ' A' ' 131' ' ' ILE . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.831 HD22 HD12 ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.734 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.513 ' CG ' HD12 ' A' ' 37' ' ' LEU . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 129' ' ' THR . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 96' ' ' VAL . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 125' ' ' LEU . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.613 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 103' ' ' MET . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo . . . . . 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.945 0.402 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 98' ' ' LYS . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' N ' HG12 ' A' ' 97' ' ' VAL . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.481 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.57 ' HE1' HD11 ' A' ' 127' ' ' ILE . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.773 HG13 HD11 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.478 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.846 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.66 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.736 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.812 HD22 HD12 ' A' ' 42' ' ' ILE . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.71 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 36' ' ' ALA . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.846 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 4.8 ttt180 . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 131' ' ' ILE . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.636 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.436 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 94' ' ' VAL . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 68' ' ' ILE . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 66' ' ' ILE . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.825 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 HG21 ' A' ' 42' ' ' ILE . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 43' ' ' THR . 17.0 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.838 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.77 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.724 ' HG3' HD11 ' A' ' 131' ' ' ILE . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.642 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.642 HD12 ' HA2' ' A' ' 122' ' ' GLY . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.691 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.78 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.511 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 128' ' ' LYS . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.757 HD12 HD22 ' A' ' 125' ' ' LEU . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' HD23 ' A' ' 125' ' ' LEU . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 66' ' ' ILE . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.514 HG21 ' HE3' ' A' ' 54' ' ' MET . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 103' ' ' MET . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 25.0 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.814 HG12 ' OE2' ' A' ' 105' ' ' GLU . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.494 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CE2' HD12 ' A' ' 66' ' ' ILE . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.814 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG13 HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.919 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.772 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.772 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.746 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 37' ' ' LEU . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.436 ' CB ' HD11 ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HG2' HD21 ' A' ' 37' ' ' LEU . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.511 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.773 HD21 ' HG2' ' A' ' 130' ' ' LYS . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.869 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.929 HD12 HD22 ' A' ' 125' ' ' LEU . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.512 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.79 ' OE1' HD23 ' A' ' 125' ' ' LEU . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 66' ' ' ILE . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 47' ' ' ILE . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.904 0.383 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 98' ' ' LYS . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.58 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.876 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 117' ' ' ALA . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.591 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD22 HD12 ' A' ' 42' ' ' ILE . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.643 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.483 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 36' ' ' ALA . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.773 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.876 HG23 HD23 ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.635 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.705 HD12 HD22 ' A' ' 125' ' ' LEU . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HB2' HG22 ' A' ' 42' ' ' ILE . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.924 HG23 HG21 ' A' ' 66' ' ' ILE . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.928 ' CD1' HG11 ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HD3' ' A' ' 51' ' ' ARG . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.924 HG21 HG23 ' A' ' 47' ' ' ILE . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 42' ' ' ILE . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 98' ' ' LYS . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 105' ' ' GLU . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.584 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.071 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.071 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.412 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.442 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 117' ' ' ALA . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 42' ' ' ILE . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.599 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.481 ' CB ' HD11 ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.635 ' HG2' HD21 ' A' ' 37' ' ' LEU . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.444 ' HB3' HG21 ' A' ' 94' ' ' VAL . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 HD22 ' A' ' 125' ' ' LEU . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.452 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.46 ' CB ' HD11 ' A' ' 64' ' ' ILE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CD1' HG11 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 51' ' ' ARG . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.999 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 66' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.397 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 35' ' ' VAL . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.767 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 118' ' ' LEU . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.572 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.799 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.823 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HG3' HD11 ' A' ' 131' ' ' ILE . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.687 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.783 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HE2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.823 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 132' ' ' VAL . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HB3' HG21 ' A' ' 94' ' ' VAL . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.695 ' CD1' HD22 ' A' ' 125' ' ' LEU . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' OE1' HD23 ' A' ' 125' ' ' LEU . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 66' ' ' ILE . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.834 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.734 ' CE ' HD13 ' A' ' 64' ' ' ILE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.734 HD13 ' CE ' ' A' ' 54' ' ' MET . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.015 HG21 HG23 ' A' ' 47' ' ' ILE . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 103' ' ' MET . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 43' ' ' THR . 3.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.518 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.446 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE2' HG12 ' A' ' 102' ' ' VAL . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.711 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.793 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 42' ' ' ILE . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.698 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.724 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.451 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.45 ' CB ' HD11 ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.581 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 33' ' ' GLY . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.716 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.755 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.767 HD12 HD22 ' A' ' 125' ' ' LEU . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 42' ' ' ILE . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 66' ' ' ILE . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.873 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.469 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.827 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 41' ' ' TRP . 4.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.922 0.391 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.497 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.611 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.77 HG12 ' OE2' ' A' ' 105' ' ' GLU . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.61 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.687 ' CD2' HD12 ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.77 ' OE2' HG12 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.086 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.086 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.852 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 117' ' ' ALA . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 42' ' ' ILE . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.755 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 36' ' ' ALA . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.852 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 33' ' ' GLY . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.611 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.787 HD12 HD22 ' A' ' 125' ' ' LEU . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.506 HE21 HG23 ' A' ' 42' ' ' ILE . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.847 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.504 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD2' HG12 ' A' ' 52' ' ' VAL . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.847 HG21 HG23 ' A' ' 47' ' ' ILE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 26.9 Cg_exo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 41' ' ' TRP . 2.2 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 41' ' ' TRP . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.523 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.812 HG12 ' OE2' ' A' ' 105' ' ' GLU . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.611 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.696 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.812 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.665 HG13 HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.049 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.411 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 117' ' ' ALA . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 HD12 ' A' ' 42' ' ' ILE . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.494 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 33' ' ' GLY . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 130' ' ' LYS . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.696 HD12 HD22 ' A' ' 125' ' ' LEU . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.456 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.59 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.813 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.834 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 103' ' ' MET . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.6 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.802 0.334 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.858 HG12 ' OE2' ' A' ' 105' ' ' GLU . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.858 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.044 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.044 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 42' ' ' ILE . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.607 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.435 ' CG ' HD12 ' A' ' 37' ' ' LEU . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.431 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 37' ' ' LEU . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 33' ' ' GLY . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HB2' HG22 ' A' ' 106' ' ' VAL . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 96' ' ' VAL . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.598 HD12 HD22 ' A' ' 125' ' ' LEU . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.031 HG23 HG21 ' A' ' 66' ' ' ILE . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' VAL . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.699 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 51' ' ' ARG . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.695 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 47' ' ' ILE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 66' ' ' ILE . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 41' ' ' TRP . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.55 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG13 HD11 ' A' ' 118' ' ' LEU . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.688 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.763 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 117' ' ' ALA . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 42' ' ' ILE . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.793 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.482 HG21 HD12 ' A' ' 125' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.572 ' HG2' HD21 ' A' ' 37' ' ' LEU . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.763 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 33' ' ' GLY . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 3.2 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG11 ' HE3' ' A' ' 130' ' ' LYS . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.809 HD12 HD22 ' A' ' 125' ' ' LEU . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 66' ' ' ILE . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.572 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 51' ' ' ARG . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.566 HD12 ' CG ' ' A' ' 51' ' ' ARG . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 42' ' ' ILE . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.8 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.929 0.395 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.558 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 66' ' ' ILE . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.637 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.54 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.788 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.803 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.809 HD22 HD12 ' A' ' 42' ' ' ILE . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.852 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.653 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 33' ' ' GLY . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.834 HG11 ' HE3' ' A' ' 130' ' ' LYS . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.666 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 HD22 ' A' ' 125' ' ' LEU . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 HG21 ' A' ' 66' ' ' ILE . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 48' ' ' GLU . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.589 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 106' ' ' VAL . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 66' ' ' ILE . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.3 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.666 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 118' ' ' LEU . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.49 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 42' ' ' ILE . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.862 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 125' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.834 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.833 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.753 HG21 HD12 ' A' ' 68' ' ' ILE . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 66' ' ' ILE . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.802 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.516 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CD1' HG11 ' A' ' 109' ' ' VAL . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.488 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.885 HG21 HG23 ' A' ' 47' ' ' ILE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 42' ' ' ILE . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 41' ' ' TRP . 15.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.858 0.361 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 98' ' ' LYS . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 97' ' ' VAL . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.419 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 35' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' CD ' ' A' ' 105' ' ' GLU . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 68' ' ' ILE . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 102' ' ' VAL . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.832 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.577 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD12 ' HA2' ' A' ' 122' ' ' GLY . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.724 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.773 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 36' ' ' ALA . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' HD21 ' A' ' 37' ' ' LEU . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.832 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 HD13 ' A' ' 131' ' ' ILE . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.725 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.563 HD21 ' CD ' ' A' ' 130' ' ' LYS . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.739 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.728 HD12 HD22 ' A' ' 125' ' ' LEU . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.906 HG23 HG21 ' A' ' 66' ' ' ILE . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 51' ' ' ARG . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.551 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.906 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.832 0.349 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 35' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.824 HG12 ' OE2' ' A' ' 105' ' ' GLU . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.725 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.824 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.538 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.736 ' HG3' HD11 ' A' ' 131' ' ' ILE . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HD12 ' A' ' 42' ' ' ILE . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.707 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.739 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.563 ' CD ' HD21 ' A' ' 37' ' ' LEU . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD12 ' HG3' ' A' ' 128' ' ' LYS . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' A' ' 94' ' ' VAL . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' HD22 ' A' ' 125' ' ' LEU . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.563 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.648 HD12 ' HD3' ' A' ' 51' ' ' ARG . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.706 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.5 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.891 0.376 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.549 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 68' ' ' ILE . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.707 HG13 HD11 ' A' ' 118' ' ' LEU . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.46 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.822 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.562 ' HD3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 117' ' ' ALA . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' A' ' 122' ' ' GLY . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.708 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 37' ' ' LEU . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HG2' HD21 ' A' ' 37' ' ' LEU . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 33' ' ' GLY . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.65 HD12 HD22 ' A' ' 125' ' ' LEU . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 42' ' ' ILE . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.88 HG23 HG21 ' A' ' 66' ' ' ILE . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.748 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.88 HG21 HG23 ' A' ' 47' ' ' ILE . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 42' ' ' ILE . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.99 0.424 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 35' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.839 HG12 ' OE2' ' A' ' 105' ' ' GLU . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.584 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.839 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.019 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.797 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.856 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 117' ' ' ALA . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.77 HD12 ' HA2' ' A' ' 122' ' ' GLY . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.727 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.465 ' CB ' HD11 ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.785 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 33' ' ' GLY . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.748 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.754 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 66' ' ' ILE . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.852 ' O ' HG23 ' A' ' 52' ' ' VAL . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.84 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 47' ' ' ILE . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 HG22 ' A' ' 66' ' ' ILE . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.959 0.409 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 41' ' ' TRP . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.593 ' HB3' HD13 ' A' ' 68' ' ' ILE . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.692 HG13 HD11 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.855 ' HG3' HD11 ' A' ' 131' ' ' ILE . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 117' ' ' ALA . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HD12 ' A' ' 42' ' ' ILE . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.748 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.747 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.505 ' CG ' HD12 ' A' ' 37' ' ' LEU . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 36' ' ' ALA . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.632 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.861 HG23 HD23 ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 1.3 ttt180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 125' ' ' LEU . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.888 HG23 HG21 ' A' ' 66' ' ' ILE . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 52' ' ' VAL . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.888 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HB3' ' A' ' 103' ' ' MET . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.53 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.416 HG12 ' CD ' ' A' ' 105' ' ' GLU . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.629 ' HB3' HD13 ' A' ' 68' ' ' ILE . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CD ' HG12 ' A' ' 102' ' ' VAL . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.565 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 117' ' ' ALA . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.69 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' HA2' ' A' ' 122' ' ' GLY . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.73 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' ALA . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.449 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.843 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.229 -0.009 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.868 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.716 HD12 HD22 ' A' ' 125' ' ' LEU . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 66' ' ' ILE . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.779 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' MET . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.6 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.912 0.387 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.544 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.83 HG12 ' OE2' ' A' ' 105' ' ' GLU . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.617 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.83 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.533 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 131' ' ' ILE . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 42' ' ' ILE . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.868 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.84 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.483 HG21 HD12 ' A' ' 125' ' ' LEU . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 132' ' ' VAL . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 96' ' ' VAL . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 125' ' ' LEU . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.87 HG23 HG21 ' A' ' 66' ' ' ILE . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 52' ' ' VAL . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.882 ' HG2' HD12 ' A' ' 64' ' ' ILE . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' ARG . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.882 HD12 ' HG2' ' A' ' 51' ' ' ARG . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.87 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 42' ' ' ILE . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 41' ' ' TRP . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 98' ' ' LYS . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.648 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 66' ' ' ILE . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 118' ' ' LEU . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.92 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.92 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.414 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.812 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.511 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 117' ' ' ALA . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 122' ' ' GLY . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.735 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.459 HG21 HD12 ' A' ' 125' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.812 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 33' ' ' GLY . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 118' ' ' LEU . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.919 HD12 HD22 ' A' ' 125' ' ' LEU . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.592 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.859 HG23 HG21 ' A' ' 66' ' ' ILE . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.464 ' HB2' HD11 ' A' ' 64' ' ' ILE . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.674 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.859 HG21 HG23 ' A' ' 47' ' ' ILE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.487 HD13 ' HB3' ' A' ' 103' ' ' MET . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.846 HG12 ' OE2' ' A' ' 105' ' ' GLU . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.846 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.662 HG13 HD11 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.067 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.067 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.62 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.738 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 42' ' ' ILE . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.652 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.752 ' HG2' HD21 ' A' ' 37' ' ' LEU . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 33' ' ' GLY . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.793 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.457 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.643 HD12 HD22 ' A' ' 125' ' ' LEU . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 66' ' ' ILE . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 48' ' ' GLU . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.486 ' CB ' HD11 ' A' ' 64' ' ' ILE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.988 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 103' ' ' MET . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.5 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 98' ' ' LYS . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.507 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.793 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.528 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.424 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.643 HD22 HD12 ' A' ' 42' ' ' ILE . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.688 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.776 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG2' HD21 ' A' ' 37' ' ' LEU . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.526 0.021 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.838 HD12 HD22 ' A' ' 125' ' ' LEU . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.429 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.936 HG23 HG21 ' A' ' 66' ' ' ILE . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.808 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.546 ' HE3' HG21 ' A' ' 64' ' ' ILE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.67 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.936 HG21 HG23 ' A' ' 47' ' ' ILE . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 103' ' ' MET . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 43' ' ' THR . 3.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.355 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.584 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 68' ' ' ILE . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.646 ' CE2' HD12 ' A' ' 66' ' ' ILE . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 118' ' ' LEU . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.729 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 117' ' ' ALA . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.838 HD22 HD12 ' A' ' 42' ' ' ILE . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.655 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.75 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.423 ' CB ' HD11 ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.464 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.781 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 94' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 125' ' ' LEU . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.46 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 66' ' ' ILE . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 121' ' ' ALA . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HG2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.549 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.859 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 66' ' ' ILE . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 41' ' ' TRP . 10.5 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.45 HG22 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.864 HG12 ' OE2' ' A' ' 105' ' ' GLU . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.622 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.864 ' OE2' HG12 ' A' ' 102' ' ' VAL . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.703 HG13 HD11 ' A' ' 118' ' ' LEU . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.03 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.459 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.703 HD22 HD12 ' A' ' 42' ' ' ILE . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.781 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ALA . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.553 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.4 ' HB3' HG21 ' A' ' 94' ' ' VAL . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 68' ' ' ILE . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 42' ' ' ILE . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.853 HG23 HG21 ' A' ' 66' ' ' ILE . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.78 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 64' ' ' ILE . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.719 ' CD1' HG11 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.853 HG21 HG23 ' A' ' 47' ' ' ILE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.595 HD12 HG21 ' A' ' 42' ' ' ILE . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo . . . . . 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 43' ' ' THR . 11.0 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.933 0.397 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.821 HG12 ' OE2' ' A' ' 105' ' ' GLU . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.651 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CD2' HD12 ' A' ' 66' ' ' ILE . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.821 ' OE2' HG12 ' A' ' 102' ' ' VAL . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.072 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.072 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.888 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 125' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 33' ' ' GLY . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.592 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.571 HD21 ' HG2' ' A' ' 130' ' ' LYS . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.627 HD12 HD22 ' A' ' 125' ' ' LEU . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.008 HG23 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.882 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.5 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.549 HG23 ' CG1' ' A' ' 106' ' ' VAL . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.008 HG21 HG23 ' A' ' 47' ' ' ILE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 103' ' ' MET . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.965 0.412 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 98' ' ' LYS . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.592 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.568 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.668 HG13 HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.017 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 131' ' ' ILE . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 117' ' ' ALA . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.627 HD22 HD12 ' A' ' 42' ' ' ILE . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.635 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.721 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 36' ' ' ALA . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.571 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 132' ' ' VAL . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.963 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.972 HG23 HG21 ' A' ' 66' ' ' ILE . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 48' ' ' GLU . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.538 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ARG . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 109' ' ' VAL . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.705 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.972 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 103' ' ' MET . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo . . . . . 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 96' ' ' VAL . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.554 HG13 ' HG2' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.481 HG12 ' OE1' ' A' ' 105' ' ' GLU . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.67 ' CE2' HD12 ' A' ' 66' ' ' ILE . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.094 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.867 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 117' ' ' ALA . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.963 HD22 HD12 ' A' ' 42' ' ' ILE . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.716 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.73 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HG2' HD21 ' A' ' 37' ' ' LEU . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.867 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 33' ' ' GLY . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.842 0.353 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 2' ' ' LEU . 0.7 OUTLIER -115.06 -38.56 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mmm -140.02 88.05 12.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.78 171.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.589 2.192 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -112.4 44.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -157.43 -44.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.45 147.7 50.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.828 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.22 100.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -93.37 145.97 24.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -146.63 172.56 13.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -78.79 164.45 24.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -102.62 120.5 40.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 60.62 160.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.79 -41.95 2.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.549 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -68.11 163.97 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.43 121.63 8.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -82.08 -27.57 32.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.92 -83.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.14 100.61 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 67.96 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.06 98.41 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.12 27.94 3.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.54 85.49 1.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.46 131.09 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.655 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 p90 -112.5 -48.96 2.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' TYR . 3.1 t -161.6 -68.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.643 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 61.72 118.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.273 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 62.3 142.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 78.03 -173.14 55.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.03 -31.84 9.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 12.6 m-85 -116.06 168.87 9.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.89 130.3 2.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.29 112.73 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -102.64 145.75 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.149 0.5 . . . . 0.0 112.179 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.546 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.39 111.55 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.629 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.65 5.56 17.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.72 147.5 24.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.743 0.306 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.6 134.2 23.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.537 2.158 . . . . 0.0 112.133 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.51 172.01 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.9 m0 -110.81 107.55 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.587 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 HD22 ' A' ' 125' ' ' LEU . 12.4 mm -83.5 121.7 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.159 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.83 170.57 16.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.27 -45.2 94.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.77 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.69 -39.05 87.04 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.966 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 42' ' ' ILE . 42.2 mt-30 -58.83 -34.6 71.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.742 0.306 . . . . 0.0 110.91 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 66' ' ' ILE . 15.6 mt -71.64 -50.09 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.655 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.785 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -83.09 -46.35 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.739 0.305 . . . . 0.0 111.627 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.21 -47.19 72.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.2 88.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.005 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -59.45 -42.06 91.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.9 t -58.76 -46.26 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.11 86.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.3 mtm -71.09 -48.1 54.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ARG . 33.3 t -56.82 -39.71 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.114 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -75.07 -29.9 60.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 120' ' ' ILE . 39.3 t60 -59.48 -53.63 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 28.4 m-85 -52.71 98.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.063 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.07 -32.33 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -102.37 32.92 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.5 165.99 2.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.509 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.89 163.57 27.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.461 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -129.85 139.35 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -115.52 149.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' C ' HD13 ' A' ' 66' ' ' ILE . 98.1 m-85 -117.33 119.49 35.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.193 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -110.53 136.92 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.404 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -29.81 5.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.872 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 103' ' ' MET . 27.7 pt -63.47 135.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.198 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.48 138.92 19.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 122.32 8.75 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.26 -46.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 124.74 89.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.01 151.45 27.31 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.09 . . . . 0.0 112.19 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -122.87 99.08 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.6 p -119.17 143.94 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.049 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.73 31.35 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 121.89 39.63 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.76 -56.33 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.457 2.105 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mt -114.52 132.51 56.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.71 33.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -87.58 110.52 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 60.74 32.33 20.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mmm -138.21 134.85 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.16 163.84 9.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -95.14 18.09 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.34 -74.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.14 128.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.9 159.94 53.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -74.93 111.72 10.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.51 141.26 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.72 46.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.8 -177.81 46.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.89 157.35 24.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 41' ' ' TRP . 3.0 m -137.33 170.15 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.54 103.99 10.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 t -59.12 130.75 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.56 160.74 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.18 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.73 160.1 68.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 41.9 Cg_exo -55.73 115.24 2.31 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 111.821 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.69 28.54 6.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.972 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -109.58 122.59 47.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' C ' ' A' ' 26' ' ' TYR . 22.0 t -81.25 103.79 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.757 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.76 ' HB3' HD13 ' A' ' 68' ' ' ILE . 28.3 mtm -89.3 -21.28 23.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 66' ' ' ILE . 62.2 m-85 -141.42 162.89 34.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.288 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.641 ' OE1' HG12 ' A' ' 102' ' ' VAL . 2.5 pm0 -167.76 120.26 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -107.45 168.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.738 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -158.87 141.23 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.74 -36.74 3.9 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.731 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.2 m -75.34 160.23 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.26 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -70.47 164.73 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -59.56 -42.6 92.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -43.41 92.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -75.02 -37.76 61.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.011 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.55 -48.15 50.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.438 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.584 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -61.69 -43.59 98.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.764 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.23 -48.55 67.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.763 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.69 -48.79 76.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.1 -31.35 69.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.465 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -38.06 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.725 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 117' ' ' ALA . 59.9 mt -55.51 -37.48 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.611 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.35 -46.12 74.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.07 -20.67 80.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.511 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -40.18 86.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 110.812 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 3.97 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.347 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.653 HD22 HD12 ' A' ' 42' ' ' ILE . 24.9 mt -84.41 156.75 62.41 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.65 0.262 . . . . 0.0 110.659 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.701 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.7 Cg_endo -87.27 16.53 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.74 2.294 . . . . 0.0 112.585 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.729 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.08 167.02 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' CG ' HD12 ' A' ' 37' ' ' LEU . 7.2 tptt -80.27 139.22 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.297 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.448 ' CB ' HD11 ' A' ' 34' ' ' LEU . 10.6 p -142.05 147.01 36.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.4 pttt -130.01 159.96 35.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.318 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.8 mm -89.39 137.3 21.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.929 HG21 ' OH ' ' A' ' 137' ' ' TYR . 7.1 m -147.54 142.19 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.01 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -77.42 165.31 24.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.05 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 27' ' ' VAL . 5.4 mtp180 -47.04 89.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 133' ' ' ARG . 11.1 t0 66.69 44.7 2.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.014 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.676 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.74 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.929 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.81 113.42 16.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.38 160.37 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -73.23 147.82 44.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.57 101.03 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.847 0.356 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.44 103.27 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.754 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -141.53 105.34 5.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.76 56.96 4.87 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.486 2.124 . . . . 0.0 112.621 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.27 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -132.78 168.46 18.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 mtt -63.51 144.19 57.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -59.88 -64.91 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.12 44.46 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.7 124.28 27.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -86.26 142.16 28.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 117.52 34.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -114.44 160.62 18.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.42 46.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.42 51.32 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.429 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.15 147.46 39.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.87 85.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -27.53 28.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.1 -156.7 40.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.16 104.51 12.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -102.26 -28.92 11.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 151.12 51.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.975 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.2 -48.41 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.582 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.87 129.55 2.07 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.539 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.91 144.63 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.1 p90 -114.39 -48.13 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.867 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.6 t -164.79 -41.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.616 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 74.84 -73.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.73 164.93 27.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.21 162.91 31.66 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -76.31 -30.59 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.7 m-85 -120.24 170.59 9.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.3 130.51 2.49 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.898 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.26 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.7 p -101.5 145.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.126 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.31 115.18 27.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.519 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.59 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.2 mt -88.71 19.94 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.89 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.07 141.6 5.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.591 0.234 . . . . 0.0 110.745 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.35 137.33 43.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.74 172.05 12.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.176 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -111.27 107.58 16.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.831 HD12 HD22 ' A' ' 125' ' ' LEU . 18.7 mm -83.47 121.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.85 173.27 12.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.959 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.59 98.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.59 -41.1 89.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.154 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -58.88 -34.77 72.02 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.876 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 19.5 mt -71.9 -49.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.579 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 52' ' ' VAL . 4.8 tp10 -83.14 -46.84 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 111.529 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.64 -47.06 73.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.125 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.37 98.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 mtm180 -59.51 -41.41 89.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.8 t -59.2 -40.89 82.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.11 73.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.518 ' HE3' HG21 ' A' ' 64' ' ' ILE . 63.0 mtm -71.13 -48.77 50.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.4 t -56.81 -36.87 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.99 -29.62 60.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -64.21 -53.67 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.299 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.0 m-85 -53.43 108.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -67.23 -37.16 83.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.21 32.96 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 69.46 -175.61 32.93 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.452 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.06 155.91 7.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.476 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -123.34 140.93 52.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.518 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.2 mt -114.53 137.77 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.42 109.27 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.48 131.91 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 mtp85 -122.09 29.35 7.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.4 pt -130.14 134.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.89 140.9 28.56 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 71.8 Cg_endo -76.95 105.49 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.563 2.175 . . . . 0.0 112.312 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.97 -44.85 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -66.91 143.98 98.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.045 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.74 149.85 43.8 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.546 2.164 . . . . 0.0 112.373 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -106.24 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.2 p -119.44 105.01 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -87.43 81.17 7.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 117.77 65.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.05 157.33 62.16 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.063 . . . . 0.0 112.275 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.36 118.44 22.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.08 121.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 102.34 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.35 -170.24 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.0 tpt -73.26 145.86 45.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.91 142.76 25.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.11 18.06 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.47 -101.11 2.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -45.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.923 0.392 . . . . 0.0 111.053 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.37 -143.67 17.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.46 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -122.18 143.71 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -90.32 147.85 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -94.65 43.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.14 -164.36 42.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 21.2 m-85 -120.63 147.47 45.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.939 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.17 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.931 0.396 . . . . 0.0 111.221 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.06 104.38 9.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.13 131.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.176 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 38.2 t -126.69 161.4 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.71 158.35 75.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -53.91 120.16 7.45 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.247 1.965 . . . . 0.0 112.014 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.05 31.09 7.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.997 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.0 tpt180 -111.88 117.64 33.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.433 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.87 HG12 ' OE2' ' A' ' 105' ' ' GLU . 21.2 t -85.17 101.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.609 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.63 -26.31 18.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.893 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.4 m-85 -124.46 151.4 44.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.385 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.87 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.8 mp0 -153.64 129.21 9.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 118' ' ' LEU . 31.1 m -119.41 150.47 21.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.234 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.71 139.17 26.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.28 -35.33 4.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.98 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.6 m -77.19 155.94 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -66.96 171.16 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -65.61 -40.7 92.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -44.12 91.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -37.79 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.98 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.2 -48.23 52.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.427 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.504 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.07 -47.01 86.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.76 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -65.24 -48.56 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.04 -48.85 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.834 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.03 -30.81 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.291 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HG3' HD11 ' A' ' 131' ' ' ILE . 13.9 mtp180 -74.46 -40.89 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.757 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.5 mt -54.99 -38.83 47.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.54 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.616 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.32 -22.4 78.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -58.85 -40.46 84.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.706 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -88.81 0.77 56.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.261 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.831 HD22 HD12 ' A' ' 42' ' ' ILE . 26.5 mt -84.47 154.94 62.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.696 0.284 . . . . 0.0 110.629 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.8 Cg_endo -88.72 20.57 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.734 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -150.9 165.01 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 111.158 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.513 ' CG ' HD12 ' A' ' 37' ' ' LEU . 4.5 tptm -76.38 143.54 40.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.0 p -147.77 149.68 32.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.6 pttt -133.71 161.58 34.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.902 0.382 . . . . 0.0 111.284 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -91.87 138.08 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.919 HG21 ' OH ' ' A' ' 137' ' ' TYR . 6.3 m -148.21 143.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -79.09 165.47 23.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.148 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 27' ' ' VAL . 3.0 ttp180 -47.4 90.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.251 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.6 t70 66.77 44.09 2.22 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.136 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.665 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.68 94.49 4.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.401 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.919 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.83 106.76 9.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.947 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -98.77 148.91 23.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.02 120.68 17.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.29 98.86 8.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.9 mp 59.47 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.74 109.76 43.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 173.82 8.9 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.236 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.73 89.52 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -140.35 32.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 103.79 3.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.64 31.77 2.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -149.07 162.29 40.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.29 149.72 26.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.99 33.71 2.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -93.51 113.31 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.88 121.8 41.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -84.69 118.87 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.87 -34.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -91.05 160.0 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -79.53 136.24 36.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -27.65 18.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.042 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.42 -67.11 3.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 164.5 3.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.42 105.17 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 43.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.557 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.68 102.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.41 130.87 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' VAL . 20.5 t80 -83.53 -75.6 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.993 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 134' ' ' ARG . 53.1 t -157.36 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.788 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.686 ' HB3' HH12 ' A' ' 67' ' ' ARG . . . 50.29 -173.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.349 . . . . 0.0 111.4 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.71 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -112.54 170.56 13.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.642 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -58.48 -41.46 85.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.966 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 31.0 m-85 -106.09 168.51 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.35 127.87 2.43 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.63 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.25 101.93 14.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.5 p -92.68 145.65 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.119 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 129' ' ' THR . . . -98.17 110.94 23.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.733 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -81.21 4.64 19.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.979 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 2.7 tp10 -149.48 139.62 13.47 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 0.0 110.634 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 40.6 Cg_endo -67.02 138.61 48.34 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.439 2.093 . . . . 0.0 112.71 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.95 170.19 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.021 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 96' ' ' VAL . 9.7 m0 -107.53 106.64 17.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 125' ' ' LEU . 17.4 mm -83.37 119.93 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.21 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 174.26 11.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.32 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.17 -42.77 86.73 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -58.79 -34.53 71.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.878 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.55 -50.1 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.555 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.45 12.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -47.19 74.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.61 90.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -43.38 93.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.705 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.54 -41.97 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.64 79.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.47 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 68.3 mtm -71.16 -49.16 46.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.285 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.1 t -56.77 -40.06 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.08 -29.37 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.999 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -61.22 -55.26 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.26 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 26.6 m-85 -48.1 106.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -58.27 -36.06 72.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -104.2 32.98 3.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.71 178.51 17.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.92 152.16 6.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -115.62 151.41 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.613 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -125.9 129.49 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -96.14 109.39 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.299 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -88.94 134.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.253 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -108.33 -30.08 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 103' ' ' MET . 28.4 pt -73.49 144.33 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -145.58 140.08 15.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.78 111.08 2.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.5 -44.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 135.04 86.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.697 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 160.66 46.21 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.392 2.062 . . . . 0.0 112.251 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 2.8 t80 -126.08 92.49 3.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.6 p -119.23 107.75 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.134 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HZ1' ' HZ3' ' A' ' 41' ' ' TRP . 5.3 mmtp -139.75 101.37 4.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.56 94.41 44.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.802 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.0 -45.01 44.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.489 2.126 . . . . 0.0 112.204 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.64 155.38 40.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.14 84.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.5 t -87.26 129.0 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 59.01 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 62.6 mtp -144.78 130.83 19.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.39 85.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -105.95 17.98 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.15 44.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -162.77 118.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.34 144.47 16.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -124.09 127.52 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 90' ' ' VAL . 12.0 p -106.04 124.94 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -93.8 46.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.85 175.75 42.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.367 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.62 161.89 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.806 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.17 172.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.225 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -129.23 102.41 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.773 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.0 t -59.14 132.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.283 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 98' ' ' LYS . 14.5 t -126.67 162.15 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' N ' HG12 ' A' ' 97' ' ' VAL . 3.5 mptp? -130.62 160.03 68.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 49.3 Cg_exo -54.56 115.27 2.28 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 112.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.17 26.94 6.4 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.234 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.481 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.9 mpt_? -111.18 124.77 52.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 t -78.22 105.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.57 ' HE1' HD11 ' A' ' 127' ' ' ILE . 51.6 mtm -86.52 -15.85 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.498 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' CE ' ' A' ' 54' ' ' MET . 66.9 m-85 -150.11 156.28 41.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.468 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -153.64 121.84 6.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.773 HG13 HD11 ' A' ' 118' ' ' LEU . 27.9 m -107.75 161.48 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.42 139.77 16.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.29 -41.04 2.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.551 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -75.75 165.04 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 p -78.11 -176.59 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.5 -39.84 64.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.26 -46.12 90.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -75.18 -40.3 59.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.29 -48.15 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.478 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.27 -45.54 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.712 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.61 -48.61 76.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.55 -48.88 79.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.787 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.846 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.96 -31.47 69.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 110.392 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.66 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -74.52 -43.09 57.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.768 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.3 mt -55.0 -37.19 41.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.78 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.9 95.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.736 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.06 -21.75 75.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.529 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -43.04 82.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.77 -0.67 56.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.812 HD22 HD12 ' A' ' 42' ' ' ILE . 32.7 mt -84.43 152.91 61.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.754 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.4 Cg_endo -88.78 21.77 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.903 2.402 . . . . 0.0 112.662 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.71 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.3 pp -146.73 162.84 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.358 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 130.51 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 36' ' ' ALA . 39.7 p -135.23 145.92 48.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG2' HD21 ' A' ' 37' ' ' LEU . 18.9 pttt -131.12 154.38 48.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.264 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.846 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.93 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.5 m -150.03 129.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.12 0.486 . . . . 0.0 111.837 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.546 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 4.8 ttt180 -68.19 165.62 17.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.521 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HG2' HG11 ' A' ' 27' ' ' VAL . 13.6 mtm180 -56.88 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.3 m-20 -164.12 26.44 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.601 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.56 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -115.6 93.98 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.752 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.8 m-85 -128.29 104.06 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -85.9 96.67 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -72.18 170.61 13.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.72 96.49 6.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.913 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.816 0.341 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.33 82.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 mmm -135.24 109.72 10.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.785 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 168.13 19.78 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.335 2.023 . . . . 0.0 112.313 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 61.17 96.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -164.47 89.17 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.9 mtt -81.96 169.3 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.26 117.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -108.51 152.29 24.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 108.56 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.56 156.56 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 128.22 35.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.55 130.28 43.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -76.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.56 -95.72 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.621 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 163.23 22.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -98.08 142.14 30.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -88.1 -27.56 21.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.53 -119.95 1.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.644 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.18 164.51 3.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.12 -174.5 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.42 178.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.22 116.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.569 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.77 144.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' ' 102' ' ' VAL . 2.7 m-20 -69.24 102.88 1.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.9 p90 -107.42 -38.8 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 134' ' ' ARG . 25.2 t -159.96 145.97 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.79 -72.2 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.439 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -138.59 -56.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.37 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -46.59 155.16 0.73 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.049 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -54.89 -32.94 61.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.897 0.38 . . . . 0.0 110.814 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.9 m-85 -115.7 170.49 8.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.536 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.86 126.95 2.03 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.693 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 131' ' ' ILE . 1.8 tm? -91.13 105.28 17.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.1 p -94.83 145.64 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.238 0.542 . . . . 0.0 112.429 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.636 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.6 109.57 22.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.158 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.436 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.9 mt -82.77 7.05 16.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -149.64 143.21 16.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.068 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 24.4 Cg_exo -63.32 134.38 44.92 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.489 2.126 . . . . 0.0 112.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.14 171.98 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 111.531 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 94' ' ' VAL . 31.7 m0 -112.87 106.07 14.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 68' ' ' ILE . 26.6 mm -83.34 116.36 27.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 168.57 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.077 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.78 -43.15 80.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.814 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.09 -37.84 78.08 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.878 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.79 -34.74 71.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 66' ' ' ILE . 24.7 mt -70.77 -50.85 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.825 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 tp10 -83.02 -46.07 13.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.725 0.298 . . . . 0.0 111.688 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.57 -47.88 72.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.29 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.43 87.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.4 t -57.97 -39.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.038 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -39.95 67.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 69.1 mtm -71.16 -50.28 35.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.269 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.9 t -56.94 -40.0 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -75.15 -29.45 60.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.25 -50.23 73.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 109' ' ' VAL . 30.2 m-85 -52.48 103.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -61.18 -34.18 74.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -101.99 32.62 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 62.95 168.59 0.93 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.23 171.62 36.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -132.9 147.99 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.7 mt -123.51 134.61 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.23 109.35 21.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.97 138.83 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.19 6.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 HG21 ' A' ' 42' ' ' ILE . 26.4 pt -123.61 129.15 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.056 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -127.21 144.32 50.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.739 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.93 104.42 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.539 2.159 . . . . 0.0 112.275 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.59 -42.11 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 129.58 94.03 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.752 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.83 157.28 29.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.498 2.132 . . . . 0.0 112.168 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' HD2' HG11 ' A' ' 94' ' ' VAL . 7.8 t80 -127.0 101.96 6.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.9 p -119.09 127.07 53.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -86.75 111.74 21.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.2 94.38 30.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' HG2' HG22 ' A' ' 81' ' ' VAL . 59.7 Cg_endo -72.53 176.96 8.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.422 2.081 . . . . 0.0 112.252 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.39 128.62 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 60.64 75.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.924 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 78' ' ' PRO . 21.4 t -86.67 127.32 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -35.89 14.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -102.83 31.15 4.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' VAL . . . -115.72 96.46 0.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.67 18.12 22.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.7 0.286 . . . . 0.0 111.287 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.58 -117.0 0.79 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -125.29 110.27 13.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 0.0 110.803 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.69 -137.79 7.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -71.41 133.61 46.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.332 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.36 137.48 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.67 52.0 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -173.94 49.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -115.73 151.31 35.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.463 HG11 ' HD2' ' A' ' 74' ' ' TYR . 17.0 m -141.84 155.73 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.186 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -99.7 102.48 13.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -58.99 129.15 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.2 t -125.35 158.69 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.68 156.2 80.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.1 Cg_endo -48.75 111.99 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.83 2.353 . . . . 0.0 112.218 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.74 37.15 3.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -117.06 129.48 56.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 111.731 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG12 ' OE2' ' A' ' 105' ' ' GLU . 16.7 t -80.86 104.34 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -95.15 -29.9 14.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.675 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.0 m-85 -136.1 150.28 49.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.962 0.411 . . . . 0.0 111.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.838 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.1 128.6 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.579 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.77 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -113.67 165.77 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.255 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -163.57 140.01 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.044 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.22 4.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.551 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -78.79 166.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.182 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.45 173.35 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.04 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.87 -39.63 79.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -63.94 -45.18 90.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -75.18 -37.64 61.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.08 -48.33 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.417 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.55 -44.5 96.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -67.16 -48.65 67.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.673 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.83 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.076 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.44 -30.9 69.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.26 179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.724 ' HG3' HD11 ' A' ' 131' ' ' ILE . 66.1 mtp180 -74.5 -39.08 62.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.1 mt -56.8 -40.63 72.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.26 -47.01 84.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.747 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.642 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.01 -21.4 79.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.555 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -39.89 82.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 3.81 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.469 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.642 HD12 ' HA2' ' A' ' 122' ' ' GLY . 24.8 mt -84.41 154.0 62.43 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.691 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.7 Cg_endo -87.3 22.85 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.874 2.383 . . . . 0.0 112.815 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.78 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.87 167.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.386 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 145.66 42.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.988 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' LEU . 34.9 p -147.87 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.6 pttt -132.0 159.04 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.08 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -94.68 134.85 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.763 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.958 HG21 ' OH ' ' A' ' 137' ' ' TYR . 9.6 m -143.99 146.57 20.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.061 0.458 . . . . 0.0 111.19 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -80.3 165.5 22.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.145 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.602 ' HA ' HG11 ' A' ' 27' ' ' VAL . 1.2 mtt-85 -46.84 89.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.3 t70 65.48 45.83 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.014 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.652 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.8 94.29 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.958 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -127.03 101.0 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.985 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.02 93.53 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.05 141.85 37.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.8 106.87 19.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.906 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.782 0.325 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 3' ' ' MET . 0.5 OUTLIER -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.593 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -97.93 137.75 20.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.06 93.51 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.527 2.151 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.03 96.05 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -92.67 127.37 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tpt -93.72 169.78 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 148.28 38.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -165.42 35.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.991 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 162.5 14.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 65.83 126.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -73.99 166.89 22.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -85.2 118.22 24.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 60.49 179.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.62 -47.06 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -137.73 139.38 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 110.936 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.78 31.22 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -27.53 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.27 24.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.58 158.53 22.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 111.059 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 p -150.35 77.75 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.35 152.54 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.59 91.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.61 136.54 16.11 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 141.57 53.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 27' ' ' VAL . 4.3 p90 -107.66 -46.15 3.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.75 HG11 ' HG2' ' A' ' 134' ' ' ARG . 18.0 t -161.09 -49.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.677 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.55 -69.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.486 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -122.38 169.2 11.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 62.8 148.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.685 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.79 -38.46 85.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.743 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.511 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.0 m-85 -108.71 170.68 7.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.462 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.34 129.34 2.27 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.931 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 129' ' ' THR . 1.9 tm? -91.34 110.1 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.7 p -98.36 145.69 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.187 0.518 . . . . 0.0 112.195 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -97.79 115.41 27.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.577 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 128' ' ' LYS . 6.0 mt -90.17 20.58 4.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.93 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 22.1 tt0 -164.14 139.0 4.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.555 0.216 . . . . 0.0 110.623 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 36.5 Cg_endo -65.47 130.64 25.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.425 2.083 . . . . 0.0 112.595 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.97 170.17 22.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.19 106.37 15.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.625 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.757 HD12 HD22 ' A' ' 125' ' ' LEU . 11.6 mm -83.5 119.03 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.72 175.03 10.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.46 -44.23 96.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.759 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.39 -41.3 89.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.931 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' HD23 ' A' ' 125' ' ' LEU . 77.9 mt-30 -58.79 -34.6 71.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 66' ' ' ILE . 14.0 mt -72.15 -49.6 42.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.9 tt0 -83.07 -46.71 12.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 0.0 111.583 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.45 -47.01 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.95 87.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 7.1 mtm180 -59.53 -41.1 89.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.6 t -59.41 -40.83 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.52 76.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.514 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.6 mtm -71.17 -48.08 53.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.144 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.6 t -56.92 -36.87 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.261 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -75.04 -29.43 60.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 116' ' ' GLU . 25.7 t60 -63.21 -51.49 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.5 m-85 -53.11 115.43 1.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.01 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -75.08 -37.06 61.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.3 32.98 2.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.5 169.66 2.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.12 166.81 30.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -130.1 142.39 50.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.514 HG21 ' HE3' ' A' ' 54' ' ' MET . 1.9 mt -117.08 127.63 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -95.03 109.3 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -93.95 126.76 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.244 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.63 -31.03 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 103' ' ' MET . 44.9 pt -71.74 139.23 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -144.35 135.67 12.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 25.0 Cg_exo -62.82 106.79 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.33 -46.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 120.08 78.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.7 141.78 52.79 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.266 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 94' ' ' VAL . 11.4 t80 -112.89 100.23 8.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.7 p -119.31 130.65 55.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -91.41 115.18 27.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.935 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -107.22 94.35 11.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' HG22 ' A' ' 81' ' ' VAL . 73.3 Cg_endo -77.61 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.479 2.119 . . . . 0.0 112.248 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 tp -74.63 121.13 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 62.39 85.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 78' ' ' PRO . 20.5 t -99.23 137.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.178 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -87.2 -79.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.6 mtp 55.02 179.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.75 29.25 64.13 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.33 -18.13 14.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 111.169 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.67 -53.92 0.15 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -162.38 145.31 11.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.79 106.42 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -70.11 138.78 52.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG22 ' N ' ' A' ' 91' ' ' GLU . 9.5 p -72.0 157.82 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 mm-40 -94.96 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.78 -173.11 53.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -123.29 164.01 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.8 m -144.0 167.74 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -118.97 102.52 8.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.4 129.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.5 t -126.58 161.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.054 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.0 mttp -130.79 160.02 68.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -54.39 116.24 2.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.361 2.04 . . . . 0.0 112.145 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.91 29.6 6.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.221 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.17 122.84 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 0.0 111.374 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.814 HG12 ' OE2' ' A' ' 105' ' ' GLU . 19.2 t -80.5 104.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.494 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 25.2 mtm -88.12 -22.13 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CE2' HD12 ' A' ' 66' ' ' ILE . 61.6 m-85 -138.34 153.28 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.467 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.814 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -152.16 126.67 9.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.554 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG13 HD11 ' A' ' 118' ' ' LEU . 35.0 m -118.5 151.17 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.907 0.384 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -147.17 142.06 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.52 -33.59 6.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.8 m -80.29 156.75 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.2 p -67.12 171.11 5.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -67.3 -37.13 82.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.24 -46.05 82.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.947 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -75.25 -37.12 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.919 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.41 -48.25 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.424 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.84 -45.68 91.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 3.1 tt0 -66.38 -48.51 69.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.624 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.94 -48.74 79.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.78 -32.04 71.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.411 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.48 -41.3 60.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.2 mt -55.01 -39.29 49.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -65.67 -42.9 90.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.592 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.772 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.59 75.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.527 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -42.71 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.813 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 0.09 49.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.301 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.772 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.39 157.03 62.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.686 0.279 . . . . 0.0 110.745 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 88.3 Cg_endo -88.15 21.6 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.887 2.392 . . . . 0.0 112.551 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.746 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -150.35 164.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 0.0 111.292 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 37' ' ' LEU . 1.7 tptm -78.82 137.77 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.436 ' CB ' HD11 ' A' ' 34' ' ' LEU . 14.3 p -141.65 146.01 35.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HG2' HD21 ' A' ' 37' ' ' LEU . 29.9 pttt -130.3 157.11 43.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 3.0 mm -87.07 136.85 22.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.745 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.913 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.8 m -147.49 141.26 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 111.162 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.02 165.55 21.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.513 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.75 ' HG2' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -44.93 88.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.425 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 133' ' ' ARG . 2.6 t70 66.73 44.06 2.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.984 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.708 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.78 94.43 4.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.392 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.913 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.83 116.19 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -103.88 157.54 17.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.51 107.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.56 98.26 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.904 0.383 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.9 mm? -80.18 168.14 19.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.73 148.1 34.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.32 113.37 3.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.76 104.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -83.03 -32.29 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -94.32 130.42 40.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt 61.67 153.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.3 167.58 10.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -80.75 124.41 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.16 107.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.26 135.03 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.57 125.58 42.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.43 159.97 8.92 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.502 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 60.76 157.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -87.1 122.64 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -27.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.74 72.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.53 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 134.18 56.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.314 . . . . 0.0 111.207 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.13 33.41 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -104.92 144.35 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.36 -176.62 21.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.442 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.1 -102.85 2.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 102' ' ' VAL . 10.4 m-20 -137.0 128.09 27.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.0 p90 -119.34 -47.61 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.981 0.42 . . . . 0.0 111.21 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 26' ' ' TYR . 7.0 t -160.25 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.812 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.21 -69.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -124.62 168.42 13.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.174 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 67.36 154.64 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.634 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -66.29 -33.31 75.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 13.8 m-85 -118.14 163.61 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.574 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.44 129.89 3.07 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.33 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -93.75 145.75 7.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 0.0 112.106 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.56 109.16 21.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.59 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.773 HD21 ' HG2' ' A' ' 130' ' ' LYS . 10.0 mt -75.52 -2.29 28.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.936 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -146.43 154.4 49.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 73.7 Cg_endo -75.17 137.46 21.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.484 2.123 . . . . 0.0 112.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.869 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -161.82 170.07 20.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -110.23 102.92 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.929 HD12 HD22 ' A' ' 125' ' ' LEU . 21.8 mm -83.49 118.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.512 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -78.67 177.53 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.91 96.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.28 -43.29 96.37 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.79 ' OE1' HD23 ' A' ' 125' ' ' LEU . 23.7 mt-30 -58.76 -34.61 71.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.767 0.318 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.807 HG23 HG21 ' A' ' 66' ' ' ILE . 21.4 mt -72.06 -49.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.574 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.28 -46.59 12.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.747 0.308 . . . . 0.0 111.479 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.47 -47.06 70.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.962 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.19 87.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.43 -42.05 90.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.642 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 48' ' ' GLU . 40.4 t -58.4 -39.86 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.98 72.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 61.3 mtm -71.05 -50.24 36.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.166 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.6 t -56.82 -39.23 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -29.5 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.979 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -59.11 -50.18 75.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.67 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.9 m-85 -57.18 105.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -67.86 -32.45 72.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -98.2 32.98 2.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.51 160.66 0.95 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.557 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.99 163.18 27.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.05 153.12 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.4 mt -126.16 145.49 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.289 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 96.9 m-85 -111.6 117.63 33.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.249 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.807 HG21 HG23 ' A' ' 47' ' ' ILE . 2.2 mm -101.45 132.89 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.257 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -109.39 -28.55 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.827 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.5 pt -73.6 139.8 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.193 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -140.05 141.7 27.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 60.5 Cg_endo -72.83 104.41 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.558 2.172 . . . . 0.0 112.254 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.21 -40.21 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -78.41 130.31 71.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.798 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 147.67 63.65 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.42 113.7 24.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.2 p -118.78 131.21 56.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -96.6 72.14 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -113.66 94.35 32.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.56 -171.37 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.41 2.073 . . . . 0.0 112.298 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 133.37 42.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 60.13 101.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.16 119.71 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -97.34 168.3 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 ttt 60.88 36.23 19.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.64 -165.94 16.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.503 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -100.14 -18.04 17.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.266 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.1 -98.64 1.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.75 109.24 2.03 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.583 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -135.58 154.22 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.796 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.96 129.93 56.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -93.22 55.73 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.43 -175.92 5.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.426 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -107.13 163.98 12.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.9 m -137.29 171.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.354 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -124.12 107.94 11.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.99 131.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.287 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 98' ' ' LYS . 18.0 t -126.56 162.17 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.029 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.17 160.05 67.38 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.578 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 46.8 Cg_exo -54.95 114.82 2.04 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.298 1.998 . . . . 0.0 112.14 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 101.88 29.56 6.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.333 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.1 127.79 55.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.746 0.307 . . . . 0.0 111.424 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 25' ' ' ASP . 26.2 t -77.66 105.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.58 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 66.8 mtm -90.57 -25.76 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 54.5 m-85 -143.16 162.59 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 1.4 pm0 -165.9 116.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.546 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -98.45 167.95 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.503 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -161.12 138.69 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.008 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 -40.88 2.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.691 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 58' ' ' PHE . 35.8 m -74.07 -178.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 0.0 111.262 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.7 p -90.28 -178.32 5.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.45 -44.5 58.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.57 -44.16 96.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -75.18 -39.51 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.29 -48.25 62.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.423 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.08 -47.86 82.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.738 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.39 -48.56 77.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -59.21 -48.91 79.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.876 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.0 -32.86 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.315 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.6 mtp85 -74.54 -39.47 62.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.609 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 117' ' ' ALA . 35.1 mt -53.76 -31.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.651 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . . . -71.58 -53.84 12.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.811 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.591 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -65.0 -19.56 65.9 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.872 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.5 82.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.801 0.334 . . . . 0.0 111.037 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -91.13 7.99 37.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD22 HD12 ' A' ' 42' ' ' ILE . 17.4 mt -84.04 157.78 62.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.628 0.251 . . . . 0.0 110.36 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.643 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 6.6 Cg_endo -86.34 17.76 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.018 2.479 . . . . 0.0 112.705 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -153.12 167.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.483 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.3 tptp -80.93 134.66 35.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 36' ' ' ALA . 26.2 p -134.86 147.71 49.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.773 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.1 pttt -131.17 154.3 48.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.229 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.876 HG23 HD23 ' A' ' 118' ' ' LEU . 3.5 mm -84.93 136.58 22.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.0 m -147.35 139.95 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -76.32 165.47 24.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.092 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HA ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -47.1 89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.185 178.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.8 t0 67.05 44.92 1.85 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.971 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.669 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.77 94.57 4.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.487 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.93 108.53 11.05 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.78 114.89 26.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.85 103.72 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.55 95.25 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.182 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.958 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER -60.5 157.05 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.31 145.16 30.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.21 -23.9 17.46 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 112.39 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 64.21 164.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.55 116.61 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 mtm -86.25 167.15 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -94.06 177.64 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 62.97 77.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -111.98 118.19 34.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.27 81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.006 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -106.05 116.89 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.95 115.56 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -72.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.31 -78.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.76 -174.91 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.1 -167.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -78.85 -7.89 58.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.384 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.77 76.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.565 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.68 133.75 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 111.112 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 p -83.7 -178.45 7.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -65.15 175.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -37.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.91 -129.36 1.85 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.581 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -91.66 -177.74 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.467 . . . . 0.0 110.996 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -136.7 116.16 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.536 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG11 ' HG2' ' A' ' 134' ' ' ARG . 3.0 t -25.75 -47.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.102 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 73.09 -77.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -115.91 163.12 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 69.05 136.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.693 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -26.92 63.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.974 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 9.9 m-85 -118.33 171.14 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.761 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.48 132.48 2.8 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.714 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.5 tm? -91.31 115.27 27.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.136 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.2 p -103.58 145.74 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 0.0 112.199 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.79 116.18 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.536 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.635 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.2 mt -90.62 20.49 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.91 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.8 tt0 -164.08 141.05 5.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.87 125.51 13.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.391 2.061 . . . . 0.0 112.543 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -154.04 172.04 18.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -107.92 107.1 17.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.705 HD12 HD22 ' A' ' 125' ' ' LEU . 19.4 mm -83.46 117.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.264 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.78 167.6 20.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.179 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.73 -43.46 80.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.875 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.17 -39.42 75.27 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.912 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HB2' HG22 ' A' ' 42' ' ' ILE . 24.7 mm-40 -58.88 -34.71 71.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.315 . . . . 0.0 110.898 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.924 HG23 HG21 ' A' ' 66' ' ' ILE . 14.9 mt -70.98 -50.4 43.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.2 tp10 -83.14 -46.38 12.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.749 0.309 . . . . 0.0 111.611 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.83 -47.19 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.14 81.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.46 -44.59 92.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.7 t -57.97 -37.54 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.64 -38.44 65.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 69.8 mtm -71.02 -47.23 59.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 38.7 t -56.91 -40.91 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -75.27 -29.47 60.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -63.6 -51.54 64.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.287 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.928 ' CD1' HG11 ' A' ' 109' ' ' VAL . 31.7 m-85 -49.11 120.56 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 111.079 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -57.48 -56.67 18.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -96.76 33.13 1.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.052 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.47 152.81 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.98 152.26 23.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -105.97 140.47 38.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.752 0.311 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HD3' ' A' ' 51' ' ' ARG . 1.6 mt -121.89 140.53 45.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 111.261 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.33 109.24 20.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.924 HG21 HG23 ' A' ' 47' ' ' ILE . 3.1 mm -91.53 129.91 41.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.69 21.72 13.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 42' ' ' ILE . 38.3 pt -125.19 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.929 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.95 142.69 41.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.89 106.71 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -129.1 21.36 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.1 119.68 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.36 142.45 47.29 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.373 2.049 . . . . 0.0 112.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.53 95.99 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' VAL . 21.2 p -119.26 147.09 44.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -137.45 50.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.429 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -108.72 138.62 20.34 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.897 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.4 177.91 7.73 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.476 2.117 . . . . 0.0 112.285 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.05 116.55 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -163.2 -52.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.31 147.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 38.77 3.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.98 149.98 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.08 158.8 22.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 -18.14 22.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.146 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 139.95 -58.25 0.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.489 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 -30.74 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.61 132.02 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -71.57 69.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 75' ' ' THR . 11.5 p -74.75 150.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.25 50.03 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.826 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.2 178.11 2.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.7 164.05 12.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -128.99 174.4 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.327 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -126.12 105.03 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -59.62 128.99 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.281 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 98' ' ' LYS . 15.3 t -126.56 162.02 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.171 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -130.77 156.48 79.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.456 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 Cg_exo -50.82 119.62 5.5 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.265 1.976 . . . . 0.0 111.995 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 96.46 34.62 5.74 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -113.89 121.7 44.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.757 0.313 . . . . 0.0 111.493 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 25' ' ' ASP . 4.8 t -77.15 105.93 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.584 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 39.6 mtm -93.03 -32.45 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.57 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 63.7 m-85 -131.46 156.05 46.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.319 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.5 mp0 -153.98 120.91 5.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 118' ' ' LEU . 35.6 m -112.43 160.35 11.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.198 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.807 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -153.34 143.52 22.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.41 -34.48 4.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.869 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.071 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.6 m -78.9 153.48 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.897 0.38 . . . . 0.0 111.326 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.8 p -67.04 165.85 14.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.67 -39.21 83.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -65.22 -46.08 82.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -75.13 -38.11 61.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.071 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.63 -48.16 56.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.412 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.81 -45.1 95.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.1 -48.6 75.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.31 -48.82 79.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.2 -32.89 71.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.406 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.442 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.69 -39.16 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 117' ' ' ALA . 26.1 mt -55.84 -31.97 31.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 -45.62 60.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.32 -24.52 76.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.563 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -57.95 -41.64 83.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.361 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -85.52 -1.71 57.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.346 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 42' ' ' ILE . 43.6 mt -84.5 155.44 62.58 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.599 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 86.9 Cg_endo -87.1 22.59 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.847 2.365 . . . . 0.0 112.78 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.12 167.05 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.332 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -81.04 133.46 35.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.481 ' CB ' HD11 ' A' ' 34' ' ' LEU . 16.4 p -136.41 146.61 46.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.501 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.635 ' HG2' HD21 ' A' ' 37' ' ' LEU . 22.2 pttt -129.27 159.66 35.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.342 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -88.45 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.746 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.854 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.7 m -149.25 141.1 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 111.217 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -81.23 165.69 21.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.396 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' HG2' HG11 ' A' ' 27' ' ' VAL . 1.7 mtm180 -45.07 88.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.571 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 70.31 40.32 1.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.481 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.586 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.7 94.83 4.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.899 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.854 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.43 92.82 3.64 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -115.92 130.88 57.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.14 104.41 3.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.15 94.95 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.9 0.381 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.98 -67.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.92 112.61 26.22 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.64 125.63 7.66 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.45 2.1 . . . . 0.0 112.374 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.64 134.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 58.32 106.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.36 129.8 36.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -67.52 -30.98 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.71 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.27 154.61 18.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -127.0 -45.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -66.46 120.34 13.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 155.67 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -109.59 168.48 9.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.75 -72.92 0.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -115.37 176.82 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.58 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.824 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -82.32 -27.48 32.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.83 -94.56 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.11 115.07 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -108.27 32.94 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -84.27 148.69 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 25.92 8.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.36 171.4 13.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.548 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -94.9 17.47 13.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.688 0.28 . . . . 0.0 111.399 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 27' ' ' VAL . 91.9 t80 51.39 -92.48 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.167 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 26' ' ' TYR . 4.6 t -165.26 -79.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.4 . . . . 0.0 110.047 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.627 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 51.79 176.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.827 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 62.91 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.509 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -100.28 168.9 21.25 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.891 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.03 -41.27 86.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.745 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 17.8 m-85 -105.33 164.78 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.83 132.07 3.45 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.193 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.42 114.95 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 100' ' ' GLY . 3.9 p -103.16 145.57 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.255 0.55 . . . . 0.0 112.109 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.88 112.48 24.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.606 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.9 mt -83.86 8.01 16.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.883 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -151.62 146.53 18.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.644 0.259 . . . . 0.0 110.846 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.53 125.45 11.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.438 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -153.72 172.02 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.294 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.444 ' HB3' HG21 ' A' ' 94' ' ' VAL . 12.6 m0 -109.62 108.42 18.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 HD22 ' A' ' 125' ' ' LEU . 18.1 mm -83.59 116.59 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.343 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.452 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.95 170.29 16.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.37 -42.97 88.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.05 -39.87 79.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.952 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -58.86 -34.73 71.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 66' ' ' ILE . 20.7 mt -71.54 -49.73 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.8 tp10 -83.17 -46.6 12.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.514 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.7 -47.3 73.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.183 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.08 -43.41 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.6 ttp180 -59.39 -42.13 91.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.706 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.5 t -57.94 -36.94 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.765 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.15 -38.2 44.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.035 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.46 ' CB ' HD11 ' A' ' 64' ' ' ILE . 65.6 mtm -71.16 -49.62 42.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.3 t -56.85 -40.77 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.251 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -29.49 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -59.31 -53.75 54.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CD1' HG11 ' A' ' 109' ' ' VAL . 10.9 m-85 -58.46 91.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.864 0.364 . . . . 0.0 110.851 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -59.1 -30.62 68.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -98.01 33.12 2.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.14 163.13 6.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.6 152.79 8.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.552 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -126.71 145.21 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 51' ' ' ARG . 4.1 mt -118.65 144.7 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.254 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 25.7 m-85 -112.33 110.13 20.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.999 HG21 HG23 ' A' ' 47' ' ' ILE . 3.6 mm -95.31 121.14 45.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 30.64 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 66' ' ' ILE . 39.7 pt -131.38 135.62 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -133.61 139.23 33.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 57.3 Cg_endo -71.09 108.88 2.43 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.488 2.125 . . . . 0.0 112.264 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -120.89 -41.55 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 126.84 87.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.95 155.11 57.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.424 2.083 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -127.5 88.76 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.209 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.4 p -119.43 135.76 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.62 121.02 18.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 147.56 45.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.47 125.67 11.46 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.71 126.62 29.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 65.9 -68.8 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.9 148.77 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.23 147.62 47.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.8 ttm -164.21 177.22 8.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.33 172.65 21.58 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -96.02 18.07 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.619 0.247 . . . . 0.0 111.152 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.31 -148.38 5.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 -31.79 11.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.51 134.03 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.412 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.74 152.0 49.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.12 138.27 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.049 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.34 47.56 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.91 178.81 31.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.483 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.34 163.46 12.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.4 m -137.81 174.62 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.36 102.9 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.05 129.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.3 t -126.55 162.2 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.9 mttm -130.66 159.68 69.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.586 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -53.14 119.79 6.69 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.395 2.063 . . . . 0.0 112.287 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.25 24.92 11.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 35' ' ' VAL . 2.0 mmt-85 -105.43 120.39 41.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.56 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' O ' ' A' ' 26' ' ' TYR . 21.6 t -83.19 102.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.74 -31.21 15.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.673 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.767 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.9 m-85 -124.35 157.03 36.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 110.925 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -164.27 114.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.569 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 118' ' ' LEU . 34.0 m -96.23 166.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.44 143.04 14.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 -32.09 6.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.648 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -83.33 166.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.9 p -73.99 177.93 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.21 -42.41 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.96 -45.98 90.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -75.23 -38.49 60.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.28 -47.95 69.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.572 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -64.29 -46.77 82.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.3 -48.58 77.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.799 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.92 -48.74 79.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.823 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.29 -30.93 69.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.426 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HG3' HD11 ' A' ' 131' ' ' ILE . 9.7 mtp180 -73.03 -40.57 65.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.451 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.4 mt -57.52 -36.42 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.733 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.93 -44.87 88.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -73.81 -21.81 78.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.566 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -58.37 -42.11 86.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 0.87 54.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.389 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.9 mt -84.51 153.71 61.92 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.638 0.256 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.687 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 93.7 Cg_endo -86.94 21.01 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.862 2.375 . . . . 0.0 112.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.783 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.8 167.07 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.935 0.397 . . . . 0.0 111.242 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.45 144.86 39.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 36' ' ' ALA . 12.2 p -150.73 149.56 29.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.601 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HE2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.83 160.47 38.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.148 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.823 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -87.07 141.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.867 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.0 m -151.42 127.55 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.378 . . . . 0.0 111.655 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -92.55 118.48 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.448 ' N ' HG21 ' A' ' 27' ' ' VAL . 2.8 mtm180 42.14 -104.42 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.494 0.664 . . . . 0.0 111.801 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.78 46.12 0.94 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.108 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.72 93.88 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.354 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.867 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.0 m-85 -127.84 117.5 21.94 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.91 94.47 6.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -64.75 103.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.75 98.74 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.844 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.15 176.75 7.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.11 102.2 37.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -51.59 -176.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 62.57 112.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 170.58 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.42 172.6 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 59.99 157.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.66 127.82 32.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.94 152.5 27.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -24.23 67.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -63.97 129.87 41.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.48 142.81 44.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.73 -44.73 6.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.826 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.16 155.24 21.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 60.17 160.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.945 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.73 -178.24 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 23.53 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.09 67.91 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.39 153.63 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 p -80.61 -31.57 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -130.52 103.79 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.76 148.26 19.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.61 179.65 33.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -87.17 -21.34 25.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.698 0.285 . . . . 0.0 111.103 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.804 ' O ' HG23 ' A' ' 27' ' ' VAL . 41.8 t80 69.43 -99.06 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 26' ' ' TYR . 4.9 t -168.88 126.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . . . -50.52 -70.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.754 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 71.2 m-85 -158.61 -47.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -51.05 157.02 2.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.828 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.89 -36.93 65.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 25.3 m-85 -112.44 171.06 7.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -153.76 127.89 2.27 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.822 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.2 tm? -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.1 p -101.73 145.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 112.121 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.24 115.58 27.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.445 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.9 mt -90.11 20.05 4.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 50.5 tt0 -164.08 139.34 4.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.238 . . . . 0.0 110.696 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 30.3 Cg_endo -63.35 131.67 32.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.555 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.81 171.09 19.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HB3' HG21 ' A' ' 94' ' ' VAL . 18.8 m0 -109.6 121.84 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.74 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.695 ' CD1' HD22 ' A' ' 125' ' ' LEU . 18.8 mm -100.69 115.33 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.82 177.26 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.88 -42.35 99.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.997 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.45 -42.91 88.48 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.11 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' OE1' HD23 ' A' ' 125' ' ' LEU . 5.8 mt-30 -58.83 -34.53 71.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.729 0.3 . . . . 0.0 111.042 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.015 HG23 HG21 ' A' ' 66' ' ' ILE . 18.4 mt -71.57 -50.05 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.592 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -83.13 -46.67 12.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.753 0.311 . . . . 0.0 111.547 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.48 -47.17 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.95 91.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.834 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.9 ttp85 -59.54 -41.3 89.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.725 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.5 -41.52 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.39 76.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.916 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.734 ' CE ' HD13 ' A' ' 64' ' ' ILE . 64.6 mtm -71.12 -50.17 36.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.8 t -57.02 -37.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -75.06 -29.48 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.225 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -61.67 -52.53 63.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.6 m-85 -56.49 109.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -69.63 -32.84 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -98.17 33.17 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.22 155.16 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.85 157.34 25.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -121.86 137.43 54.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.734 HD13 ' CE ' ' A' ' 54' ' ' MET . 3.5 mt -111.49 144.58 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -110.02 109.39 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.015 HG21 HG23 ' A' ' 47' ' ' ILE . 2.9 mm -96.84 129.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.52 28.79 7.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 103' ' ' MET . 30.1 pt -127.71 130.65 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -131.48 137.26 30.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 57.7 Cg_endo -71.38 104.39 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.401 2.068 . . . . 0.0 112.163 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.18 -47.13 2.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.19 142.13 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.59 153.57 44.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.422 2.082 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -102.41 87.42 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 p -118.98 139.08 52.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -108.3 63.63 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 94.21 45.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.05 -58.53 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.697 2.265 . . . . 0.0 112.218 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 79' ' ' LEU . 4.9 mp -60.49 143.32 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.4 -177.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.61 148.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -57.95 -31.12 66.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -88.35 148.09 24.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.92 -156.59 23.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -85.11 -18.14 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.36 42.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -177.4 151.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.46 135.73 1.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.571 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -84.88 94.6 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 p -80.2 136.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.12 60.08 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.3 -154.65 52.69 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -123.99 149.67 45.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 43' ' ' THR . 3.3 m -145.49 172.57 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.294 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.83 103.18 10.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.803 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.72 130.55 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.57 160.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.114 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.8 160.1 68.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.4 Cg_exo -54.42 116.15 2.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.292 1.995 . . . . 0.0 112.048 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.39 33.36 5.42 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.148 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.518 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.96 118.44 33.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.323 . . . . 0.0 111.625 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 25' ' ' ASP . 16.5 t -81.24 103.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -94.74 -29.22 14.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 66' ' ' ILE . 60.8 m-85 -124.25 148.37 47.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 111.335 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 28' ' ' ALA . 8.5 mp0 -151.66 127.31 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.657 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.711 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -114.42 160.74 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.775 0.322 . . . . 0.0 111.227 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -157.75 140.77 15.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.29 24.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.702 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.793 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.7 m -91.19 163.67 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -70.25 178.12 2.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -73.52 -44.85 56.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.63 -42.85 97.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -75.16 -40.26 59.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.79 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.793 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.95 -48.19 66.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.143 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -60.77 -47.6 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.609 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.84 -48.68 77.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.63 -48.71 78.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.75 -31.28 71.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.438 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.53 -40.39 61.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.617 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 117' ' ' ALA . 55.0 mt -57.58 -35.27 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.75 92.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.12 -19.92 78.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.594 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -57.81 -41.15 81.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 0.25 56.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 42' ' ' ILE . 35.2 mt -84.3 153.79 62.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.661 0.267 . . . . 0.0 110.697 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.698 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.2 Cg_endo -88.26 22.99 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.927 2.418 . . . . 0.0 112.527 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.724 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -150.68 164.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.451 ' CG ' HD12 ' A' ' 37' ' ' LEU . 18.8 tptt -80.66 134.08 35.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.45 ' CB ' HD11 ' A' ' 34' ' ' LEU . 11.0 p -137.45 148.33 46.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.581 ' HG2' HD21 ' A' ' 37' ' ' LEU . 31.3 pttt -130.29 160.79 32.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.7 mm -90.86 136.26 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.884 HG21 ' OH ' ' A' ' 137' ' ' TYR . 4.2 m -141.17 131.83 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 111.421 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -75.78 165.39 25.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.209 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HA ' HG21 ' A' ' 27' ' ' VAL . 11.6 ttp180 -48.89 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.112 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 133' ' ' ARG . 24.3 t0 73.63 38.92 0.59 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.638 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.88 94.16 4.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.1 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.884 ' OH ' HG21 ' A' ' 132' ' ' VAL . 2.1 m-85 -127.19 119.05 25.52 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.031 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.2 94.74 9.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.68 112.62 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.46 104.38 11.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.859 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.4 120.79 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.59 127.49 60.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.74 132.26 48.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.413 2.075 . . . . 0.0 112.258 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -84.25 99.26 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 60.98 -175.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mtt -63.41 122.68 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -68.2 110.95 4.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 166.67 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.17 119.37 36.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -120.64 -54.45 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -64.0 152.33 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -107.22 149.7 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.08 5.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.01 153.81 34.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.8 166.21 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.9 133.73 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -96.43 23.53 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -96.28 178.26 34.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -59.11 172.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.18 151.95 33.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.23 -179.29 16.51 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.96 108.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.29 154.13 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.688 ' O ' HG23 ' A' ' 27' ' ' VAL . 3.8 t80 -179.4 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.7 t 123.07 -80.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.294 0.996 . . . . 0.0 109.93 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.55 167.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.476 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.441 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 3.9 m-85 62.63 -79.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.794 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -90.91 165.01 30.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.69 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -71.96 -26.08 62.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 8.7 m-85 -117.06 171.23 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.751 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -159.93 132.95 3.12 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -91.36 115.68 28.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.3 p -105.35 144.36 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 111.901 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -95.64 111.56 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.772 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.716 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.5 mt -80.34 3.57 20.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.895 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.2 tt0 -146.74 147.43 29.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.7 0.285 . . . . 0.0 110.829 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.4 132.64 19.5 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.458 2.105 . . . . 0.0 112.421 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.755 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.28 172.12 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.305 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.4 m0 -108.99 116.19 31.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.658 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.767 HD12 HD22 ' A' ' 125' ' ' LEU . 11.8 mm -93.16 120.59 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.362 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.87 174.49 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.49 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.732 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.47 -42.08 95.5 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.916 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 42' ' ' ILE . 8.8 mt-30 -58.8 -34.49 71.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 66' ' ' ILE . 22.5 mt -71.57 -50.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.467 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 tt0 -83.08 -46.69 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.766 0.317 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.79 -47.0 74.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.71 95.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.873 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -61.06 -41.51 96.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.525 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.0 t -57.95 -45.34 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.787 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.93 94.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.469 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 58.5 mtm -71.11 -48.44 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.8 t -56.83 -37.16 52.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -74.98 -29.53 60.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -63.52 -52.13 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.252 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -58.97 87.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -60.49 -27.64 67.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -98.09 32.53 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.31 152.83 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.409 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.49 158.74 22.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.91 150.46 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.784 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.827 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.4 mt -127.54 143.2 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 29' ' ' PHE . 56.7 m-85 -114.62 109.49 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.663 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 47' ' ' ILE . 4.6 mm -98.24 138.1 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.76 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 103' ' ' MET . 29.3 pt -60.16 151.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.56 138.62 11.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.8 112.16 3.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.284 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -132.02 -45.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 126.18 89.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.38 171.48 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 2.3 t80 -124.5 86.1 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.9 p -119.32 128.56 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -104.93 30.79 5.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 96.73 40.46 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 149.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.577 2.185 . . . . 0.0 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.47 134.49 34.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG23 ' A' ' 81' ' ' VAL . 14.7 pt-20 -159.35 -46.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' A' ' 80' ' ' GLU . 21.6 t -112.94 134.69 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.96 92.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.7 88.14 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.13 136.15 7.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.424 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -87.1 -18.14 31.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.92 -88.69 2.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 157.11 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.28 -160.46 31.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.487 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -59.54 119.02 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.38 137.07 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 mm-40 -87.0 55.64 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 -170.28 28.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.92 157.42 18.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 41' ' ' TRP . 4.0 m -146.07 174.49 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.137 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.28 102.56 8.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' TRP . 5.7 t -58.9 130.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.9 t -126.61 161.17 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.74 160.03 68.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.741 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.1 Cg_exo -54.37 114.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.434 2.089 . . . . 0.0 112.017 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.497 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.33 31.83 5.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.261 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.611 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -114.34 116.05 28.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.77 HG12 ' OE2' ' A' ' 105' ' ' GLU . 9.4 t -80.93 103.87 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.61 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.48 -23.87 18.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.968 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.687 ' CD2' HD12 ' A' ' 66' ' ' ILE . 53.2 m-85 -124.37 157.61 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.135 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.77 ' OE2' HG12 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -158.25 120.91 3.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 118' ' ' LEU . 33.5 m -111.24 159.81 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.836 0.351 . . . . 0.0 111.109 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.794 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.72 143.22 19.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.1 -27.03 16.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.8 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.086 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -84.46 153.3 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.207 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -66.88 163.68 19.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -58.61 -38.76 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.01 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.67 -46.0 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -74.97 -37.57 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.086 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.52 -48.13 50.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -44.42 96.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.824 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -66.87 -48.56 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 58' ' ' PHE . . . -56.61 -48.85 76.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.852 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.41 -39.02 62.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 117' ' ' ALA . 84.3 mt -56.82 -47.96 82.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.447 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.53 -46.75 77.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.81 -24.55 76.5 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.433 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.17 80.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 0.04 56.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 42' ' ' ILE . 46.1 mt -84.47 157.09 62.03 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.767 0.318 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.1 Cg_endo -87.22 19.78 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.78 2.32 . . . . 0.0 112.724 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.755 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.33 166.84 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.68 143.12 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 36' ' ' ALA . 10.9 p -147.78 151.41 35.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -135.8 166.07 24.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.852 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -92.06 141.4 14.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.992 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.8 m -147.16 139.35 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.272 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.87 165.42 21.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.299 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.84 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.4 t70 71.96 37.68 1.0 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.705 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.589 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.75 94.89 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.743 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.827 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.38 89.96 3.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.68 129.13 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.49 107.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.39 94.83 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.049 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.906 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.22 106.04 2.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.88 116.35 58.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.2 -28.02 19.19 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.427 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -165.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 64.1 99.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 ptp -80.0 115.45 19.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.83 -35.63 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -88.56 -179.9 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.65 132.65 53.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -122.4 114.2 20.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -88.05 137.86 31.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.8 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -164.32 102.11 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.61 68.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.35 164.01 14.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 -170.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -88.94 -27.5 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.54 89.11 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . . . -109.23 164.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.748 HG21 HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -131.94 140.68 49.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 153.74 30.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.88 -172.09 25.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.573 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 58.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -141.44 -176.08 4.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.976 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -139.43 117.62 11.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.763 179.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 28' ' ' ALA . 6.3 t -28.56 -74.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.843 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 63.06 126.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.206 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 59.58 96.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.785 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 111.57 167.82 18.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.07 -38.72 15.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.5 m-85 -111.37 171.26 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.947 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.54 133.51 3.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.58 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 129' ' ' THR . 2.4 tm? -91.27 116.45 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 101' ' ' ARG . 5.3 p -104.25 145.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.168 0.508 . . . . 0.0 112.069 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.611 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -96.94 114.4 26.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.439 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD13 HG21 ' A' ' 21' ' ' THR . 6.3 mt -85.9 10.67 13.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.882 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -153.29 147.38 18.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 127.28 13.31 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.441 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.01 172.06 19.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 111.369 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 10.5 m0 -112.05 112.98 25.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.633 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.787 HD12 HD22 ' A' ' 125' ' ' LEU . 15.2 mm -87.26 122.05 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 177.49 8.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -65.5 -45.08 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.732 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.84 -41.36 95.65 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.506 HE21 HG23 ' A' ' 42' ' ' ILE . 12.4 mt-30 -58.84 -34.34 71.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.847 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.32 -50.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.539 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 tp10 -83.12 -46.03 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 111.741 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.65 -47.1 70.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.68 91.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 mtm180 -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.705 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.9 t -59.54 -45.54 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.67 88.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.504 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.6 mtm -71.05 -48.34 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.075 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.83 -36.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD2' HG12 ' A' ' 52' ' ' VAL . 1.2 mtt180 -75.18 -29.91 60.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -63.26 -52.28 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.8 m-85 -57.42 118.04 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -68.87 -39.76 79.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -98.09 33.03 2.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.71 157.11 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.409 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.42 152.14 21.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.58 131.42 55.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.794 0.33 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' HE3' ' A' ' 54' ' ' MET . 2.0 mt -112.71 128.2 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -97.83 109.4 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.847 HG21 HG23 ' A' ' 47' ' ' ILE . 5.5 mm -93.38 130.58 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.218 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -104.68 -29.62 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.6 pt -71.69 138.18 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.35 135.0 12.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 26.9 Cg_exo -62.33 129.37 26.61 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 112.128 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.46 -46.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -76.86 111.41 16.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.69 124.54 10.32 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.348 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.684 ' CD2' HG13 ' A' ' 94' ' ' VAL . 8.2 p90 -102.41 144.41 30.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.598 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 p -118.79 135.96 54.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.124 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -142.25 113.54 7.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -112.68 94.37 28.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.66 -42.8 63.96 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.555 2.17 . . . . 0.0 112.223 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 161.53 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.32 154.07 42.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 82' ' ' ARG . 21.5 t -93.52 154.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -131.87 -46.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.15 103.34 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.96 95.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -18.04 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.664 0.268 . . . . 0.0 111.227 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -156.65 57.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -145.14 61.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.82 109.37 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -95.11 95.71 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.692 HG22 ' H ' ' A' ' 92' ' ' GLY . 8.1 p -65.09 137.03 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.66 28.81 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 90' ' ' VAL . . . 122.31 171.78 13.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.417 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.32 158.23 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 ' CD2' ' A' ' 74' ' ' TYR . 2.2 m -136.11 173.83 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 111.242 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.67 102.36 7.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 41' ' ' TRP . 10.7 t -60.85 128.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.429 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 21.8 t -126.57 160.95 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.996 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.3 mtmp? -130.69 160.08 68.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.826 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.7 Cg_exo -53.67 115.22 2.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.398 2.065 . . . . 0.0 112.127 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.14 34.1 5.23 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.523 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.52 122.54 46.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 111.502 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.812 HG12 ' OE2' ' A' ' 105' ' ' GLU . 8.7 t -77.37 105.44 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.507 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.611 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -91.43 -36.9 13.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.682 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.696 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -124.41 158.4 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.504 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.812 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.7 mp0 -154.95 129.22 8.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.681 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.665 HG13 HD11 ' A' ' 118' ' ' LEU . 29.2 m -120.68 156.35 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 111.215 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -151.66 141.85 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 -24.28 30.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.869 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.049 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.3 m -86.78 155.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 p -67.08 163.84 19.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.06 -39.07 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.51 -44.84 81.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.07 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -75.0 -36.95 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.934 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.43 -48.28 50.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.411 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.6 -47.22 84.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.834 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.69 -48.51 76.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.07 -48.94 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.83 -32.4 71.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.278 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -41.11 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.666 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 117' ' ' ALA . 27.2 mt -53.87 -33.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.707 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.32 -48.32 65.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.579 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.0 -22.48 70.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.445 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -58.78 -45.17 90.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.717 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -84.75 -0.45 53.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.787 HD22 HD12 ' A' ' 42' ' ' ILE . 33.3 mt -84.44 154.44 62.61 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.71 0.29 . . . . 0.0 110.704 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.8 Cg_endo -87.18 21.71 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.797 2.331 . . . . 0.0 112.679 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.93 166.95 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -79.33 143.02 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.494 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.3 p -145.95 147.12 31.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.715 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.513 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -131.72 158.12 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.062 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -84.98 144.65 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.136 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.4 m -149.65 146.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.211 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -87.13 165.86 15.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' HA ' HG21 ' A' ' 27' ' ' VAL . 26.1 mtp180 -43.99 87.99 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.713 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.4 t0 69.25 40.25 1.55 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.494 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.592 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.76 95.01 5.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.855 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.24 112.9 16.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -58.89 116.0 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.02 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 131.95 40.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -98.03 97.04 8.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.8 0.333 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.72 -45.99 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mmt -113.26 90.07 15.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -51.08 173.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.506 2.138 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -73.64 136.98 43.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -132.26 100.58 5.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.58 154.32 40.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 113.44 7.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 60.65 51.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -110.98 118.12 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -114.36 148.74 37.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.11 164.65 10.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.92 117.14 33.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -47.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.31 140.57 11.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 60.35 164.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.44 141.42 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -27.61 17.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.86 -58.97 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.53 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.69 140.7 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.102 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.06 59.18 5.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -116.86 173.11 6.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.34 -43.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.521 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.51 -109.33 1.84 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.356 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.12 118.35 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.311 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.827 ' O ' HG23 ' A' ' 27' ' ' VAL . 2.4 p90 -107.88 -50.33 3.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.5 t -170.99 132.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.32 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . . . -108.84 99.83 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 62.12 170.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 69.01 -173.35 35.36 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 0.7 OUTLIER -97.46 -42.88 7.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.757 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 16.1 m-85 -105.54 171.28 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.35 134.12 3.83 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.897 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.17 116.13 28.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.6 p -103.47 144.6 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.227 0.537 . . . . 0.0 112.157 -178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.0 109.93 22.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 130' ' ' LYS . 7.4 mt -81.04 4.41 19.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.973 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.6 OUTLIER -146.97 148.87 33.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.704 0.287 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.12 129.68 13.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.542 2.161 . . . . 0.0 112.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -161.83 172.08 16.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 111.389 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -108.9 118.77 37.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.696 HD12 HD22 ' A' ' 125' ' ' LEU . 31.0 mm -93.66 121.06 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.456 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.81 169.79 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.29 -43.83 92.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.83 -40.18 83.44 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.01 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -58.91 -34.67 71.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.818 0.342 . . . . 0.0 110.937 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 66' ' ' ILE . 19.6 mt -71.18 -50.3 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.17 -46.38 12.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.546 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.1 -48.46 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.117 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.39 95.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.1 ttm180 -59.42 -42.92 92.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 48' ' ' GLU . 41.2 t -58.23 -47.38 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.58 87.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.59 ' HE3' HG21 ' A' ' 64' ' ' ILE . 62.5 mtm -71.14 -48.53 51.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.5 t -56.87 -35.84 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.218 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -75.14 -29.53 60.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -63.37 -55.24 26.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.295 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 12.5 m-85 -53.57 94.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.918 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.96 -34.9 68.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -98.11 33.09 2.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.39 163.94 3.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.44 166.62 35.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.27 148.65 51.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.813 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.9 mt -129.68 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -97.25 109.5 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.444 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.834 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -93.47 133.44 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.298 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -29.25 8.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 103' ' ' MET . 46.3 pt -69.89 140.58 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -144.26 133.61 11.46 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 24.4 Cg_exo -63.0 104.55 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.378 2.052 . . . . 0.0 112.106 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 -43.69 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 142.84 87.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.86 146.06 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.95 85.97 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.2 p -119.37 107.67 13.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.225 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -69.12 100.68 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.671 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.49 94.31 8.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -167.69 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.477 2.118 . . . . 0.0 112.118 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 104.3 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.79 120.88 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.04 130.13 67.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? 60.63 68.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 ptm -178.78 101.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.9 41.88 0.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.444 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -98.24 18.1 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.44 -136.85 4.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -177.61 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.9 -114.87 4.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -115.4 133.03 56.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.332 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -83.78 149.88 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.6 48.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -169.7 30.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.59 154.77 25.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 43' ' ' THR . 1.6 m -134.74 174.49 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.06 102.43 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.03 132.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.123 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 101' ' ' ARG . 19.0 t -126.5 159.31 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.277 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.66 150.04 75.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 2.4 Cg_endo -45.46 116.36 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.908 2.406 . . . . 0.0 112.137 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.11 34.18 5.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.932 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 7.4 tpt180 -114.84 119.95 38.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.858 HG12 ' OE2' ' A' ' 105' ' ' GLU . 4.5 t -82.32 99.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.625 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -88.57 -28.99 20.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.885 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 55.0 m-85 -124.14 153.48 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 111.067 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.858 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.5 mp0 -154.68 126.18 7.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -115.65 156.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.904 0.383 . . . . 0.0 111.089 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.14 141.03 21.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 -25.78 25.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.673 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.044 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -87.06 154.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 0.0 111.279 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.4 p -66.96 164.02 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.97 -38.42 82.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.052 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -75.27 -36.43 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.044 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.66 -48.18 49.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.32 -44.93 95.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.769 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.96 -48.54 70.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.71 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.44 -48.83 78.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.06 -30.41 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.352 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -42.34 59.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 117' ' ' ALA . 53.9 mt -55.74 -37.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.6 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.98 89.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.683 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.09 -20.89 77.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.563 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -35.41 70.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 3.85 53.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.341 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 42' ' ' ILE . 31.5 mt -84.5 156.66 62.17 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.674 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.607 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.9 Cg_endo -87.42 19.09 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.857 2.372 . . . . 0.0 112.737 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -150.47 167.15 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.859 0.361 . . . . 0.0 111.183 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.435 ' CG ' HD12 ' A' ' 37' ' ' LEU . 15.3 tptm -78.63 138.55 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.431 ' CB ' HD11 ' A' ' 34' ' ' LEU . 8.6 p -143.84 151.61 40.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.734 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 37' ' ' LEU . 5.1 pttt -139.01 161.19 37.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 118' ' ' LEU . 3.4 mm -84.91 140.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.9 HG21 ' OH ' ' A' ' 137' ' ' TYR . 6.3 m -148.12 139.26 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.508 . . . . 0.0 111.282 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -80.74 165.79 21.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.36 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.63 ' HG2' HG11 ' A' ' 27' ' ' VAL . 9.3 mtm-85 -44.66 88.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.479 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.5 t70 68.25 43.17 1.57 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.078 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.677 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.75 94.61 4.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.277 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.9 ' OH ' HG21 ' A' ' 132' ' ' VAL . 2.0 m-85 -126.62 108.35 11.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.62 127.87 55.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.785 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.55 114.18 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.45 98.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.17 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.789 0.328 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.25 117.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtp -121.55 139.94 30.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.62 143.09 29.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.82 165.11 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 128.89 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.2 ptp -80.02 153.9 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -142.58 -47.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -61.94 141.0 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.35 111.82 23.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp 60.69 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -74.11 121.51 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -94.03 129.72 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 60.14 -173.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.37 89.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -105.03 160.43 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -83.87 171.18 13.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -78.74 -27.63 44.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.78 63.87 0.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.543 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 99.89 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.334 . . . . 0.0 111.125 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -109.98 -32.13 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 136.09 40.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.61 34.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.564 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.51 -26.82 3.27 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.602 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -73.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.119 0.485 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 62.29 118.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.692 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 137' ' ' TYR . 28.7 t -34.07 143.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.261 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.27 77.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 111.586 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 0.1 OUTLIER 170.58 -58.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.89 -167.65 11.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.03 -47.17 78.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HB2' HG22 ' A' ' 106' ' ' VAL . 41.9 m-85 -108.86 171.38 7.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -158.18 135.16 4.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.366 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.2 tm? -91.45 109.45 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 110.137 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.6 p -98.7 145.57 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.876 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.76 108.46 21.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.803 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.6 mt -75.44 -2.49 28.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.74 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.05 148.92 50.52 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.69 0.281 . . . . 0.0 110.801 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 69.6 Cg_endo -74.41 131.09 14.62 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.563 2.176 . . . . 0.0 112.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -156.55 172.08 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.314 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 96' ' ' VAL . 25.0 m0 -107.85 105.81 15.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.598 HD12 HD22 ' A' ' 125' ' ' LEU . 22.6 mm -83.36 118.87 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.9 174.01 11.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.5 96.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.675 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.8 -39.21 84.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.059 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -58.93 -34.65 71.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 110.954 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.031 HG23 HG21 ' A' ' 66' ' ' ILE . 19.9 mt -72.06 -49.42 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.608 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' VAL . 25.4 tt0 -83.12 -46.56 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.306 . . . . 0.0 111.587 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.71 -47.29 70.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.282 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.02 -42.16 85.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.41 -42.71 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.0 t -58.14 -40.97 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 -38.01 76.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.184 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.699 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 56.9 mtm -71.05 -46.74 61.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 51' ' ' ARG . 49.1 t -56.89 -33.66 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.269 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -75.0 -29.49 60.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.99 -53.92 46.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.2 m-85 -55.56 97.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -64.63 -33.23 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -96.82 33.07 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.39 156.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.15 152.14 11.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.15 132.52 54.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.695 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -112.22 135.9 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.238 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 80.5 m-85 -108.42 109.39 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.532 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 47' ' ' ILE . 1.6 mm -87.39 134.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 25.63 10.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG12 HG22 ' A' ' 66' ' ' ILE . 32.2 pt -128.13 133.72 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.97 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.3 141.2 36.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 72.4 Cg_endo -76.66 123.03 6.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.542 2.161 . . . . 0.0 112.178 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -137.83 -46.07 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 144.07 98.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.27 156.82 58.42 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.554 2.169 . . . . 0.0 112.317 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.55 88.19 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.043 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.6 p -119.27 105.04 10.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.045 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 22.7 mttm -112.64 81.03 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.12 94.24 47.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.728 2.285 . . . . 0.0 112.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 148.53 28.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.996 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.23 130.69 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 83' ' ' MET . 18.0 t -76.76 133.54 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.89 75.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -61.22 -31.98 71.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.84 126.41 3.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -18.12 36.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.708 0.289 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.74 -112.01 0.91 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -110.12 -31.83 7.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.78 138.93 10.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.523 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -105.99 126.44 52.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.378 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 p -76.17 140.09 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -89.18 53.23 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.79 172.56 5.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 18.6 m-85 -99.86 162.71 12.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.928 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.92 172.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.274 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.32 102.44 8.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.722 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 41' ' ' TRP . 3.7 t -61.83 129.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.293 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.6 t -126.7 162.24 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -130.74 159.57 70.52 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -51.82 121.41 8.64 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.297 1.998 . . . . 0.0 112.219 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 93.11 32.12 8.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.206 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.55 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -111.42 117.56 33.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 111.649 -179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.21 104.56 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.643 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.04 -27.05 15.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.761 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 55.4 m-85 -124.4 163.02 22.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.24 115.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG13 HD11 ' A' ' 118' ' ' LEU . 34.9 m -97.69 167.88 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.52 138.04 2.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.65 64.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.937 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.4 m -119.34 166.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.8 p -74.45 168.58 19.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.27 -38.89 88.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -44.25 94.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -75.09 -38.42 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.73 -48.08 60.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.395 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.688 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.32 -45.21 92.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.61 -48.75 65.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.88 -48.76 77.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.763 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -29.63 69.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.21 -40.86 64.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.246 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 117' ' ' ALA . 51.5 mt -57.65 -38.3 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.751 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -64.63 -45.4 87.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.79 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.08 -21.03 76.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -37.18 75.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 3.31 55.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 42' ' ' ILE . 22.7 mt -84.4 154.83 62.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.672 0.272 . . . . 0.0 110.687 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.673 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.0 Cg_endo -87.26 20.79 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.906 2.404 . . . . 0.0 112.859 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.793 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.61 166.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 0.0 111.29 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -75.21 139.69 42.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.482 HG21 HD12 ' A' ' 125' ' ' LEU . 20.0 p -143.93 154.58 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.572 ' HG2' HD21 ' A' ' 37' ' ' LEU . 20.7 pttt -140.01 163.2 33.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.93 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.763 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -91.24 130.31 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 33' ' ' GLY . 33.7 m -135.69 137.03 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 111.702 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 135' ' ' ASP . 3.2 ttt180 -94.83 166.05 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.053 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -45.61 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' ARG . 9.9 t0 75.7 28.41 0.92 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.39 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.34 94.92 4.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.677 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 27' ' ' VAL . 1.5 m-85 -126.48 108.14 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.29 121.47 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -76.22 152.03 36.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.82 106.82 16.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.879 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.14 30.65 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.15 89.15 38.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.14 168.29 22.48 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.569 2.179 . . . . 0.0 112.409 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.3 134.67 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -136.58 -46.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 103.46 2.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -34.72 6.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -113.66 127.69 56.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 123.51 30.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -62.89 -40.17 96.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.58 150.72 32.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.86 120.67 41.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -134.96 31.2 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.78 156.42 27.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.9 174.31 6.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -87.11 83.3 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.69 23.59 14.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.36 80.22 0.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.93 126.5 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.077 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.96 110.0 19.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.17 36.92 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.94 126.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.04 136.38 6.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.63 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -71.41 -172.59 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 0.0 110.864 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 116.52 10.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.881 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG21 ' N ' ' A' ' 134' ' ' ARG . 2.4 t -30.05 -45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.984 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.79 -71.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.298 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -114.69 154.22 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 75.59 161.41 10.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.5 -45.43 30.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.747 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 28.9 m-85 -105.52 171.14 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -159.69 139.53 6.23 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.042 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.8 tm? -99.81 112.35 24.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 0.0 110.206 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG11 ' HE3' ' A' ' 130' ' ' LYS . 3.6 p -100.72 145.46 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.036 0.446 . . . . 0.0 111.886 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.48 110.74 22.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.275 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.4 mt -81.39 5.48 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -151.05 146.8 19.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.18 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 20.1 Cg_exo -65.38 135.77 44.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.607 2.205 . . . . 0.0 112.049 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -165.04 172.15 13.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.63 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.7 m0 -112.94 106.31 14.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.809 HD12 HD22 ' A' ' 125' ' ' LEU . 15.5 mm -83.43 119.57 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.168 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.01 169.83 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.36 -43.95 92.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.764 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.14 -38.97 80.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.974 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 5.3 mt-30 -58.83 -34.74 71.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.684 0.278 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 66' ' ' ILE . 14.8 mt -71.35 -49.57 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.662 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -83.19 -46.8 12.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 111.54 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.47 -47.13 76.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.21 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.4 -41.53 93.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.572 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.0 ttp180 -59.29 -43.02 92.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.8 t -57.89 -35.32 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -38.57 53.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.044 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 60.5 mtm -71.34 -50.67 29.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.345 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 51' ' ' ARG . 57.3 t -56.87 -37.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.216 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -75.0 -29.47 60.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.14 -46.1 90.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 109' ' ' VAL . 27.1 m-85 -53.63 124.91 16.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.031 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -35.92 67.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -107.67 33.12 4.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 68.71 173.22 8.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.401 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.66 152.5 7.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.512 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -113.91 144.52 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.566 HD12 ' CG ' ' A' ' 51' ' ' ARG . 2.0 mt -120.26 141.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.294 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 105' ' ' GLU . 71.3 m-85 -111.3 117.87 34.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.193 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -102.81 134.36 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -106.05 -31.73 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.71 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 42' ' ' ILE . 29.3 pt -65.69 142.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -143.57 134.75 12.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 34.5 Cg_endo -64.9 109.96 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.455 2.103 . . . . 0.0 112.137 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -124.6 -52.15 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.614 ' HD2' HG21 ' A' ' 96' ' ' VAL . 34.7 tttm -66.91 139.2 95.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 158.3 57.92 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.262 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 6.1 t80 -127.4 94.66 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.8 p -119.37 116.66 26.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 19.3 mttt -142.5 42.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.52 110.47 3.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 79' ' ' LEU . 59.7 Cg_endo -72.27 -45.07 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.369 2.046 . . . . 0.0 112.323 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.443 HD12 ' HG2' ' A' ' 78' ' ' PRO . 3.0 mp -96.98 158.2 15.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.59 -31.16 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.58 135.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.76 139.27 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.28 -104.26 0.51 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.525 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -100.87 18.11 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.681 0.277 . . . . 0.0 111.236 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.57 -62.35 0.5 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 30.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.99 116.49 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -130.68 134.91 47.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.05 138.33 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -95.49 41.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.81 -173.11 53.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.73 164.03 18.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.8 m -142.36 173.1 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -121.83 106.08 10.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.84 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 72' ' ' LYS . 6.1 t -61.1 127.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.348 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 98' ' ' LYS . 33.4 t -126.59 160.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.2 mttp -130.71 155.33 81.46 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.793 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 6.6 Cg_endo -49.02 114.93 1.45 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.733 2.289 . . . . 0.0 112.188 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.41 36.77 4.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.128 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.56 120.33 38.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 0.0 111.555 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 25' ' ' ASP . 26.0 t -74.89 103.78 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.336 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.558 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 29.5 mtm -92.1 -29.79 16.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 66' ' ' ILE . 62.4 m-85 -132.97 163.1 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -166.66 114.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.637 HG13 HD11 ' A' ' 118' ' ' LEU . 30.5 m -100.09 168.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.418 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.65 139.64 11.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.21 -31.88 7.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.762 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.1 m -83.19 165.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.279 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -75.86 171.92 13.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.928 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -66.52 -38.96 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -46.06 85.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -75.16 -38.2 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.15 -48.03 63.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.54 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.92 -51.28 67.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.65 -48.59 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.788 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.59 -48.78 78.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.732 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.803 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.8 -29.2 69.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.467 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -74.54 -39.56 62.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.4 mt -57.33 -43.04 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -59.8 -44.05 94.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.84 -18.88 80.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.721 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -41.67 98.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 2.6 45.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.364 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.809 HD22 HD12 ' A' ' 42' ' ' ILE . 33.8 mt -84.51 158.24 60.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.738 0.304 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.852 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 71.9 Cg_endo -88.78 19.41 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.775 2.317 . . . . 0.0 112.67 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.7 pp -152.77 166.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -76.29 145.87 39.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.5 p -148.43 149.16 31.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.743 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.653 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.83 162.48 31.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -89.71 142.91 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -146.19 138.66 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.188 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -97.04 120.89 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' N ' HG21 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 40.88 -103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.537 0.684 . . . . 0.0 111.917 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.01 46.46 0.92 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.129 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.74 94.63 4.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.824 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -127.03 118.05 23.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.57 159.96 16.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -63.47 102.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.06 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -106.56 -35.6 7.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 ttp -143.47 86.16 9.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -68.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.488 2.126 . . . . 0.0 112.458 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.8 mtt85 -161.47 111.6 1.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.0 135.52 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.78 127.14 50.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -76.09 95.58 3.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.69 86.83 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.69 112.0 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -40.37 91.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.4 118.73 12.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -77.35 138.3 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -31.15 65.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.0 -94.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.92 168.14 9.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.23 170.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -97.39 23.66 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.73 -149.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.05 95.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 p -123.05 -177.48 3.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -79.95 159.53 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.88 -173.17 13.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.29 -167.48 31.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.839 ' HB2' HG23 ' A' ' 102' ' ' VAL . 7.2 m-20 -59.32 -174.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.714 ' O ' HG23 ' A' ' 27' ' ' VAL . 45.0 t80 -99.76 -74.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 177.7 -35.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' A' ' 27' ' ' VAL . . . 69.81 -162.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.967 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.46 165.43 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.161 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 86.27 178.44 49.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.594 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -42.27 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 133' ' ' ARG . 19.2 m-85 -105.34 169.43 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.651 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.92 130.34 2.81 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.048 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 2.0 tm? -91.47 118.55 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.834 HG11 ' HE3' ' A' ' 130' ' ' LYS . 7.6 p -104.79 145.71 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.239 0.542 . . . . 0.0 112.377 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.666 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -97.41 111.55 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.407 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 ' HE2' ' A' ' 130' ' ' LYS . 6.5 mt -83.15 7.79 15.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -155.66 150.7 20.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.649 0.261 . . . . 0.0 111.188 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 12.5 Cg_exo -69.52 136.21 33.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 0.0 112.427 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -165.68 168.77 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -109.74 115.2 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.662 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 HD22 ' A' ' 125' ' ' LEU . 20.9 mm -88.85 117.57 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.92 168.67 19.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -57.23 -43.53 82.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.731 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.55 -40.5 91.79 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.89 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mt-30 -58.73 -34.7 71.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 HG21 ' A' ' 66' ' ' ILE . 16.8 mt -70.7 -50.47 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.0 tt0 -83.2 -46.37 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.612 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.81 -47.22 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.182 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.17 -43.44 91.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 mtm180 -59.37 -42.51 91.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 48' ' ' GLU . 46.4 t -58.17 -39.28 72.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.42 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.589 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 53.4 mtm -71.15 -45.08 64.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.7 t -56.95 -37.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.01 -29.46 60.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -63.73 -48.49 76.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CD1' HG11 ' A' ' 109' ' ' VAL . 25.4 m-85 -51.58 102.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -58.58 -33.58 70.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -109.33 33.05 4.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.98 163.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.43 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . 177.64 152.99 10.54 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.656 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.742 0.306 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 106' ' ' VAL . 2.7 mt -113.92 128.86 70.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 18.9 m-85 -98.5 114.91 27.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.469 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -101.18 127.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.72 21.76 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 66' ' ' ILE . 26.8 pt -121.82 132.64 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.832 0.348 . . . . 0.0 110.979 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 135.94 21.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.763 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.67 104.41 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.366 2.044 . . . . 0.0 112.085 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -114.77 -44.41 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -78.13 139.55 60.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.09 154.58 52.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.445 2.097 . . . . 0.0 112.282 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -107.94 88.99 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.2 p -119.5 122.74 42.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.042 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 31.49 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 145.71 47.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.789 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.76 158.34 55.91 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.519 2.146 . . . . 0.0 112.282 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 105.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -173.29 36.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 142.49 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 147.58 32.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 mmm -68.81 105.03 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.15 71.12 1.28 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -84.92 -18.14 35.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.273 . . . . 0.0 111.153 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.36 -47.01 2.37 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.97 130.46 27.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.88 126.79 1.89 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.574 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -123.3 127.17 48.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.79 151.9 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.51 53.39 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.89 -176.57 1.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.515 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.25 153.89 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.3 m -136.74 170.46 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -119.43 102.4 8.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.65 131.33 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 27.2 t -126.61 159.49 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -130.72 160.19 67.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.541 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.5 Cg_exo -54.25 120.17 7.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.408 2.072 . . . . 0.0 111.903 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 94.89 32.38 7.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.1 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 6.3 tpt180 -110.08 127.29 54.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.71 0.291 . . . . 0.0 111.551 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 25' ' ' ASP . 32.3 t -82.36 101.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.509 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.666 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 1.3 mpp? -90.4 -33.9 15.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.357 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.7 m-85 -129.68 161.25 31.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.36 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 5.8 pm0 -165.88 115.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.409 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 118' ' ' LEU . 33.2 m -102.83 162.78 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -153.57 141.27 19.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.0 -38.16 3.27 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.587 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.4 m -77.36 161.48 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -70.53 177.68 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -35.66 67.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -67.07 -44.58 79.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -75.14 -38.73 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.7 -48.11 60.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.324 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.49 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.3 -51.5 65.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.38 -48.61 80.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.687 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.96 -48.58 79.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.9 mtp85 -72.99 -41.84 63.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.528 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.8 mt -55.69 -37.09 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.679 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -63.68 -46.29 86.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.765 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.06 -22.09 77.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.514 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.99 -35.65 71.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 5.63 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.386 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 42' ' ' ILE . 22.2 mt -84.51 161.97 52.29 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.676 0.274 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 5.1 Cg_endo -85.47 10.77 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.025 2.484 . . . . 0.0 112.384 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.862 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.8 pp -149.8 167.0 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.736 0.303 . . . . 0.0 111.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -75.67 148.5 38.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 125' ' ' LEU . 10.8 p -150.09 146.47 26.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.834 ' HE3' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.43 163.29 27.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.833 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -92.44 144.24 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.849 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.5 m -151.69 148.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.716 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 4.2 ttp180 -109.31 121.01 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.425 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 27' ' ' VAL . 12.8 mmt180 38.71 -105.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.512 0.672 . . . . 0.0 112.098 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -103.07 43.38 1.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.145 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.607 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.71 93.96 4.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.162 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.849 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 2.5 m-85 -127.66 89.89 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.771 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.87 157.39 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -80.41 100.97 8.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.9 5.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.882 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.79 152.88 18.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.75 85.48 16.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.99 178.59 6.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.667 2.244 . . . . 0.0 112.379 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.03 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -148.7 176.75 10.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ttm -72.03 135.84 46.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.68 153.41 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -72.8 178.64 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 133.48 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -79.2 -59.25 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.81 116.68 29.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 114.71 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -103.44 106.57 17.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 91.37 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -96.62 -178.26 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -140.07 100.61 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 23.64 6.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.998 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 17' ' ' LEU . . . -74.03 140.02 27.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.524 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.28 159.6 25.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 p 50.54 -178.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 60.64 111.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.01 84.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.84 121.87 0.7 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.15 172.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.05 0.452 . . . . 0.0 111.493 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.466 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -162.49 109.92 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.688 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 3.4 t -21.81 -53.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.186 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 73.34 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.235 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.5 159.34 17.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.834 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 75.13 132.73 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.512 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 21.4 m-20 -55.16 -28.12 50.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 133' ' ' ARG . 20.0 m-85 -125.63 171.31 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.66 135.63 4.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.689 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.5 tm? -92.26 110.58 21.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.3 p -97.82 146.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 112.405 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -98.38 116.72 31.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.69 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.0 mt -91.82 18.62 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 3.2 tt0 -164.18 142.01 5.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.588 0.232 . . . . 0.0 110.986 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 29.0 Cg_exo -61.25 138.54 77.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.552 2.168 . . . . 0.0 112.36 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.09 172.06 11.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.368 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -114.73 108.35 16.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.753 HG21 HD12 ' A' ' 68' ' ' ILE . 14.0 mm -84.54 116.65 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.82 174.4 11.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.17 -43.82 98.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.713 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -60.35 -41.73 94.24 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.005 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.1 mt-30 -58.84 -34.55 71.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.943 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 66' ' ' ILE . 15.2 mt -71.91 -49.27 45.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.581 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.802 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.9 tt0 -83.0 -47.47 11.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.74 -46.86 74.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.62 -41.27 88.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.953 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.52 -42.86 93.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.9 t -58.42 -49.46 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.47 77.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.516 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 64.2 mtm -71.18 -48.21 53.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.136 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.3 t -56.73 -34.32 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.131 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -75.14 -29.52 60.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -65.8 -58.87 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.378 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CD1' HG11 ' A' ' 109' ' ' VAL . 24.6 m-85 -47.63 97.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -62.36 -33.66 75.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -97.55 33.02 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.61 157.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.02 171.71 44.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -136.35 136.77 39.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.734 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.488 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.5 mt -113.79 134.65 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.14 110.02 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.552 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.885 HG21 HG23 ' A' ' 47' ' ' ILE . 5.3 mm -95.28 136.62 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.26 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -31.11 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 42' ' ' ILE . 27.8 pt -64.62 142.37 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -145.95 138.36 13.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 70.1 Cg_endo -74.2 108.2 2.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.511 2.141 . . . . 0.0 112.285 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -127.85 -44.75 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HD3' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -74.52 143.91 79.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.944 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 172.8 12.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.553 2.169 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -127.5 129.75 47.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.0 p -118.72 127.66 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -83.66 120.65 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -113.34 94.48 31.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.38 -173.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.569 2.179 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.31 150.28 23.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 60.37 26.9 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.11 141.12 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 112.6 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.0 ttm 60.46 159.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.1 140.84 48.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.02 18.16 12.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 0.0 111.169 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.87 28.88 6.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.454 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 138.64 16.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 122.4 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.412 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -125.12 135.01 52.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.2 p -80.96 122.5 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -94.14 45.93 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.97 -178.94 49.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.4 m-85 -105.88 134.02 49.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 41' ' ' TRP . 15.2 m -124.2 165.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -110.55 102.58 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG21 ' HD3' ' A' ' 72' ' ' LYS . 5.0 t -59.28 132.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 98' ' ' LYS . 45.9 t -126.62 159.58 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 97' ' ' VAL . 6.5 pttm -130.79 159.04 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.537 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.1 Cg_exo -52.32 122.78 11.31 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.249 1.966 . . . . 0.0 111.944 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 91.46 38.01 6.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.989 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 35' ' ' VAL . 8.0 tpt85 -117.24 119.7 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.659 0.266 . . . . 0.0 111.402 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' CD ' ' A' ' 105' ' ' GLU . 4.1 t -79.46 100.74 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.365 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 68' ' ' ILE . 20.8 mtm -87.23 -33.6 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.8 m-85 -124.61 159.84 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.261 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 102' ' ' VAL . 5.0 mp0 -159.17 122.92 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG13 HD11 ' A' ' 118' ' ' LEU . 34.8 m -110.8 159.42 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.802 0.334 . . . . 0.0 111.254 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.834 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.98 142.86 22.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.64 -41.27 2.49 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -72.45 155.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.4 p -68.45 -177.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.105 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -73.52 -40.68 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.023 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -46.02 91.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -39.5 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.86 -48.24 66.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.497 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -45.08 93.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.1 -48.63 70.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.91 -48.85 78.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.065 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.832 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.21 -30.93 70.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.585 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.653 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.4 mt -57.46 -42.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.584 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.27 82.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.577 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.98 -18.9 76.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.789 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 3.19 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.251 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD12 ' HA2' ' A' ' 122' ' ' GLY . 22.6 mt -84.53 152.41 60.43 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.724 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.6 Cg_endo -87.0 22.4 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.749 2.3 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.773 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.74 161.13 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -74.47 135.6 42.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 36' ' ' ALA . 28.3 p -137.44 154.82 49.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' HD21 ' A' ' 37' ' ' LEU . 39.4 pttt -138.23 159.8 41.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.212 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.832 HG23 HD23 ' A' ' 118' ' ' LEU . 2.5 mm -88.29 139.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.592 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 10.5 m -147.52 137.11 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.147 0.499 . . . . 0.0 111.469 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -86.07 166.09 16.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.473 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HG3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -43.52 87.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.979 178.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.8 t0 71.59 35.13 1.5 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.987 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.594 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.04 95.18 5.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.579 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.717 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.0 OUTLIER -126.07 96.56 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.83 105.26 15.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.45 154.61 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.33 103.05 12.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.918 179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mt 60.31 94.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptm -110.26 135.04 20.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.11 -168.27 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.501 2.134 . . . . 0.0 112.35 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -88.46 122.35 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.78 145.17 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.29 142.95 35.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -96.97 112.9 24.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.11 76.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -85.13 161.9 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.86 103.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.49 152.07 22.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -82.43 133.34 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -148.13 98.96 3.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.75 178.13 44.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.538 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.59 ' O ' HD22 ' A' ' 17' ' ' LEU . 7.3 mtt85 60.8 -177.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.811 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -144.26 163.56 33.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -87.8 -27.56 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.08 72.18 0.72 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.48 154.84 21.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 111.095 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -31.86 9.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.98 135.9 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.38 99.13 2.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.532 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.13 -104.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.7 p30 -91.15 24.82 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' CE1' ' CE1' ' A' ' 137' ' ' TYR . 1.8 t80 -79.35 81.42 5.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.937 HG23 ' OH ' ' A' ' 137' ' ' TYR . 2.6 t 53.89 101.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -45.09 -81.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 28' ' ' ALA . 43.5 m-85 -145.15 179.56 7.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.12 -124.61 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.546 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 4.8 m-20 -135.55 -52.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.448 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 11.9 m-85 -105.46 170.56 7.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.233 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.29 125.38 1.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.601 HD23 HD13 ' A' ' 131' ' ' ILE . 3.4 tm? -91.22 101.93 14.65 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -91.16 145.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.002 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.725 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.87 107.78 19.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.563 HD21 ' CD ' ' A' ' 130' ' ' LYS . 8.6 mt -77.06 0.23 22.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.003 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -143.32 151.34 54.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.043 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.85 137.15 19.57 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.615 2.21 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.739 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -166.06 172.09 11.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.326 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -109.3 106.33 16.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.728 HD12 HD22 ' A' ' 125' ' ' LEU . 10.6 mm -84.86 117.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.464 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.72 174.6 11.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.048 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -61.5 -42.97 99.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.87 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.1 -42.58 90.86 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.995 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -58.71 -34.45 71.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.744 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.906 HG23 HG21 ' A' ' 66' ' ' ILE . 18.0 mt -71.19 -50.81 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.635 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -83.12 -46.4 12.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 111.6 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.71 -47.11 74.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.4 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.5 -42.84 93.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.711 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.8 t -58.14 -39.65 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 -38.01 72.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.895 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 63.5 mtm -71.11 -50.37 34.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.192 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 51' ' ' ARG . 35.1 t -56.82 -39.99 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.134 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.02 -29.48 60.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.063 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.48 -50.44 73.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 109' ' ' VAL . 19.9 m-85 -54.31 117.61 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -70.07 -32.6 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -106.33 32.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.06 175.38 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.85 179.89 43.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.567 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -139.34 154.05 47.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.551 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -134.26 131.81 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -100.67 109.32 21.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.906 HG21 HG23 ' A' ' 47' ' ' ILE . 4.2 mm -96.51 127.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.09 -29.22 11.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.767 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.1 pt -70.34 135.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -140.88 132.95 14.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.919 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.04 108.82 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.448 2.099 . . . . 0.0 112.129 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -118.94 -47.16 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.0 124.36 86.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.02 159.42 7.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 0.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -124.7 97.89 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.521 HG22 HG23 ' A' ' 90' ' ' VAL . 31.1 p -119.28 147.23 44.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -137.71 149.14 46.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -110.03 94.12 16.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.95 -167.24 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.738 2.292 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 161.64 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.761 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.19 -30.0 24.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.91 110.52 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.067 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -178.34 3.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.42 171.65 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.32 -160.79 15.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.564 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -98.87 -18.14 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.2 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.85 -132.49 8.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.509 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.38 80.55 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.82 -104.54 0.71 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.4 134.21 56.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.521 HG23 HG22 ' A' ' 75' ' ' THR . 11.2 p -65.1 158.26 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.049 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' N ' HG22 ' A' ' 90' ' ' VAL . 1.1 mm-40 -84.78 57.8 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.06 -178.78 12.22 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.15 163.94 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.7 m -139.0 170.13 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.271 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.42 105.23 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.96 130.8 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.245 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.0 t -126.62 160.84 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.429 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 1.5 mttt -130.7 157.61 77.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 50.3 Cg_exo -52.63 114.43 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.381 2.054 . . . . 0.0 112.078 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.33 32.73 4.79 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.061 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.517 ' N ' HG23 ' A' ' 35' ' ' VAL . 3.7 tpt180 -112.86 128.56 56.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.331 . . . . 0.0 111.462 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.824 HG12 ' OE2' ' A' ' 105' ' ' GLU . 12.0 t -81.68 103.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.413 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.725 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 41.9 mtm -93.25 -28.45 16.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 66' ' ' ILE . 67.3 m-85 -137.76 148.58 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 111.291 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.824 ' OE2' HG12 ' A' ' 102' ' ' VAL . 5.5 mp0 -151.0 120.25 6.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -107.83 166.97 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.74 138.09 4.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.17 -26.51 24.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.562 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 114' ' ' ALA . 30.6 m -85.47 164.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 111.256 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.6 p -67.0 167.39 11.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -38.27 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.58 -41.17 76.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -75.12 -35.95 61.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.21 -48.23 57.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.538 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmt -63.16 -46.1 88.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.616 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.81 -48.6 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.79 -48.88 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.847 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.38 -30.59 69.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.291 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.736 ' HG3' HD11 ' A' ' 131' ' ' ILE . 51.5 mtp85 -74.5 -39.72 62.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.702 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 117' ' ' ALA . 60.0 mt -55.68 -38.55 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.659 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.29 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.66 -20.81 79.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.469 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -39.1 78.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.0 110.783 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 3.36 55.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.728 HD22 HD12 ' A' ' 42' ' ' ILE . 25.8 mt -84.42 152.73 61.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.546 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.707 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 92.1 Cg_endo -87.63 23.38 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.772 2.315 . . . . 0.0 112.742 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.739 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.89 166.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.074 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.56 141.9 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.925 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 60.4 p -142.66 149.54 39.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.563 ' CD ' HD21 ' A' ' 37' ' ' LEU . 28.6 pttt -136.64 155.9 49.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.313 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.847 HG23 HD23 ' A' ' 118' ' ' LEU . 2.9 mm -89.87 139.48 17.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.536 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.9 m -152.62 127.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 112.033 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 1.7 ttt180 -68.87 165.8 19.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.907 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HA ' HG11 ' A' ' 27' ' ' VAL . 4.5 mtm180 -55.28 1.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.5 m-20 -161.15 25.36 0.13 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.83 93.94 4.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.937 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.4 m-85 -128.54 109.63 11.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.79 93.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.09 155.02 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.5 93.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.27 -38.89 3.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 ttt -65.94 110.04 4.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.316 2.011 . . . . 0.0 112.384 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 53.52 99.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 111.028 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -161.18 -66.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.049 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -71.52 154.48 41.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.99 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -87.08 -12.72 46.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.287 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.22 97.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.94 157.27 20.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.64 81.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.88 121.78 34.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.54 126.17 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 60.82 93.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.805 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.05 -28.68 2.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -104.36 161.65 13.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.27 166.72 19.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.38 23.65 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.22 58.34 5.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.521 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.41 109.58 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.34 -179.13 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 35.32 4.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.23 -122.22 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.09 140.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -45.96 -81.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 27' ' ' VAL . 10.9 t80 68.92 -67.19 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.06 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 162.68 -27.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.512 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 68.76 -174.65 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -57.76 113.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 142.82 150.13 5.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.58 -44.81 77.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 28.1 m-85 -109.65 171.13 7.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.12 132.25 3.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.692 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.3 tm? -91.31 110.45 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.161 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.7 p -99.61 145.71 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.228 0.537 . . . . 0.0 112.106 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.21 112.47 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.832 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD12 ' HG3' ' A' ' 128' ' ' LYS . 7.3 mt -81.41 4.88 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.862 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.9 tt0 -150.68 144.31 17.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.675 0.274 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 43.8 Cg_endo -68.04 134.4 31.76 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.443 2.095 . . . . 0.0 112.62 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.59 171.96 18.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.145 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' A' ' 94' ' ' VAL . 14.9 m0 -111.88 108.33 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' HD22 ' A' ' 125' ' ' LEU . 14.6 mm -83.4 118.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.75 176.97 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -63.63 -44.25 94.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.29 -40.0 94.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.026 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 2.3 mt-30 -58.79 -34.66 71.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 66' ' ' ILE . 15.1 mt -71.13 -49.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 tt0 -83.05 -47.69 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 111.36 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.29 -47.07 72.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.013 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -66.16 -41.38 90.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.74 -42.96 94.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.642 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.4 t -57.69 -45.07 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.76 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.563 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.16 -47.17 59.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ARG . 48.4 t -56.92 -34.86 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -62.03 -53.28 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.2 m-85 -55.4 92.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -68.85 -28.21 66.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.2 mtp85 -96.84 33.04 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.74 152.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.54 39.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -146.57 148.37 32.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.648 HD12 ' HD3' ' A' ' 51' ' ' ARG . 5.2 mt -118.3 148.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 82.1 m-85 -113.78 116.92 30.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.347 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.839 HG21 HG23 ' A' ' 47' ' ' ILE . 2.8 mm -105.98 128.39 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -109.14 -25.85 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.815 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.706 HD13 ' HB3' ' A' ' 103' ' ' MET . 33.5 pt -69.57 137.72 23.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.1 144.1 36.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.798 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 58.3 Cg_endo -71.69 104.51 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.472 2.115 . . . . 0.0 112.316 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -134.12 31.65 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.06 127.99 14.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.97 143.09 99.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.448 2.099 . . . . 0.0 112.133 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.95 117.23 22.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.9 p -118.78 147.05 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -118.32 31.1 6.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.53 141.25 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.13 -28.56 18.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.515 2.143 . . . . 0.0 112.251 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.53 148.76 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.811 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.59 135.77 55.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.958 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.75 144.2 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 -176.96 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.96 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.34 170.26 37.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -86.67 -18.09 32.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.93 115.28 0.49 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.75 30.41 5.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.17 -156.32 7.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.529 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -109.04 153.07 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.98 136.7 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.27 54.87 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.07 157.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.399 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -90.23 147.86 23.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.5 m -121.42 174.51 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.217 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.15 106.03 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.0 130.12 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.4 t -126.68 162.1 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.147 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' N ' HG12 ' A' ' 97' ' ' VAL . 20.4 mtpt -130.77 160.0 68.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.3 Cg_exo -54.64 116.39 3.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.425 2.083 . . . . 0.0 112.181 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.43 29.18 7.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.288 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.31 120.63 41.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.386 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 25' ' ' ASP . 26.2 t -76.67 103.86 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.829 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 68' ' ' ILE . 37.5 mtm -86.63 -24.44 25.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.417 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CD2' ' HE1' ' A' ' 54' ' ' MET . 50.6 m-85 -134.77 163.05 30.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 65' ' ' PHE . 2.4 pm0 -164.36 115.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.665 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.707 HG13 HD11 ' A' ' 118' ' ' LEU . 35.7 m -97.54 168.08 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.388 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -164.28 140.16 6.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.71 -27.5 19.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.694 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -88.74 174.22 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 p -82.98 -179.38 7.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.976 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.54 -43.16 60.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -44.94 95.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.14 -39.67 60.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.01 -48.12 66.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.223 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.46 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -62.58 -54.2 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.751 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.08 -48.61 78.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.55 -48.78 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.822 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.73 -30.25 69.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.562 ' HD3' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.56 -40.15 61.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 117' ' ' ALA . 57.8 mt -56.3 -45.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.728 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.15 -48.25 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -69.03 -22.92 76.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.39 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -59.7 -41.95 91.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -0.53 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' A' ' 122' ' ' GLY . 31.1 mt -84.47 154.06 62.25 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 110.684 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.708 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.2 Cg_endo -86.33 19.28 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.85 2.367 . . . . 0.0 112.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -148.26 167.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 111.243 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 37' ' ' LEU . 19.7 tptp -80.76 133.73 35.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.7 p -136.99 153.85 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.667 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HG2' HD21 ' A' ' 37' ' ' LEU . 15.6 pttt -139.11 161.79 36.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 118' ' ' LEU . 2.0 mm -88.41 138.64 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.654 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.787 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.4 m -146.78 135.83 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.275 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 15.6 ttt-85 -95.44 118.12 31.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.259 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' N ' HG21 ' A' ' 27' ' ' VAL . 8.6 mmt180 40.4 -102.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.447 0.641 . . . . 0.0 112.085 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -103.47 44.72 1.0 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.081 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.602 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.38 4.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 2.3 m-85 -127.21 104.4 7.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -111.05 150.71 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.08 128.75 36.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -122.73 101.95 7.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 mtt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.73 168.99 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptm -133.09 144.82 54.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.14 104.95 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -89.05 134.35 34.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.9 31.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.67 172.2 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -114.56 91.32 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.22 144.4 22.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.01 153.29 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -66.23 174.85 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.805 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.68 145.99 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -105.53 132.03 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -71.79 164.36 26.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.71 -101.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.6 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.88 -179.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -162.83 109.81 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -27.45 13.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.3 64.11 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.535 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 21' ' ' THR . . . -120.15 121.35 38.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.078 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -169.24 -178.24 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.6 162.59 13.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.8 -108.94 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.43 24.26 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.41 163.19 18.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 27' ' ' VAL . 4.6 t80 -177.04 -49.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 26' ' ' TYR . 24.9 t 126.47 97.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 124.305 1.003 . . . . 0.0 110.0 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . . . -52.97 -60.69 2.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -138.9 -175.76 4.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.83 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 59.67 170.97 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.672 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.5 42.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 7.9 m-85 -115.55 171.16 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -161.64 133.91 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.712 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.49 115.99 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.257 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.7 p -105.1 143.25 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.66 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' ' SD ' ' A' ' 103' ' ' MET . . . -95.15 108.93 21.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.678 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.7 mt -77.42 -0.21 25.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -143.47 149.02 46.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 61.5 Cg_endo -72.92 136.82 25.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.536 2.157 . . . . 0.0 112.484 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.57 172.01 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 111.412 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -108.56 105.62 15.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.65 HD12 HD22 ' A' ' 125' ' ' LEU . 16.7 mm -83.53 117.83 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.357 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -79.75 168.28 19.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.179 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.33 -43.31 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.6 -38.81 75.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.885 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 42' ' ' ILE . 6.8 mm-40 -58.92 -34.83 72.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.744 0.307 . . . . 0.0 110.789 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.88 HG23 HG21 ' A' ' 66' ' ' ILE . 27.7 mt -71.54 -49.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.543 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.748 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.4 tt0 -83.0 -46.95 12.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 111.462 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.14 -47.15 75.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.92 -35.88 79.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.09 -42.87 96.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 48' ' ' GLU . 44.3 t -57.95 -43.31 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.13 90.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.886 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.483 ' CB ' HD11 ' A' ' 64' ' ' ILE . 66.3 mtm -71.28 -47.96 53.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.385 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 47.9 t -56.79 -37.02 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -75.13 -29.42 60.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.2 -54.03 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.1 m-85 -55.31 92.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.937 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -65.76 -28.77 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -97.41 32.97 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.049 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 165.59 1.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 168.34 26.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -138.64 142.8 39.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -114.29 133.96 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.222 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -107.05 109.31 21.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.88 HG21 HG23 ' A' ' 47' ' ' ILE . 2.4 mm -87.69 136.28 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.136 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -107.34 -26.93 10.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 42' ' ' ILE . 25.1 pt -73.13 159.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.102 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -152.54 137.76 11.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 69' ' ' PHE . 98.1 Cg_endo -79.5 105.29 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.605 2.203 . . . . 0.0 112.294 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -126.61 -45.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -66.96 115.98 30.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -51.7 153.05 11.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.31 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 10.4 t80 -119.15 90.08 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.5 p -119.54 130.12 55.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 10.4 mtpp -125.03 36.34 4.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -116.61 94.38 43.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.795 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.37 -25.9 29.95 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.403 2.069 . . . . 0.0 112.242 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -82.72 157.46 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' H ' HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -145.58 86.3 1.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 79' ' ' LEU . 10.7 m -85.49 126.52 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 63.85 134.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.88 148.79 25.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.16 166.62 24.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.516 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.29 18.24 12.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.65 0.262 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.41 -125.26 2.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -133.25 -66.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.439 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.98 -163.93 25.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.09 94.18 8.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.25 141.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -87.29 55.19 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.73 176.49 5.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' HB2' ' HB2' ' A' ' 70' ' ' PRO . 13.1 m-85 -108.4 156.68 19.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -132.39 174.54 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -125.76 110.24 13.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.73 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.38 128.79 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 98' ' ' LYS . 19.3 t -126.72 161.24 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.98 158.29 75.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.459 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 57.7 Cg_exo -51.15 115.13 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 100.74 36.99 3.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.36 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 35' ' ' VAL . 1.1 tpt85 -118.45 116.7 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.542 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG12 ' OE2' ' A' ' 105' ' ' GLU . 6.3 t -71.89 104.23 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.131 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.584 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 37.5 mtm -90.51 -36.06 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.909 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . 49.0 m-85 -124.38 160.47 28.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 111.366 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.839 ' OE2' HG12 ' A' ' 102' ' ' VAL . 3.7 mp0 -155.01 132.34 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.724 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 HD11 ' A' ' 118' ' ' LEU . 35.2 m -125.43 150.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.283 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.83 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -147.82 142.74 26.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.87 -23.9 28.87 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.785 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.019 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.9 m -86.88 153.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.292 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.0 p -66.88 164.75 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.28 -39.97 88.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.16 -46.02 85.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.964 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -75.11 -36.83 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.85 -48.1 55.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.347 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.2 mmt -63.5 -48.7 76.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -62.83 -48.51 78.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.797 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.63 -48.93 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.856 HD11 HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -63.3 -31.65 72.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HG3' HD11 ' A' ' 131' ' ' ILE . 8.3 mtt180 -74.62 -39.26 62.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 117' ' ' ALA . 22.4 mt -57.04 -34.9 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.76 78.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.49 -22.48 78.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.685 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -58.39 -45.25 88.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.22 54.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.77 HD12 ' HA2' ' A' ' 122' ' ' GLY . 38.5 mt -84.5 153.03 61.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.766 0.317 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.0 Cg_endo -87.14 24.33 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.886 2.391 . . . . 0.0 112.903 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.727 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.69 166.12 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.8 0.333 . . . . 0.0 111.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -80.22 137.22 36.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.465 ' CB ' HD11 ' A' ' 34' ' ' LEU . 7.1 p -141.35 149.84 41.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.674 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HG2' HD21 ' A' ' 37' ' ' LEU . 8.4 pttt -134.08 160.75 36.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.055 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.785 HG23 HD23 ' A' ' 118' ' ' LEU . 3.7 mm -88.52 142.56 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.84 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.8 m -149.18 146.77 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.103 0.477 . . . . 0.0 111.363 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -89.39 165.59 14.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.382 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' HG3' HG11 ' A' ' 27' ' ' VAL . 8.2 mtp180 -46.62 89.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.606 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ARG . 8.4 t0 71.79 36.4 1.22 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.597 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.89 94.72 4.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.893 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.84 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.6 m-85 -126.49 91.74 3.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.63 165.28 15.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.79 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -80.46 105.45 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.836 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.43 105.22 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.955 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.885 0.374 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 2' ' ' LEU . 8.8 tp -176.47 47.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.7 ttm -98.52 121.73 55.65 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 170.44 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.477 2.118 . . . . 0.0 112.282 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.2 72.6 0.63 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.28 155.35 5.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.58 157.97 17.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm 62.44 147.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.69 161.85 19.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -111.44 105.47 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -33.19 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.03 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.02 146.59 41.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.57 116.98 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -130.28 143.19 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.23 107.82 3.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.75 160.68 37.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.72 92.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.34 23.57 7.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.99 -54.04 5.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 130.73 44.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.141 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -109.17 -30.35 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.98 167.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.48 -108.89 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.46 -140.97 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -76.93 -178.79 5.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.006 0.432 . . . . 0.0 111.029 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -145.96 118.5 8.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.771 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HG3' ' A' ' 134' ' ' ARG . 9.0 t -30.93 -65.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.589 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . 71.99 -68.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -95.17 144.52 25.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 111.085 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 173.08 1.7 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.713 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -40.39 18.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 6.5 m-85 -105.55 171.09 7.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -157.91 145.47 11.86 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.078 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.9 tm? -104.85 107.47 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 101' ' ' ARG . 6.6 p -96.24 145.71 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 112.124 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.62 116.14 29.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.509 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 130' ' ' LYS . 5.5 mt -87.79 13.98 9.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.117 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 55.7 tt0 -159.2 140.83 9.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 32.2 Cg_endo -63.88 130.17 26.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.361 2.04 . . . . 0.0 112.41 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.748 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -157.94 172.09 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 94' ' ' VAL . 19.5 m0 -111.25 107.41 16.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.645 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.754 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.45 116.83 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.86 170.16 17.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.183 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -43.28 89.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.575 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.31 -39.54 79.63 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.953 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.9 -34.75 72.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 66' ' ' ILE . 20.0 mt -71.94 -49.5 44.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.564 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.852 ' O ' HG23 ' A' ' 52' ' ' VAL . 11.2 tt0 -83.11 -46.67 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.523 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.76 -47.18 74.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.84 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -43.67 92.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.6 t -58.42 -36.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.052 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.3 -37.83 51.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.44 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 59.6 mtm -71.15 -48.42 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.8 t -56.83 -38.22 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -74.99 -29.48 60.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -60.01 -52.64 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 109' ' ' VAL . 14.4 m-85 -57.58 115.07 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.837 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -84.33 -29.17 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.076 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -97.44 33.03 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.23 153.26 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.18 158.03 18.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.84 145.46 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -114.64 149.97 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.298 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 100.0 m-85 -119.21 115.7 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 47' ' ' ILE . 2.0 mm -103.28 127.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.188 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -115.2 25.04 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG12 HG22 ' A' ' 66' ' ' ILE . 27.8 pt -123.35 129.79 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -128.82 132.71 24.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 19.9 Cg_exo -65.75 104.9 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.525 2.15 . . . . 0.0 112.064 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -113.14 -49.13 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' CE ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -72.65 139.0 80.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.994 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 72' ' ' LYS . 56.6 Cg_endo -70.67 166.86 27.33 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.434 2.09 . . . . 0.0 112.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 4.2 t80 -127.61 90.45 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -119.4 108.26 14.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' CE1' ' A' ' 74' ' ' TYR . 4.5 mmmt -129.35 138.45 51.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -121.17 94.25 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.5 -34.06 86.43 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 tp -89.63 152.17 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.34 165.51 23.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 81' ' ' VAL . 30.7 m -66.62 112.7 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -134.88 -71.94 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.77 100.7 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.32 113.61 2.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.522 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.63 18.12 13.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.275 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.66 114.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -119.4 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.86 -104.81 1.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.43 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 36.16 87.48 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.42 137.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.69 57.63 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.61 161.75 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -83.49 163.56 20.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 43' ' ' THR . 1.2 m -142.74 174.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -124.97 105.24 9.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 41' ' ' TRP . 4.3 t -59.62 129.32 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 98' ' ' LYS . 23.1 t -126.63 162.03 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -130.64 160.06 68.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.681 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.8 Cg_exo -54.68 114.59 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.28 1.987 . . . . 0.0 112.029 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 99.94 34.82 4.75 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.126 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.0 121.77 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.516 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 25' ' ' ASP . 14.1 t -77.34 104.62 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.612 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.593 ' HB3' HD13 ' A' ' 68' ' ' ILE . 31.1 mtm -92.52 -33.91 14.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 66' ' ' ILE . 52.0 m-85 -127.36 163.15 24.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -167.81 118.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.692 HG13 HD11 ' A' ' 118' ' ' LEU . 30.1 m -104.09 168.02 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.348 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -159.59 137.8 10.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.9 -32.64 7.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.711 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.0 m -81.12 159.6 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.1 p -67.07 173.61 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -40.95 73.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.3 -42.66 96.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -75.09 -38.9 61.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.51 -48.18 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.188 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.31 -45.82 91.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.814 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.92 -48.69 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.18 -48.96 77.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.59 -29.79 69.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.342 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.855 ' HG3' HD11 ' A' ' 131' ' ' ILE . 10.4 mtp85 -74.57 -38.92 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.667 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 117' ' ' ALA . 48.8 mt -54.75 -38.5 43.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.739 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.51 92.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.61 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -70.05 -24.67 76.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.514 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -59.29 -32.6 70.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -96.14 -2.26 46.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.213 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD22 HD12 ' A' ' 42' ' ' ILE . 30.8 mt -84.41 155.59 62.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.748 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 96.6 Cg_endo -89.27 24.34 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.881 2.387 . . . . 0.0 112.546 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.747 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 pp -152.68 167.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.294 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.505 ' CG ' HD12 ' A' ' 37' ' ' LEU . 9.7 tptt -81.95 132.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 36' ' ' ALA . 22.2 p -135.25 146.6 48.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.632 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.67 158.69 39.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.861 HG23 HD23 ' A' ' 118' ' ' LEU . 3.6 mm -84.92 136.8 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 25.5 m -139.75 141.26 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.24 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ASP . 1.3 ttt180 -88.48 165.76 14.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.569 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.636 ' HG3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.8 88.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.092 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ARG . 4.1 t70 71.86 32.3 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.226 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.87 95.02 5.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.429 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-85 -126.28 109.02 11.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.45 126.22 40.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -71.07 138.08 49.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.72 102.25 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.888 179.925 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mt -119.77 -41.48 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.06 147.86 34.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 145.74 41.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.47 2.113 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 62.64 118.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 106.55 16.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -134.86 31.47 3.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.16 128.43 33.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.08 135.28 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 88.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -104.04 153.95 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -66.51 139.0 57.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.91 170.83 9.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.25 -90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.572 ' NH2' HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 63.17 141.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.81 154.38 23.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -103.19 -27.48 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.12 -62.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.06 110.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.839 0.352 . . . . 0.0 111.154 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.16 116.43 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -100.15 87.94 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.58 149.72 5.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.92 61.69 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 102' ' ' VAL . 2.3 m-20 -81.48 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.2 t80 63.67 82.58 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.037 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.873 HG23 ' OH ' ' A' ' 137' ' ' TYR . 4.4 t 49.04 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.654 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.71 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 84.4 -53.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.92 165.67 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 161.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.688 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' H ' ' HB2' ' A' ' 107' ' ' ALA . 6.6 m-20 -64.76 -47.43 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.684 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -105.4 170.26 7.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.9 127.42 2.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.236 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.34 106.45 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.4 p -98.81 144.46 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.183 0.516 . . . . 0.0 112.2 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.4 107.21 19.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' NH2' ' A' ' 16' ' ' ARG . 9.1 mt -75.02 -2.13 25.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.102 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 1.7 tt0 -143.93 155.15 59.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.663 0.268 . . . . 0.0 111.138 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.59 137.37 25.04 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 112.338 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -166.06 168.2 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.418 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -108.43 106.93 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 125' ' ' LEU . 11.4 mm -83.44 117.17 28.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.254 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.72 170.25 16.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.53 -43.74 89.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.797 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.42 -41.05 88.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.955 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.84 -34.73 71.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.827 0.346 . . . . 0.0 110.825 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.888 HG23 HG21 ' A' ' 66' ' ' ILE . 16.0 mt -72.31 -49.18 44.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.499 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 52' ' ' VAL . 7.8 tt0 -83.15 -46.74 12.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 0.0 111.597 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.66 -47.0 74.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.055 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -67.25 -42.29 84.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.37 -42.11 90.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.865 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.5 t -58.25 -39.55 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -38.06 70.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.469 ' CE ' ' CD2' ' A' ' 104' ' ' PHE . 62.5 mtm -71.13 -48.44 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.081 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ARG . 39.0 t -56.86 -40.58 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.082 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -75.07 -29.44 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -60.31 -49.67 76.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.4 m-85 -55.34 101.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -57.33 -30.23 64.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -107.32 32.63 4.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.76 175.21 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.503 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.45 -170.62 42.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -145.47 152.28 39.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.9 mt -129.61 141.77 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.204 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.17 109.41 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.372 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.888 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -95.5 124.94 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.312 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -100.47 -30.8 11.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HB3' ' A' ' 103' ' ' MET . 31.9 pt -70.78 141.5 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -147.1 133.91 9.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 20.7 Cg_exo -65.08 130.77 26.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.4 2.066 . . . . 0.0 112.025 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.3 m-20 -134.46 -51.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.84 144.15 38.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.94 173.96 7.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 0.0 112.123 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.54 83.48 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.3 p -119.65 112.78 19.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 31.31 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.796 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.4 100.01 31.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.862 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.32 -42.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.349 2.033 . . . . 0.0 112.33 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 129.93 55.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.844 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.25 59.99 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 t -112.83 106.99 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.48 -73.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mmm -97.38 -56.57 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 57.73 28.45 60.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -102.42 -18.02 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.599 0.238 . . . . 0.0 111.2 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.89 -136.73 9.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 -37.7 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.07 -176.48 21.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -122.48 114.73 21.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -106.3 137.57 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -95.57 40.84 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.39 153.2 8.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.551 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.3 m-85 -75.05 159.55 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.38 172.16 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.49 104.12 7.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.768 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.16 130.24 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.298 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 98' ' ' LYS . 22.0 t -126.6 161.19 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.327 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.63 159.5 70.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.7 Cg_exo -53.86 111.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.337 2.025 . . . . 0.0 112.114 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 105.56 31.12 4.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.243 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.53 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.97 124.49 52.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 111.536 -179.59 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 25' ' ' ASP . 10.4 t -78.14 105.54 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.629 ' HB3' HD13 ' A' ' 68' ' ' ILE . 42.2 mtm -92.48 -26.3 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.611 -179.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 66' ' ' ILE . 68.9 m-85 -138.49 151.58 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.319 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CD ' HG12 ' A' ' 102' ' ' VAL . 12.3 mp0 -151.65 116.27 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 118' ' ' LEU . 35.8 m -104.19 164.3 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 31' ' ' ASP . . . -162.09 138.42 7.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.23 -27.68 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.64 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.2 m -85.94 161.98 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.0 p -66.96 171.49 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -32.71 67.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -45.1 71.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.18 -35.87 61.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.34 -48.13 62.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.251 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.565 ' HA ' HG21 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -64.49 -45.89 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.656 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.19 -48.51 70.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.85 -48.85 78.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.05 -31.91 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.312 179.414 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.707 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 117' ' ' ALA . 36.4 mt -53.09 -34.84 21.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.712 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.26 -48.53 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.69 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -66.38 -22.42 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.473 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.38 -45.72 93.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 110.701 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 1.8 ptpm? -82.31 0.13 43.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.369 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.69 HD12 ' HA2' ' A' ' 122' ' ' GLY . 33.8 mt -84.42 153.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-O 120.788 0.327 . . . . 0.0 110.567 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.73 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 87.7 Cg_endo -85.86 14.89 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.778 2.319 . . . . 0.0 112.68 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.778 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -144.05 167.16 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 137.51 35.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' ALA . 19.1 p -138.51 151.17 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.562 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.449 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.2 pttt -134.41 152.98 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 111.268 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.843 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.03 137.08 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.2 m -149.39 130.09 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.0 111.673 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.491 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.17 165.37 18.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.562 178.734 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.654 ' HA ' HG21 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.51 4.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 133' ' ' ARG . 1.2 m-20 -161.79 23.48 0.12 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.832 0.349 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.558 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.37 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.06 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.873 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.5 m-85 -128.16 103.22 7.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.17 93.5 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -73.26 150.53 41.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.74 98.73 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.853 0.359 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.6 mt -152.54 127.07 9.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 mmm -105.83 88.64 3.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.76 132.89 22.59 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.553 2.169 . . . . 0.0 112.283 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 137.47 51.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mtt-85 -150.78 110.88 4.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.19 127.38 32.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -65.93 -23.42 66.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -55.82 110.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.966 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -99.94 149.1 23.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.29 82.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.11 166.05 23.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -72.26 115.91 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.2 89.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -128.51 1.19 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -87.2 -166.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 17' ' ' LEU . 1.6 tm? 46.23 87.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.218 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -27.66 15.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.59 -147.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.534 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.07 146.96 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 111.099 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 p -74.51 -31.39 62.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.47 131.64 56.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.59 161.91 53.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -179.58 52.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.498 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.85 87.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.153 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -134.93 80.06 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.137 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.948 HG23 ' OH ' ' A' ' 137' ' ' TYR . 4.8 t 48.11 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.5 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.82 167.57 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 66.13 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.527 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -92.4 174.42 36.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.895 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' A' ' 107' ' ' ALA . 8.0 m-20 -72.08 -39.61 68.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CD2' ' CB ' ' A' ' 114' ' ' ALA . 12.1 m-85 -105.51 169.19 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.4 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HG22 ' A' ' 27' ' ' VAL . . . -154.49 133.59 3.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.251 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.4 tm? -95.42 107.68 19.84 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.79 145.07 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.975 -179.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.69 110.18 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.762 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.0 mt -78.08 1.47 21.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.128 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.0 tt0 -148.25 150.39 34.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.051 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.18 136.2 39.78 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.686 2.257 . . . . 0.0 112.421 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.868 ' HB1' ' HG2' ' A' ' 126' ' ' PRO . . . -161.02 169.96 21.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.477 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -113.22 105.88 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.515 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.716 HD12 HD22 ' A' ' 125' ' ' LEU . 17.5 mm -83.44 119.59 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.92 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.0 97.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.805 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.54 -38.03 85.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.125 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.1 mt-30 -58.92 -34.64 71.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.907 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.779 HG23 HG21 ' A' ' 66' ' ' ILE . 20.8 mt -70.09 -51.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.69 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -83.23 -46.21 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.554 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.42 -47.26 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -65.27 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.47 -43.05 93.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 48' ' ' GLU . 43.6 t -58.13 -42.0 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.71 86.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 59.7 mtm -71.16 -46.62 61.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.5 t -56.92 -35.6 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.273 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -75.15 -29.39 60.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.233 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.21 -53.43 49.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.331 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' A' ' 109' ' ' VAL . 22.5 m-85 -49.4 115.1 1.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.96 -40.56 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -98.21 33.03 2.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 66.77 175.97 7.35 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.393 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.1 160.2 11.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.513 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.85 150.52 42.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.5 mt -123.51 126.92 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -98.35 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.731 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.779 HG21 HG23 ' A' ' 47' ' ' ILE . 4.5 mm -91.43 141.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -113.25 -30.47 6.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' MET . 32.8 pt -68.72 152.15 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -152.55 134.66 8.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.6 Cg_exo -64.98 114.59 2.86 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.421 2.081 . . . . 0.0 112.061 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.7 -47.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 143.96 98.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.46 163.03 38.7 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 4.5 t80 -127.49 93.12 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -119.16 136.19 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 18.6 mtpt -150.14 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 94.41 48.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -40.73 2.81 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.473 2.115 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.67 157.82 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 46.14 -169.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.352 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.41 142.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -113.38 136.95 52.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -67.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.04 123.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.47 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.41 10.43 29.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.605 0.24 . . . . 0.0 111.369 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.65 32.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 117.93 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.01 -142.67 10.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.84 111.1 21.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.5 149.45 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.95 41.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.59 -179.0 49.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.47 156.81 20.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 162.56 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 102.84 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.73 131.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 98' ' ' LYS . 17.8 t -126.66 161.45 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 97' ' ' VAL . 4.4 mtpm? -130.68 160.13 67.78 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.0 Cg_exo -54.24 112.35 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.492 2.128 . . . . 0.0 112.087 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.4 29.98 5.17 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.239 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.544 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.95 116.38 31.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.784 0.325 . . . . 0.0 111.538 -179.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.839 HG21 ' H ' ' A' ' 27' ' ' VAL . 7.8 t -82.17 103.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.495 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.617 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -93.4 -27.06 16.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.998 -178.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.8 m-85 -124.28 153.13 42.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.175 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.83 ' OE2' HG12 ' A' ' 102' ' ' VAL . 1.4 mp0 -155.26 115.28 3.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.754 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 118' ' ' LEU . 34.3 m -106.16 150.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.34 . . . . 0.0 111.175 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 31' ' ' ASP . . . -146.47 141.54 27.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.02 -26.54 23.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.647 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -86.02 158.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.6 p -66.97 172.79 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.0 -36.37 75.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -42.47 75.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.18 -37.28 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -70.01 -48.14 59.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.533 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -62.65 -48.12 80.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.726 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.48 -48.67 76.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.65 -48.73 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.21 -30.31 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 131' ' ' ILE . 23.3 mtp180 -74.05 -40.39 62.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.69 -46.42 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -57.49 -44.62 85.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.772 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.67 -22.13 77.62 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.534 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -36.65 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -89.02 1.02 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 42' ' ' ILE . 42.5 mt -84.45 161.27 54.65 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 110.737 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.868 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 38.1 Cg_endo -91.59 21.53 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.095 2.53 . . . . 0.0 112.566 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.84 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.82 167.12 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.214 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 127.62 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.213 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.483 HG21 HD12 ' A' ' 125' ' ' LEU . 15.2 p -126.58 153.95 44.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.518 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.5 pttt -135.69 154.34 51.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 111.257 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.96 135.28 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.683 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.3 m -146.24 128.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 111.443 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' C ' ' H ' ' A' ' 135' ' ' ASP . 4.0 ttt180 -67.95 165.36 17.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.629 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -60.59 10.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.467 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 133' ' ' ARG . 3.3 m-20 -165.33 22.43 0.05 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.55 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -116.18 94.05 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.948 ' OH ' HG23 ' A' ' 27' ' ' VAL . 5.6 m-85 -128.44 110.95 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -107.25 93.41 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -77.5 164.4 25.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -118.44 99.2 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.092 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.879 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.893 0.378 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 3' ' ' MET . 1.3 tt -163.0 154.03 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.471 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -124.89 137.48 29.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.829 -179.931 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.19 99.91 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.492 2.128 . . . . 0.0 112.198 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -80.78 150.44 29.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -176.5 140.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.82 170.38 9.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.97 47.77 24.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 59.74 -179.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.96 125.24 53.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -166.13 148.58 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -105.97 122.01 45.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -81.42 150.84 28.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.09 -57.58 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.28 -69.01 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.547 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 61.19 153.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.09 81.66 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -100.48 23.62 10.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.13 162.93 13.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.42 121.74 26.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.0 p -67.99 95.92 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -107.88 125.26 51.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.48 164.13 12.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.46 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.62 -48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.432 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -76.18 -178.01 4.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.055 0.455 . . . . 0.0 111.022 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -147.66 117.46 7.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.73 179.181 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 134' ' ' ARG . 9.2 t -27.46 105.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.89 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.784 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -58.73 -77.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.174 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -119.68 -176.19 3.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.688 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 61.25 178.64 2.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.603 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -87.58 -39.66 14.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CD2' ' A' ' 118' ' ' LEU . 32.3 m-85 -105.37 165.57 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -154.05 132.01 3.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.94 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.7 tm? -91.54 116.96 29.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 101' ' ' ARG . 7.1 p -104.77 145.67 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.206 0.527 . . . . 0.0 112.204 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.03 115.99 28.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.475 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.6 mt -91.16 19.62 5.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.953 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 3.9 tt0 -164.09 143.2 6.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.662 0.268 . . . . 0.0 111.031 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 26.4 Cg_exo -62.47 133.44 42.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.564 2.176 . . . . 0.0 112.46 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -162.6 168.76 21.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.39 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 96' ' ' VAL . 19.0 m0 -112.19 109.92 19.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 125' ' ' LEU . 19.0 mm -83.42 117.59 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.76 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.41 90.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -61.44 -38.65 87.96 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.74 -34.78 71.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.749 0.309 . . . . 0.0 111.008 -179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.87 HG23 HG21 ' A' ' 66' ' ' ILE . 15.4 mt -71.4 -49.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.595 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 52' ' ' VAL . 8.4 tt0 -83.11 -46.6 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.575 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.91 -46.82 74.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.67 -44.7 81.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.238 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.882 ' HG2' HD12 ' A' ' 64' ' ' ILE . 3.0 ttp180 -59.3 -41.51 89.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.1 t -57.74 -34.8 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 110.637 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.04 -37.02 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.726 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 121' ' ' ALA . 57.1 mtm -71.21 -52.57 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' ARG . 76.5 t -56.85 -39.63 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -29.53 64.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -60.66 -51.18 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.189 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' HG11 ' A' ' 109' ' ' VAL . 13.2 m-85 -56.6 97.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -65.15 -29.13 69.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 33.04 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.93 154.49 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.434 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.41 165.58 32.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -133.95 151.76 51.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.882 HD12 ' HG2' ' A' ' 51' ' ' ARG . 5.4 mt -121.6 149.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.272 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HB2' ' HG2' ' A' ' 105' ' ' GLU . 90.4 m-85 -116.07 110.75 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.87 HG21 HG23 ' A' ' 47' ' ' ILE . 4.3 mm -101.66 130.56 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 -29.62 8.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 42' ' ' ILE . 49.4 pt -66.94 144.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 143.01 25.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 93' ' ' TYR . 85.8 Cg_endo -81.82 112.36 2.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.602 2.201 . . . . 0.0 112.325 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -126.91 -40.78 1.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HD2' HG21 ' A' ' 96' ' ' VAL . 2.4 mtpm? -66.88 109.65 3.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.973 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.723 ' HB3' HG21 ' A' ' 90' ' ' VAL . 9.1 Cg_exo -71.54 122.66 8.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.668 2.245 . . . . 0.0 112.46 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.712 ' CD2' HG13 ' A' ' 94' ' ' VAL . 5.5 p90 -103.08 147.55 26.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.316 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 p -119.0 137.32 53.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 111.311 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -109.69 -156.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 146.09 88.32 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.814 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.86 148.77 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.512 2.141 . . . . 0.0 112.429 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.37 161.44 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 17.98 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.245 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.05 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -73.9 -37.69 64.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 172.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.33 -143.85 14.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -102.22 18.06 21.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 0.0 111.19 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.12 -135.81 4.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -39.62 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.43 120.2 5.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.436 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -116.0 123.35 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG21 ' HB3' ' A' ' 73' ' ' PRO . 14.6 p -64.84 141.92 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CE1' ' A' ' 74' ' ' TYR . 3.5 mm-40 -95.96 29.58 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.282 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 90' ' ' VAL . . . 114.08 166.99 15.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.501 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.633 ' HE1' HG11 ' A' ' 90' ' ' VAL . 7.6 m-30 -111.56 157.52 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.992 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.712 HG13 ' CD2' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -123.58 174.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . . . -125.83 104.46 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.534 HG21 ' HD2' ' A' ' 72' ' ' LYS . 12.0 t -66.4 130.19 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 98' ' ' LYS . 41.3 t -126.58 159.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.148 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.78 160.13 67.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.4 Cg_exo -53.32 119.52 6.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.308 2.005 . . . . 0.0 111.986 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 92.51 37.8 5.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.128 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -115.82 123.85 49.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 25' ' ' ASP . 15.4 t -82.54 102.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.648 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.1 -35.1 12.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.571 -179.513 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 66' ' ' ILE . 70.5 m-85 -124.23 156.88 36.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.794 0.331 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.784 ' OE2' ' HB3' ' A' ' 28' ' ' ALA . 3.8 pm0 -164.36 115.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 118' ' ' LEU . 33.9 m -97.73 167.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.688 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -162.55 143.12 9.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.39 -26.26 20.51 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.659 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.92 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -88.29 158.21 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 111.235 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.3 p -67.07 169.28 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.43 -45.75 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.115 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.07 -46.11 85.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -75.2 -40.72 59.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.92 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -64.89 -48.12 75.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.414 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -63.6 -50.08 70.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.56 -48.52 81.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.4 -48.64 76.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.812 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.55 -31.53 71.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.442 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.511 ' HD2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -73.66 -39.54 64.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 117' ' ' ALA . 73.0 mt -58.07 -39.18 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.48 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 54' ' ' MET . . . -62.16 -49.71 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.634 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.75 -20.59 79.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.479 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -39.5 80.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.801 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 3.85 54.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.327 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 122' ' ' GLY . 25.0 mt -84.41 155.18 62.99 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.721 0.296 . . . . 0.0 110.598 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.735 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.4 Cg_endo -86.78 20.91 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.809 2.339 . . . . 0.0 112.726 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.782 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.51 167.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 137.14 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.459 HG21 HD12 ' A' ' 125' ' ' LEU . 10.4 p -140.61 149.27 42.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.7 pttt -131.47 166.09 22.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.812 HG23 HD23 ' A' ' 118' ' ' LEU . 2.2 mm -96.73 142.78 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.818 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 8.4 m -150.13 134.75 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.161 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 32' ' ' TYR . 18.0 ttt180 -95.13 119.89 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.294 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' N ' HG21 ' A' ' 27' ' ' VAL . 0.7 OUTLIER 40.79 -101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.447 0.641 . . . . 0.0 112.003 179.138 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -106.81 45.29 0.99 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.145 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.588 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.68 94.55 4.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.818 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.9 m-85 -126.98 89.94 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.07 121.05 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -96.12 129.74 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.91 104.2 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.077 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.948 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.22 65.76 6.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.0 mtp -107.61 139.02 20.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 79.33 2.71 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.338 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 155.31 45.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -34.69 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.48 106.18 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 129.77 41.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.59 144.8 33.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.94 139.43 36.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -139.62 101.04 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -64.39 141.56 58.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -69.17 115.08 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.28 -66.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.23 162.98 30.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.691 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -142.97 172.79 12.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 0.0 110.942 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -146.12 175.48 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -85.55 -27.54 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 89.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.47 15.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 111.098 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.11 -176.81 4.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 134.55 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.98 -177.91 22.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.6 -68.59 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.346 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -99.87 133.54 44.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' VAL . 18.7 p90 -106.35 -47.58 3.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.417 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 29' ' ' PHE . 73.7 t -158.01 -78.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.833 -179.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 56.82 31.0 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.529 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 171.66 135.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.791 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.48 159.18 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.625 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.76 -34.75 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 118' ' ' LEU . 4.0 m-85 -115.57 165.38 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 132' ' ' VAL . . . -153.95 127.16 2.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.114 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 2.5 tm? -91.31 108.23 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -98.1 144.84 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.238 0.542 . . . . 0.0 112.458 -178.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -94.57 109.77 21.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.278 178.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -78.88 2.55 19.73 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -145.9 150.21 41.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 -179.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 65.3 Cg_endo -74.14 126.37 10.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.505 2.136 . . . . 0.0 112.048 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -157.85 172.12 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.514 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -109.81 109.73 20.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.919 HD12 HD22 ' A' ' 125' ' ' LEU . 9.1 mm -84.88 120.68 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.68 174.2 11.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -62.74 -43.16 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.592 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.84 -42.45 84.44 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 11.4 mt-30 -58.83 -34.71 71.85 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.804 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.859 HG23 HG21 ' A' ' 66' ' ' ILE . 19.1 mt -70.77 -50.37 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.635 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.3 tt0 -83.14 -46.79 12.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.535 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.03 -47.19 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 124' ' ' LYS . . . -64.41 -42.77 95.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.56 -43.94 93.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.702 179.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.4 t -58.38 -42.07 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.9 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.464 ' HB2' HD11 ' A' ' 64' ' ' ILE . 62.6 mtm -70.97 -48.06 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 51' ' ' ARG . 40.3 t -56.86 -36.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.005 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -75.1 -29.54 60.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.054 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.68 -55.04 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.674 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.2 m-85 -53.0 94.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -63.59 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -98.27 32.89 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.21 160.25 0.38 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.35 176.44 47.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -142.61 145.3 33.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.2 mt -121.3 140.55 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -110.7 109.33 19.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.859 HG21 HG23 ' A' ' 47' ' ' ILE . 3.3 mm -94.15 130.52 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.219 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -110.71 -11.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.487 HD13 ' HB3' ' A' ' 103' ' ' MET . 34.2 pt -90.76 136.98 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.176 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -140.18 133.36 15.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.724 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 23.3 Cg_exo -64.01 132.48 34.62 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.417 2.078 . . . . 0.0 112.114 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -145.73 -48.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -74.37 121.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.787 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.49 157.11 9.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -124.44 89.97 3.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 90' ' ' VAL . 28.7 p -119.16 132.73 56.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.089 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.6 53.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 136.1 20.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.51 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.535 2.157 . . . . 0.0 112.441 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.79 134.52 38.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 61.18 90.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.89 110.16 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.9 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -139.4 -46.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.86 108.61 0.34 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.598 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -93.87 -18.19 22.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.28 -59.38 0.47 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.499 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -150.72 124.68 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.12 -151.4 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -122.79 130.44 52.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 75' ' ' THR . 14.5 p -78.45 124.05 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -91.07 51.48 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.776 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.03 172.94 45.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -105.12 155.84 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.707 0.289 . . . . 0.0 110.854 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 43' ' ' THR . 2.2 m -136.63 174.51 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.693 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.45 104.12 7.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.545 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 t -56.99 129.23 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.658 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 98' ' ' LYS . 12.1 t -126.61 161.21 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.887 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.7 mptp? -130.53 157.06 78.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.775 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 10.0 Cg_endo -51.4 113.13 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.78 2.32 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 103.14 31.54 4.99 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.247 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.69 126.08 55.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 111.528 -179.528 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.846 HG12 ' OE2' ' A' ' 105' ' ' GLU . 15.4 t -79.95 105.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.533 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 33.8 mtm -91.6 -27.98 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.0 m-85 -134.93 150.91 50.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.846 ' OE2' HG12 ' A' ' 102' ' ' VAL . 7.3 mp0 -150.61 119.16 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.662 HG13 HD11 ' A' ' 118' ' ' LEU . 35.5 m -111.68 158.9 11.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.117 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.1 137.53 17.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.99 2.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.799 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.067 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.7 m -72.75 156.36 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.307 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.8 p -68.5 165.29 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -59.69 -41.66 91.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -42.97 90.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -75.17 -39.31 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.067 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.61 -48.09 50.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.62 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -61.18 -45.98 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.12 -48.56 70.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.73 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.11 -48.68 79.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -58.94 -31.54 68.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.415 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -40.21 61.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 117' ' ' ALA . 58.1 mt -52.8 -37.69 26.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.578 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.07 -43.69 86.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.559 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.738 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -71.87 -27.23 71.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.274 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -59.12 -33.56 71.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 110.773 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -93.33 -1.96 55.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 42' ' ' ILE . 37.8 mt -84.44 158.23 60.67 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.54 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.652 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.6 Cg_endo -86.57 13.63 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.765 2.31 . . . . 0.0 112.528 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.722 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -145.98 166.93 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.833 0.349 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.01 143.12 32.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 36' ' ' ALA . 14.3 p -143.96 147.93 34.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.623 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.752 ' HG2' HD21 ' A' ' 37' ' ' LEU . 17.0 pttt -128.79 158.06 39.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -89.81 138.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.917 HG21 ' OH ' ' A' ' 137' ' ' TYR . 5.7 m -151.1 140.45 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 111.305 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -77.59 165.39 24.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.038 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HA ' HG11 ' A' ' 27' ' ' VAL . 3.4 ttt180 -47.0 89.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.288 178.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 133' ' ' ARG . 7.2 t70 67.6 43.36 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.711 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.86 94.65 4.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.917 ' OH ' HG21 ' A' ' 132' ' ' VAL . 1.7 m-85 -126.69 92.17 3.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.908 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.02 153.05 38.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.91 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.64 103.83 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' HD23 ' A' ' 2' ' ' LEU . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.778 0.323 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 1' ' ' MET . 29.2 mt -123.23 -64.15 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mtt -83.24 112.93 42.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.26 97.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.424 2.083 . . . . 0.0 112.233 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.47 33.01 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.16 80.28 8.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mmt -108.51 118.68 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.24 128.25 18.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 170.74 7.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -87.01 153.89 21.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.44 135.18 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -89.56 159.74 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -102.73 156.4 17.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 32.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.42 44.77 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 173.43 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -151.02 97.12 2.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.945 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 23.52 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' H ' HD13 ' A' ' 17' ' ' LEU . . . 145.7 91.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.49 156.58 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 p -129.26 -178.36 4.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.32 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.73 -116.15 0.63 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.37 64.64 0.8 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -74.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.188 0.518 . . . . 0.0 110.872 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.4 OUTLIER 62.37 119.0 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.869 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG23 ' OH ' ' A' ' 137' ' ' TYR . 8.5 t -30.27 120.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.725 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -86.86 95.79 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 63.24 149.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 90.08 -168.64 34.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.592 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.7 -32.98 6.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 133' ' ' ARG . 8.8 m-85 -116.51 171.41 7.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 105' ' ' GLU . . . -164.56 144.4 9.35 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.969 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -100.34 110.72 22.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 101' ' ' ARG . 4.2 p -99.53 145.59 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.296 0.57 . . . . 0.0 112.045 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.793 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -97.55 113.11 24.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.794 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt -82.6 6.23 18.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.836 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 4.2 tt0 -150.67 143.57 16.5 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.815 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' ' 99' ' ' PRO . 44.4 Cg_endo -67.94 133.14 28.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.48 2.12 . . . . 0.0 112.432 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -160.14 172.02 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.457 ' HB3' HG21 ' A' ' 94' ' ' VAL . 20.9 m0 -109.97 108.32 18.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.643 HD12 HD22 ' A' ' 125' ' ' LEU . 16.1 mm -86.61 118.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.383 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.0 172.63 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -60.37 -42.95 96.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.9 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -57.24 -42.44 81.48 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.002 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 27.0 mm100 -58.7 -34.71 71.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.725 0.298 . . . . 0.0 110.923 -179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 66' ' ' ILE . 21.2 mt -71.32 -50.06 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.3 tt0 -83.06 -46.43 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.505 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -55.83 -47.27 77.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -67.48 -41.71 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.39 -42.65 92.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.765 179.94 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 48' ' ' GLU . 36.6 t -58.23 -45.6 88.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.9 91.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.988 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.486 ' CB ' HD11 ' A' ' 64' ' ' ILE . 62.5 mtm -71.19 -51.12 26.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.368 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 51' ' ' ARG . 42.2 t -56.75 -38.59 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -74.9 -29.48 61.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -59.35 -53.99 51.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.056 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 109' ' ' VAL . 11.3 m-85 -57.91 119.29 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.761 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -29.36 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.122 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -96.81 33.09 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.44 159.69 2.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.562 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.4 160.01 16.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -135.47 148.88 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 54' ' ' MET . 2.6 mt -118.59 141.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.235 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.51 109.43 21.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.988 HG21 HG23 ' A' ' 47' ' ' ILE . 4.4 mm -95.84 128.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.252 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -105.63 -29.6 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 103' ' ' MET . 35.4 pt -69.34 133.95 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 m-85 -136.28 139.98 31.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 127.36 11.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.544 2.163 . . . . 0.0 112.208 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 11.8 m-20 -148.16 -52.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.13 144.06 98.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 163.57 36.16 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.071 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -127.48 106.09 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.291 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 p -118.93 143.45 47.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -104.97 -152.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -60.68 116.99 20.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -90.43 38.19 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.897 2.398 . . . . 0.0 112.51 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.12 151.23 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 59.19 89.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.941 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -83.38 135.35 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.6 -28.01 12.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 11.8 ttt -172.84 -41.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.64 73.84 0.24 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.542 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -18.06 49.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.68 0.276 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.52 -45.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -126.79 99.62 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.79 -149.62 19.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -117.25 123.08 45.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 91' ' ' GLU . 11.3 p -78.1 156.04 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 90' ' ' VAL . 4.9 mm-40 -93.95 46.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.37 -176.91 40.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 71' ' ' ASP . 3.5 m-30 -103.33 163.73 12.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 41' ' ' TRP . 2.5 m -147.44 171.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 0.0 111.22 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' PHE . . . -120.45 103.92 9.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.798 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.08 131.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 98' ' ' LYS . 20.3 t -126.51 162.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.64 160.05 68.07 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.814 179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 52.2 Cg_exo -54.75 117.39 3.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.431 2.087 . . . . 0.0 112.09 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.17 29.2 8.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.381 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.64 120.45 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.394 -179.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.65 102.86 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.631 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.793 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 mtm -87.79 -22.57 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.742 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 66' ' ' ILE . 59.2 m-85 -135.99 163.08 31.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.717 0.294 . . . . 0.0 111.284 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.658 ' OE2' ' HB3' ' A' ' 28' ' ' ALA . 11.7 mp0 -160.43 118.97 2.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 118' ' ' LEU . 29.0 m -110.34 157.28 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -154.82 140.42 17.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.44 -26.62 23.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.636 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 114' ' ' ALA . 34.5 m -86.85 157.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.172 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -67.1 173.63 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -69.27 -41.85 76.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -44.06 97.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -75.09 -38.88 61.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -69.55 -48.2 61.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.446 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.528 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.7 -45.22 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.26 -48.59 67.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.62 -48.83 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -61.04 -30.25 70.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.428 179.471 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.424 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.63 -37.55 62.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.626 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 65.5 mt -56.5 -42.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.57 95.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -74.31 -18.53 79.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.102 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.692 0.246 . . . . 0.0 111.036 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.15 41.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.483 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.643 HD22 HD12 ' A' ' 42' ' ' ILE . 20.3 mt -84.22 154.21 63.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.625 0.25 . . . . 0.0 110.555 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.688 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 90.2 Cg_endo -87.81 21.13 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.856 2.371 . . . . 0.0 112.75 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.776 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 pp -152.74 167.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -78.19 140.07 38.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 18.3 p -145.09 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG2' HD21 ' A' ' 37' ' ' LEU . 3.1 pttt -135.49 159.85 40.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.915 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -85.34 135.41 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 26.9 m -139.31 139.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.139 0.495 . . . . 0.0 111.581 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -90.59 165.82 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -46.76 88.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.994 179.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 133' ' ' ARG . 6.2 t70 73.16 29.88 1.66 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.481 178.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -114.99 95.07 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.52 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 136' ' ' ALA . 1.2 m-85 -126.42 104.08 7.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.78 93.49 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 118.3 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.85 94.07 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.061 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.889 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.23 111.95 23.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 6.8 ttp -104.74 105.29 50.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 3' ' ' MET . 37.9 Cg_endo -66.34 110.89 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.344 2.03 . . . . 0.0 112.225 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 159.44 36.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.036 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.1 76.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.3 mtt -100.89 164.93 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 78.17 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.54 49.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -76.08 154.73 35.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 177.93 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -67.35 163.01 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -63.6 114.16 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -137.43 39.65 2.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.9 -68.76 0.34 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.529 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.6 153.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.63 104.87 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -97.2 23.59 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.25 -118.17 2.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.94 145.17 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.9 -45.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.63 148.26 19.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.44 -113.61 2.57 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.56 157.29 32.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.582 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -80.14 -171.3 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -142.35 118.07 10.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.962 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.836 HG23 ' OH ' ' A' ' 137' ' ' TYR . 14.3 t -29.3 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.835 178.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 65.79 151.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.338 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 64.71 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.486 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.832 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -79.83 166.71 50.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.014 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 134' ' ' ARG . 3.1 m-20 -79.46 -27.55 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' CE1' ' HD2' ' A' ' 133' ' ' ARG . 12.8 m-85 -117.12 168.94 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 27' ' ' VAL . . . -155.26 139.69 6.84 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.216 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 1.8 tm? -101.1 103.89 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.3 p -95.27 143.76 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.195 0.521 . . . . 0.0 111.996 -178.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -96.22 104.68 16.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.262 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD21 ' HG2' ' A' ' 130' ' ' LYS . 7.6 mt -73.54 -4.55 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.819 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 35.3 tt0 -139.71 141.25 27.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.509 0.195 . . . . 0.0 110.683 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 55.8 Cg_endo -70.03 135.52 30.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.261 1.974 . . . . 0.0 112.528 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 127' ' ' ILE . . . -160.98 171.5 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.183 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.3 m0 -105.99 105.08 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.838 HD12 HD22 ' A' ' 125' ' ' LEU . 17.6 mm -83.39 117.69 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.194 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.429 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.66 170.01 17.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.21 88.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -58.22 -40.31 81.35 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.745 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -58.89 -34.68 71.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.796 0.331 . . . . 0.0 110.96 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.936 HG23 HG21 ' A' ' 66' ' ' ILE . 21.1 mt -71.68 -49.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.619 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.808 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.9 tt0 -83.19 -46.48 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.544 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.74 -47.24 70.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.243 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.16 84.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -59.54 -44.09 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.745 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 48' ' ' GLU . 39.4 t -57.91 -43.08 83.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.88 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.546 ' HE3' HG21 ' A' ' 64' ' ' ILE . 65.5 mtm -71.18 -48.14 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 51' ' ' ARG . 41.2 t -56.84 -38.05 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -75.12 -29.38 60.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -61.73 -52.61 63.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 109' ' ' VAL . 16.5 m-85 -56.58 111.89 1.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -69.03 -34.27 74.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -100.18 33.04 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.47 172.05 4.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.391 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.37 158.29 14.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.61 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -122.91 141.34 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 110.846 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.67 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.1 mt -120.76 129.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.34 119.91 39.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.287 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.936 HG21 HG23 ' A' ' 47' ' ' ILE . 4.8 mm -101.43 122.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.24 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -30.66 15.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 103' ' ' MET . 49.1 pt -73.95 139.24 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.19 136.55 17.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.753 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.5 104.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.41 2.073 . . . . 0.0 112.219 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.53 -42.57 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -75.87 124.26 88.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.3 147.43 83.19 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.439 2.093 . . . . 0.0 112.243 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 91' ' ' GLU . 1.9 t80 -113.01 92.15 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 p -118.95 124.95 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.138 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -153.06 33.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -82.8 110.83 25.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.67 125.58 8.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.474 2.116 . . . . 0.0 112.386 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.98 106.56 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -162.45 -49.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.39 151.84 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -76.84 127.18 32.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.4 ttm -66.3 -179.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.17 -113.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -84.34 -18.11 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.68 0.276 . . . . 0.0 111.217 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.51 -155.53 9.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -145.67 35.75 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 143.74 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.492 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -100.3 146.53 26.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 91' ' ' GLU . 11.6 p -71.96 158.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -93.82 40.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.023 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.52 152.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.25 149.07 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.762 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 43' ' ' THR . 3.1 m -125.71 165.52 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -117.63 104.1 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -59.9 129.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 11.2 t -126.68 161.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.452 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -130.79 160.08 68.2 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 51.2 Cg_exo -51.76 126.42 19.75 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.355 2.037 . . . . 0.0 112.227 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 89.7 31.27 11.51 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.006 -179.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.584 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -111.44 118.15 35.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 25' ' ' ASP . 31.7 t -76.75 106.0 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.522 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 68' ' ' ILE . 38.2 mtm -90.63 -32.34 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.396 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.646 ' CE2' HD12 ' A' ' 66' ' ' ILE . 41.7 m-85 -130.29 163.06 27.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.184 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.9 pm0 -167.26 115.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 118' ' ' LEU . 28.0 m -100.02 168.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.3 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -159.26 143.07 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.49 -38.82 2.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.759 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 114' ' ' ALA . 33.8 m -75.53 167.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -75.42 178.44 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -73.56 -42.86 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.987 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.54 -43.69 98.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.11 -39.47 60.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.729 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -68.63 -48.15 64.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.511 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -61.97 -45.34 94.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.16 -48.65 72.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.729 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.17 -48.85 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -60.63 -32.12 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.343 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -38.49 62.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 117' ' ' ALA . 29.7 mt -56.67 -36.07 47.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.482 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.56 -47.62 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -68.15 -23.85 74.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.424 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -42.85 85.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.39 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -86.77 -1.18 57.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.838 HD22 HD12 ' A' ' 42' ' ' ILE . 38.9 mt -84.4 153.28 62.01 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.691 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.655 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 94.7 Cg_endo -89.54 27.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.851 2.367 . . . . 0.0 112.548 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.75 HG23 ' HB2' ' A' ' 40' ' ' ALA . 2.2 pp -151.99 166.29 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.291 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.41 125.44 32.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.423 ' CB ' HD11 ' A' ' 34' ' ' LEU . 25.1 p -127.64 152.61 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.679 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' HD21 ' A' ' 37' ' ' LEU . 13.4 pttt -134.42 153.65 51.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 118' ' ' LEU . 3.9 mm -84.84 133.98 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.264 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 14.1 m -141.58 129.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.992 0.425 . . . . 0.0 111.5 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -68.34 165.49 18.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.842 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 50.0 ttt-85 -58.43 5.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 133' ' ' ARG . 4.7 m-20 -162.37 23.5 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.96 94.02 4.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.033 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.836 ' OH ' HG23 ' A' ' 27' ' ' VAL . 6.4 m-85 -128.28 120.26 26.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.67 153.9 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.38 121.06 12.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.13 99.64 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.898 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -47.07 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.68 126.12 23.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.68 137.31 27.2 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.434 2.089 . . . . 0.0 112.354 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -142.63 47.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 60.74 171.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 118.86 8.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -143.97 146.35 32.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.15 44.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -84.1 145.82 28.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -99.76 -59.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -104.07 143.81 32.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.68 162.48 16.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -43.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.985 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.64 109.68 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.636 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.75 176.38 5.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.82 119.55 32.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.853 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -109.52 23.61 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -174.25 1.75 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.1 129.73 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.017 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 p -124.83 -43.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -79.0 91.83 4.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.943 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.84 -124.78 2.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.41 -130.37 6.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.532 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.29 -175.52 2.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' VAL . 23.8 t80 -173.96 -67.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.016 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 26' ' ' TYR . 1.1 t 161.04 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.285 179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.1 -75.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.547 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.47 -179.09 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.609 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 64.03 134.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.447 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 134' ' ' ARG . 9.2 m-20 -52.33 -31.29 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 10.4 m-85 -117.68 171.27 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 104' ' ' PHE . . . -157.87 133.84 3.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.943 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.6 tm? -91.95 111.91 23.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -102.5 145.39 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.167 0.508 . . . . 0.0 112.052 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -98.03 109.79 22.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.647 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.464 HD21 ' HG2' ' A' ' 130' ' ' LYS . 9.0 mt -77.43 -0.17 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.786 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -144.88 147.59 35.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.92 133.72 20.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.502 2.135 . . . . 0.0 112.468 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.781 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -159.54 172.01 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.367 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 94' ' ' VAL . 30.9 m0 -108.56 108.44 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 125' ' ' LEU . 16.9 mm -83.44 118.56 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.69 170.7 16.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -58.74 -43.92 90.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.49 -41.41 98.79 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.955 -179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.69 -34.53 71.38 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.851 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 66' ' ' ILE . 14.4 mt -71.24 -51.14 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.648 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.9 tp10 -83.05 -46.22 13.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.726 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.42 -47.31 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 121' ' ' ALA . . . -64.72 -41.99 95.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HG2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.82 -40.04 87.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 48' ' ' GLU . 48.0 t -61.06 -33.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.945 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.44 -37.47 51.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.181 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.549 ' HE3' ' CD2' ' A' ' 104' ' ' PHE . 59.4 mtm -71.09 -47.44 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.91 -39.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -75.07 -29.36 60.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.19 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.65 -51.94 66.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.019 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD1' HG11 ' A' ' 109' ' ' VAL . 21.6 m-85 -54.08 105.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -39.34 80.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtp85 -99.17 33.11 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.24 158.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.44 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.53 155.19 24.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -112.0 138.01 49.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.859 HD12 ' HG2' ' A' ' 51' ' ' ARG . 2.7 mt -115.94 142.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.129 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.49 109.34 20.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.474 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.0 mm -100.51 138.76 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.12 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.59 27.56 5.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 HG22 ' A' ' 66' ' ' ILE . 32.8 pt -121.55 132.46 70.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.49 131.8 17.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.5 104.54 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.352 2.035 . . . . 0.0 112.069 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.96 -50.63 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -66.95 144.04 98.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 155.88 62.49 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.525 2.15 . . . . 0.0 112.403 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HD2' HG11 ' A' ' 94' ' ' VAL . 7.2 t80 -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -119.22 119.66 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 168.73 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.661 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -124.58 106.52 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.027 -179.664 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 141.15 30.01 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.451 2.101 . . . . 0.0 112.413 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.26 161.68 15.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.16 -27.55 34.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.26 154.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.017 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 64.68 165.45 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.31 137.63 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.55 90.62 0.72 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.568 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -107.56 -18.08 13.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.235 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.73 25.93 4.96 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp 73.07 3.98 4.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.87 137.45 0.01 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -133.62 154.56 50.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.764 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 90' ' ' VAL . 13.5 p -64.92 112.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.038 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.71 75.11 7.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.04 -171.97 7.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.426 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -111.14 158.61 18.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 41' ' ' TRP . 10.5 m -145.87 164.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.245 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.87 107.52 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.45 HG22 ' CD1' ' A' ' 41' ' ' TRP . 6.6 t -66.83 131.29 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 98' ' ' LYS . 13.0 t -126.51 161.6 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.212 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -130.9 158.05 76.17 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 179.587 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.9 Cg_exo -51.26 117.91 3.85 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.295 1.997 . . . . 0.0 112.169 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 97.0 32.28 6.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.08 -179.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -110.43 117.75 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.701 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.864 HG12 ' OE2' ' A' ' 105' ' ' GLU . 18.6 t -81.33 103.85 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.354 179.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.622 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -97.31 -29.4 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 66' ' ' ILE . 65.5 m-85 -124.19 153.72 41.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 111.189 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.864 ' OE2' HG12 ' A' ' 102' ' ' VAL . 4.2 mp0 -154.67 130.47 10.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.641 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.703 HG13 HD11 ' A' ' 118' ' ' LEU . 32.2 m -120.32 153.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.609 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -149.14 142.91 25.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.81 -26.28 21.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.728 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.03 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.5 m -86.4 153.93 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.276 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -67.02 165.47 15.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.03 -40.67 90.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -63.87 -46.06 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -75.07 -36.89 61.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.53 -48.16 50.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.401 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.459 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -62.99 -47.46 83.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.762 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -63.91 -48.63 75.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.6 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.59 -48.6 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.839 HD23 HG23 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -61.44 -30.9 70.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.395 179.489 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -40.2 61.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.69 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.9 mt -56.19 -38.93 56.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.643 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -63.28 -42.01 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -76.1 -21.51 75.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -58.06 -40.4 80.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.28 0.54 56.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.322 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.703 HD22 HD12 ' A' ' 42' ' ' ILE . 37.6 mt -84.32 153.07 62.16 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.724 0.297 . . . . 0.0 110.689 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 89.9 Cg_endo -86.88 22.67 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.817 2.345 . . . . 0.0 112.845 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.781 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -151.62 167.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.775 0.322 . . . . 0.0 111.268 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -79.31 137.41 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ALA . 21.2 p -139.31 154.56 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.67 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HG2' HD21 ' A' ' 37' ' ' LEU . 23.3 pttt -140.18 157.08 46.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 111.255 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.839 HG23 HD23 ' A' ' 118' ' ' LEU . 3.1 mm -84.76 139.18 17.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.429 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 5.0 m -149.51 131.0 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 112.079 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.532 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.34 165.76 17.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.012 178.577 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 27' ' ' VAL . 3.1 mtm105 -55.43 -0.29 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 133' ' ' ARG . 5.5 m-20 -162.77 27.37 0.1 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.6 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.552 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.54 94.12 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.737 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 3.9 m-85 -128.15 115.96 19.2 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.22 105.85 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.64 121.97 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.46 94.42 9.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -104.12 -172.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.82 179.976 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -115.44 86.5 15.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.49 -160.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.574 2.183 . . . . 0.0 112.226 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.46 104.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -177.38 123.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.45 103.32 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.56 78.42 1.26 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.92 156.34 44.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -93.94 141.66 28.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 158.66 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 139.61 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -63.46 123.18 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -119.05 -58.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.9 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.49 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 150.54 8.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.55 163.14 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -81.87 -27.55 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.91 36.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.05 155.68 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -77.47 -32.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -79.62 -179.78 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.41 1.72 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.99 138.65 3.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' HB3' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -75.23 178.21 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -147.63 118.35 7.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.862 179.269 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ALA . 14.3 t -31.82 -78.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.549 178.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 54.74 171.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.584 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HB3' ' CG ' ' A' ' 65' ' ' PHE . 7.4 m-85 62.42 -81.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.337 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -90.94 168.66 32.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.749 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 26.1 m-20 -69.81 -34.04 73.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.805 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.553 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.3 m-85 -111.59 171.15 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -152.52 128.66 2.55 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.572 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.0 tm? -91.2 111.53 23.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.134 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 101' ' ' ARG . 3.9 p -100.85 145.65 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.219 0.533 . . . . 0.0 112.124 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -96.57 113.71 25.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.112 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.3 mt -86.47 19.85 2.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 5.4 tt0 -164.07 144.16 6.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.235 . . . . 0.0 111.039 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' CD ' ' HD3' ' A' ' 99' ' ' PRO . 24.3 Cg_exo -63.31 133.83 42.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.54 2.16 . . . . 0.0 112.121 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -164.72 172.11 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.91 0.386 . . . . 0.0 111.645 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.4 ' HB3' HG21 ' A' ' 94' ' ' VAL . 28.5 m0 -113.02 114.72 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.68 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 68' ' ' ILE . 16.3 mm -88.13 117.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.83 171.08 15.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.007 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -59.14 -43.71 92.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -62.34 -41.08 98.29 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.021 -179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 42' ' ' ILE . 3.1 mt-30 -58.79 -34.46 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.979 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.853 HG23 HG21 ' A' ' 66' ' ' ILE . 12.4 mt -72.87 -49.08 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.517 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.78 ' O ' HG23 ' A' ' 52' ' ' VAL . 17.8 tp10 -83.12 -46.79 12.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.591 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -53.91 -46.87 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.74 95.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.021 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.889 ' HG2' HD12 ' A' ' 64' ' ' ILE . 4.4 ttp180 -60.2 -42.14 94.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 48' ' ' GLU . 45.2 t -57.91 -35.01 50.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -35.83 51.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.821 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.555 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 65.4 mtm -71.14 -51.3 25.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.94 -37.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -75.16 -29.39 60.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -64.62 -45.97 84.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.153 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.719 ' CD1' HG11 ' A' ' 109' ' ' VAL . 18.8 m-85 -53.85 106.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -68.57 -31.95 71.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -104.51 32.23 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.04 165.27 1.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.484 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.09 164.43 24.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.02 153.64 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 51' ' ' ARG . 3.3 mt -123.51 147.37 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' CG ' ' HB3' ' A' ' 29' ' ' PHE . 69.5 m-85 -114.09 109.45 18.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.542 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.853 HG21 HG23 ' A' ' 47' ' ' ILE . 4.0 mm -97.98 135.24 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.267 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -112.28 -30.81 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.595 HD12 HG21 ' A' ' 42' ' ' ILE . 39.8 pt -65.98 144.42 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -148.59 132.25 8.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.0 Cg_exo -65.23 134.05 37.66 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.446 2.097 . . . . 0.0 112.125 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.73 -52.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -67.06 135.24 93.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.9 155.35 23.23 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HD2' HG11 ' A' ' 94' ' ' VAL . 8.6 t80 -127.58 106.36 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.978 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 p -119.05 147.04 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -115.58 80.83 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -118.47 106.46 44.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.72 163.42 35.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.404 2.069 . . . . 0.0 112.227 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.59 104.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -151.12 157.15 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.59 141.89 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 60.48 94.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.9 ptp -96.33 159.72 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.47 110.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -106.44 -18.08 14.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.629 0.252 . . . . 0.0 111.21 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.06 -49.68 1.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 30.91 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.52 -179.07 52.57 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -117.54 114.12 22.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 90' ' ' VAL . 14.3 p -83.38 122.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.99 40.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.49 40.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -99.09 164.03 12.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.804 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.468 HG11 ' HD2' ' A' ' 74' ' ' TYR . 11.0 m -150.89 160.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.336 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.2 105.68 15.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 72' ' ' LYS . 5.2 t -60.58 130.75 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.43 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 98' ' ' LYS . 25.5 t -126.61 159.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.052 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 97' ' ' VAL . 19.8 mttt -130.68 156.94 79.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 9.4 Cg_endo -50.81 112.86 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.689 2.26 . . . . 0.0 112.076 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 102.24 34.13 4.33 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.232 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.539 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -114.85 119.18 35.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.735 -179.542 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.821 HG12 ' OE2' ' A' ' 105' ' ' GLU . 11.9 t -80.58 104.4 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.393 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.651 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -95.65 -29.52 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.127 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CD2' HD12 ' A' ' 66' ' ' ILE . 71.4 m-85 -124.38 154.21 40.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.478 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.821 ' OE2' HG12 ' A' ' 102' ' ' VAL . 2.5 mp0 -154.39 123.11 6.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 118' ' ' LEU . 34.6 m -111.71 158.3 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -155.87 143.01 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.38 -20.2 47.89 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.813 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.072 HG23 ' HB2' ' A' ' 114' ' ' ALA . 27.1 m -89.68 155.57 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.7 p -66.96 160.24 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.41 -34.97 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.5 -46.17 67.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.23 -35.99 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.103 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.072 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.58 -48.24 49.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.618 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmt -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.91 -48.37 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.888 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -56.48 -48.85 76.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.05 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -59.24 -33.24 70.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.366 179.643 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -74.52 -38.67 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.649 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 117' ' ' ALA . 32.1 mt -56.83 -41.25 75.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.607 179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.54 98.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -75.54 -22.3 75.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.508 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.55 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.671 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.5 1.33 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 122' ' ' GLY . 30.5 mt -84.52 155.75 62.42 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.669 0.271 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 98.5 Cg_endo -86.94 18.07 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.591 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -149.62 166.78 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -73.55 150.06 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 125' ' ' LEU . 57.3 p -149.73 146.82 27.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 37' ' ' LEU . 27.8 pttt -134.67 155.88 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.171 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 118' ' ' LEU . 3.2 mm -86.86 140.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.9 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 6.1 m -146.97 156.07 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 111.467 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -97.58 165.95 11.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.419 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 2.8 mtp-105 -42.49 86.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.86 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 133' ' ' ARG . 3.7 t70 68.41 40.58 1.97 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.601 179.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.604 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.83 94.87 4.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.815 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.9 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.4 m-85 -126.37 90.59 3.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.46 107.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.59 112.59 8.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.85 97.01 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.0 tp -104.55 51.65 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.5 mtp -111.51 95.19 25.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.34 -173.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.26 91.86 8.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -143.81 72.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.78 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -90.25 103.39 16.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.79 -34.42 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.56 122.54 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.788 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.51 115.36 24.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.56 110.59 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.55 22.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -106.54 140.66 39.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 62.48 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.96 -179.35 17.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.86 138.13 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.61 142.41 22.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -78.58 -27.5 45.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.65 166.31 7.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.47 126.11 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -131.71 -45.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.7 121.2 14.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.4 133.26 8.87 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.91 175.95 27.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -84.78 116.35 23.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' ALA . 2.0 t80 -100.13 93.3 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.953 HG23 ' OH ' ' A' ' 137' ' ' TYR . 17.0 t 43.86 -85.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.685 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.675 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 79.72 -69.34 0.11 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.459 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.05 154.8 17.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . 58.91 153.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.021 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -61.89 -32.68 73.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.998 0.428 . . . . 0.0 110.558 179.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -115.19 171.08 7.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.502 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.7 129.27 2.45 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.822 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 118' ' ' LEU . 2.2 tm? -91.38 101.87 14.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.592 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.5 p -92.8 142.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 111.947 -179.103 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB2' ' CE ' ' A' ' 103' ' ' MET . . . -93.67 108.82 20.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.449 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.571 HD21 ' HG2' ' A' ' 130' ' ' LYS . 11.2 mt -75.67 -0.92 22.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.089 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -142.04 151.38 58.91 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 126.87 9.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.166 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -158.65 171.98 19.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 111.568 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -105.16 126.04 51.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.692 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.627 HD12 HD22 ' A' ' 125' ' ' LEU . 21.6 mm -105.95 116.76 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.282 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -78.84 169.65 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.85 -42.47 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.703 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.93 -45.05 71.12 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 67.2 mm-40 -58.92 -34.82 72.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.685 0.279 . . . . 0.0 111.077 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.008 HG23 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.33 -51.0 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.625 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.1 tt0 -83.06 -46.12 13.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 111.622 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -56.24 -49.74 73.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.218 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLN . . . -64.01 -40.63 96.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.882 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.45 -43.85 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 48' ' ' GLU . 38.2 t -58.04 -43.22 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.51 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.5 ' HE3' HG21 ' A' ' 64' ' ' ILE . 64.4 mtm -71.11 -46.97 60.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.291 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 51' ' ' ARG . 43.2 t -56.83 -35.92 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -75.1 -29.51 60.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.137 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -62.33 -52.49 63.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 109' ' ' VAL . 20.8 m-85 -52.81 120.39 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 mtp-105 -62.36 -49.04 77.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.18 32.98 2.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.976 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.46 163.3 0.33 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.95 169.58 40.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -123.52 133.93 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.549 HG23 ' CG1' ' A' ' 106' ' ' VAL . 1.3 mt -117.04 118.39 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.08 109.35 20.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.479 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.008 HG21 HG23 ' A' ' 47' ' ' ILE . 6.7 mm -90.9 121.48 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -93.85 -29.66 15.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 103' ' ' MET . 33.4 pt -70.78 151.22 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 70' ' ' PRO . 0.9 OUTLIER -152.52 142.97 15.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.926 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 69' ' ' PHE . 74.1 Cg_endo -75.44 104.71 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.55 2.167 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.38 29.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.53 136.11 21.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.92 137.06 40.26 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.426 2.084 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CE1' ' HE2' ' A' ' 76' ' ' LYS . 4.1 t80 -107.7 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 p -119.27 127.32 53.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.119 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -103.96 31.17 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.887 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.69 156.46 35.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.87 164.53 31.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.513 2.142 . . . . 0.0 112.295 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.17 109.39 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.37 146.11 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG12 ' HG3' ' A' ' 82' ' ' ARG . 21.5 t -104.33 130.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG3' HG12 ' A' ' 81' ' ' VAL . 18.3 mtt-85 60.61 178.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.2 mtt 60.27 80.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.63 52.44 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.41 18.22 14.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.678 0.275 . . . . 0.0 111.19 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.93 -103.04 0.64 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.423 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.63 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.937 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.85 -51.87 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.555 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 38.67 86.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 91' ' ' GLU . 9.4 p -92.14 154.57 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 90' ' ' VAL . 33.5 mm-40 -95.55 43.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.14 -179.46 49.64 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.508 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -107.32 164.12 12.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 43' ' ' THR . 2.8 m -151.44 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.169 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.9 102.38 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.61 129.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.381 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 98' ' ' LYS . 6.5 t -126.55 159.65 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 97' ' ' VAL . 2.0 mtpp -130.65 160.08 67.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 11.2 Cg_endo -54.61 111.23 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.641 2.227 . . . . 0.0 111.999 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 104.5 30.35 5.0 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.193 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.592 ' N ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.44 122.61 45.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.83 0.348 . . . . 0.0 111.433 -179.53 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.682 HG21 ' H ' ' A' ' 27' ' ' VAL . 7.5 t -77.58 104.26 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.568 ' CE ' ' HB2' ' A' ' 36' ' ' ALA . 36.0 mtm -87.77 -28.35 21.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.471 -179.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 66' ' ' ILE . 51.9 m-85 -132.09 155.55 47.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 111.253 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -153.91 127.75 8.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.668 HG13 HD11 ' A' ' 118' ' ' LEU . 27.1 m -119.24 157.5 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.156 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.604 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -152.9 142.66 22.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.8 20.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.671 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.1 m -85.06 156.1 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 111.252 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p -66.96 163.15 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -39.76 86.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.91 -44.74 84.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -75.01 -36.29 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.017 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.39 -48.23 51.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -62.14 -50.69 70.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.693 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.45 -48.41 81.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.652 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.58 -48.86 78.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.59 -30.24 69.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.268 179.478 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 131' ' ' ILE . 18.1 mtm180 -74.65 -39.66 61.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 117' ' ' ALA . 42.7 mt -55.21 -39.66 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.81 79.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.85 -20.86 80.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -35.62 71.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.353 . . . . 0.0 110.847 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 4.91 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.627 HD22 HD12 ' A' ' 42' ' ' ILE . 25.6 mt -84.54 156.83 61.99 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.635 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 97.2 Cg_endo -87.15 16.0 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.77 2.313 . . . . 0.0 112.703 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.721 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -148.56 167.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.23 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 36' ' ' ALA . 68.7 p -142.56 145.63 33.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.571 ' HG2' HD21 ' A' ' 37' ' ' LEU . 28.0 pttt -132.76 153.03 51.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.269 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 118' ' ' LEU . 2.8 mm -84.9 138.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.41 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 4.6 m -148.96 127.88 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.951 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.543 ' H ' ' HB3' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.28 165.72 17.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.898 178.635 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.649 ' HA ' HG11 ' A' ' 27' ' ' VAL . 8.5 mtm105 -56.13 1.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 133' ' ' ARG . 2.3 m-20 -162.02 25.52 0.11 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.551 ' C ' ' CD1' ' A' ' 137' ' ' TYR . . . -115.71 94.19 4.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.953 ' OH ' HG23 ' A' ' 27' ' ' VAL . 4.3 m-85 -128.19 112.97 15.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.41 116.76 10.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.83 144.77 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.12 97.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.956 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -144.28 117.21 8.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mtt -109.87 81.84 2.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.91 136.88 17.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.547 2.165 . . . . 0.0 112.397 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.24 44.25 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -59.74 154.78 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ttp -103.02 167.63 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.5 109.07 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.972 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -121.35 -177.78 3.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.58 156.68 18.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 90.72 2.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -73.76 155.82 38.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 131.36 36.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -127.81 99.94 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.4 35.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.46 152.35 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -159.06 132.65 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -78.49 -27.52 46.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.21 87.77 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.586 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.67 149.59 22.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.46 99.86 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -111.77 -175.84 2.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.94 107.66 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.09 163.79 16.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -59.61 -177.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.792 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.807 ' O ' HG23 ' A' ' 27' ' ' VAL . 47.0 t80 -108.24 -98.94 0.37 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 26' ' ' TYR . 6.1 t -169.23 -77.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.003 0.43 . . . . 0.0 109.919 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 56.46 167.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.797 179.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CG ' ' A' ' 65' ' ' PHE . 2.5 m-85 66.01 -82.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 107' ' ' ALA . . . -100.73 166.94 19.57 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.87 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 -33.81 76.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.766 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 133' ' ' ARG . 11.5 m-85 -105.39 171.14 7.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.549 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 132' ' ' VAL . . . -157.73 130.76 2.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.969 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 118' ' ' LEU . 1.9 tm? -91.3 108.93 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 101' ' ' ARG . 2.8 p -99.09 144.16 12.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 112.003 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' PRO . . . -95.62 107.74 19.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.485 178.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 130' ' ' LYS . 8.9 mt -74.92 -2.57 27.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -142.43 152.37 60.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.72 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' GLU . 74.5 Cg_endo -75.39 136.35 19.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.151 . . . . 0.0 112.058 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 127' ' ' ILE . . . -165.54 172.02 12.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.022 0.439 . . . . 0.0 111.453 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.43 108.23 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.611 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.963 HD12 HD22 ' A' ' 125' ' ' LEU . 17.3 mm -83.87 123.24 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.84 171.83 14.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.77 96.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.734 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -59.46 -39.17 82.8 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.102 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.88 -34.55 71.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.95 -179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.972 HG23 HG21 ' A' ' 66' ' ' ILE . 24.9 mt -72.23 -48.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.614 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.2 tt0 -83.01 -47.33 11.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.426 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' GLN . . . -54.58 -46.68 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.05 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.34 94.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.17 -42.09 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.754 179.904 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 48' ' ' GLU . 35.1 t -58.97 -40.79 81.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.44 71.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.538 ' HE1' ' CD2' ' A' ' 104' ' ' PHE . 61.8 mtm -71.08 -48.63 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ARG . 44.5 t -56.91 -37.64 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.197 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -75.03 -29.42 60.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -64.38 -50.28 68.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 109' ' ' VAL . 23.3 m-85 -51.47 108.08 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.072 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -77.15 -32.82 56.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -98.25 33.0 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 109' ' ' VAL . . . 65.65 165.76 1.59 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.27 173.64 33.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.473 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 149.72 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.705 HD12 ' HG2' ' A' ' 51' ' ' ARG . 1.7 mt -118.73 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' CG ' ' CD1' ' A' ' 29' ' ' PHE . 52.5 m-85 -114.93 109.41 18.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.972 HG21 HG23 ' A' ' 47' ' ' ILE . 3.5 mm -95.95 138.32 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 -179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 29' ' ' PHE . 42.1 mmm-85 -113.5 -30.34 6.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 103' ' ' MET . 26.5 pt -63.56 143.91 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.242 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 1.8 t80 -144.59 125.6 7.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' PHE . 21.8 Cg_exo -65.13 128.45 20.6 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.537 2.158 . . . . 0.0 112.276 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -160.02 27.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 114.84 8.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB3' HG21 ' A' ' 90' ' ' VAL . 61.4 Cg_endo -72.83 117.4 5.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.392 2.062 . . . . 0.0 112.203 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD2' HG13 ' A' ' 94' ' ' VAL . 8.3 p90 -102.38 141.65 34.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.75 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 42.4 p -119.13 120.0 35.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -95.08 104.64 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.39 114.83 27.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.47 -31.77 21.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.41 2.073 . . . . 0.0 112.302 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -110.99 161.42 15.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -71.96 123.2 22.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.1 m -68.64 139.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.27 63.44 8.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.04 107.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 134.56 1.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.517 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -97.54 18.13 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.654 0.264 . . . . 0.0 111.167 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.06 139.84 6.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -140.52 34.01 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.43 -106.82 1.21 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.3 155.29 29.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.339 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 73' ' ' PRO . 14.9 p -81.41 138.14 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' ' CE1' ' A' ' 74' ' ' TYR . 51.9 mt-10 -82.19 73.71 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.34 -162.42 0.1 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.205 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.61 164.05 20.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.908 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG13 ' CD2' ' A' ' 74' ' ' TYR . 1.9 m -137.69 174.5 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.41 . . . . 0.0 111.272 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -122.43 102.43 8.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.562 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 96' ' ' VAL . 5.9 t -57.87 128.7 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.554 HG13 ' HG2' ' A' ' 101' ' ' ARG . 26.3 t -126.58 157.98 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.993 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -130.68 156.28 80.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.839 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 7.9 Cg_endo -50.21 119.41 4.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.724 2.283 . . . . 0.0 112.037 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . 95.81 32.56 6.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.948 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 97' ' ' VAL . 20.4 tpt180 -113.03 115.85 29.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 111.681 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 25' ' ' ASP . 19.8 t -83.28 95.73 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.494 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -86.8 -25.32 24.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.15 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.67 ' CE2' HD12 ' A' ' 66' ' ' ILE . 63.4 m-85 -124.23 150.08 45.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 102' ' ' VAL . 1.1 mp0 -152.07 127.14 9.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.624 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 118' ' ' LEU . 27.3 m -118.98 157.51 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 111.319 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . . . -151.56 142.84 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.87 12.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.705 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.094 HG23 ' HB2' ' A' ' 114' ' ' ALA . 35.9 m -83.66 152.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 111.275 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.4 p -66.93 164.82 16.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.45 -39.48 79.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.69 -45.45 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.162 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -75.1 -38.05 61.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.088 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -71.4 -48.25 50.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -62.18 -49.38 76.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.63 -48.58 78.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -57.54 -48.88 78.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.867 HD23 HG23 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -60.49 -30.62 69.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.403 179.48 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -74.53 -39.56 62.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.634 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 117' ' ' ALA . 40.3 mt -55.18 -39.81 52.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.92 94.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 125' ' ' LEU . . . -72.19 -21.94 79.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.476 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -40.56 81.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -88.95 0.81 56.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.328 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.963 HD22 HD12 ' A' ' 42' ' ' ILE . 34.9 mt -84.39 153.99 62.47 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.735 0.302 . . . . 0.0 110.541 179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.716 ' HG2' ' HB1' ' A' ' 40' ' ' ALA . 95.3 Cg_endo -87.46 23.14 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.855 2.37 . . . . 0.0 112.723 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.73 ' CG2' ' HB2' ' A' ' 40' ' ' ALA . 2.6 pp -152.26 167.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.796 0.331 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD2' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.51 132.65 35.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.278 -179.684 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 36' ' ' ALA . 17.3 p -135.42 154.38 51.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.605 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HG2' HD21 ' A' ' 37' ' ' LEU . 7.1 pttt -138.43 158.37 44.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.867 HG23 HD23 ' A' ' 118' ' ' LEU . 2.6 mm -84.95 136.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.672 179.756 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 137' ' ' TYR . 3.7 m -141.08 134.66 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -78.05 165.59 23.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.237 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HA ' HG21 ' A' ' 27' ' ' VAL . 43.7 mtt180 -47.73 90.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 133' ' ' ARG . 10.8 t0 73.11 38.35 0.7 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.442 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.603 ' C ' ' HD1' ' A' ' 137' ' ' TYR . . . -114.69 94.34 4.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.027 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 132' ' ' VAL . 1.8 m-85 -126.72 106.35 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.15 122.46 39.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.15 122.3 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.72 94.63 6.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.895 179.994 . . . . . . . . 0 0 . 1 stop_ save_